Abstract

Atrial fibrillation (Afib) can lead to life threatening conditions such as heart failure and stroke. During Afib treatment, clinicians aim to repress unusual electrical activity by electrically isolating the pulmonary veins (PV) from the left atrium (LA) using radiofrequency ablation. However, current clinical tools are limited in reliably assessing transmurality of the ablation lesions and detecting the presence of gaps within ablation lines, which can warrant repeat procedures. In this study, we developed an endoscopic multispectral reflectance imaging (eMSI) system for enhanced discrimination of tissue treatment at the PV junction. The system enables direct visualization of cardiac lesions through an endoscope at acquisition rates up to 25 Hz. Five narrowband, high-power LEDs were used to illuminate the sample (450, 530, 625, 810 and 940nm) and combinatory parameters were calculated based on their relative reflectance. A stitching algorithm was employed to generate large field-of-view, multispectral mosaics of the ablated PV junction from individual eMSI images. A total of 79 lesions from 15 swine hearts were imaged, ex vivo. Statistical analysis of the acquired five spectral data sets and ratiometric maps revealed significant differences between transmural lesions, non-transmural lesions around the venoatrial junctions, unablated posterior wall of left atrium tissue, and pulmonary vein (p < 0.0001). A pixel-based quadratic discriminant analysis classifier was applied to distinguish four tissue types: PV, untreated LA, non-transmural and transmural lesions. We demonstrate tissue type classification accuracies of 80.2% and 92.1% for non-transmural and transmural lesions, and 95.0% and 92.8% for PV and untreated LA sites, respectively. These findings showcase the potential of eMSI for lesion validation and may help to improve AFib treatment efficacy.

© 2019 Optical Society of America under the terms of the OSA Open Access Publishing Agreement

1. Introduction

Atrial fibrillation (AFib) is the most common arrhythmia and afflicts more than 2.2 million people-in the United States [1]. AFib can lead to life threatening conditions such as heart failure and stroke [2–4]. It is projected that over 5.6 million Americans will suffer from AFib by 2050 [5]. AFib can be treated through medication but with limited efficacy [6,7]. As an alternative, minimally invasive strategies such as catheter ablation are performed to restore sinus rhythm. In such cases, a catheter is inserted through the femoral vein and a transseptal puncture is used to advance the catheter to the left atrium to ablate areas of the myocardium that trigger abnormal electrical activity, primarily around the PV. Electrical signals generated from the PV reach the atrium through PV ostium [8]. Radio-frequency ablation and cryoablation therapy are common techniques used for PV isolation [9–11]. The success of catheter ablation therapies depends on creating transmural and continuous lesions around the PV [12,13]. Some studies have shown up to 46% of patients after PV isolation and linear ablation were free from AFib recurrences after their first treatment [14,15]. Currently, clinicians lack the intraprocedural imaging tools to visualize in real time, the precise location and depth of lesions. They indirectly monitor formation of ablation lesions through, drop in impedance, contact force, ablation time using force time integral from ablation catheter [16]. These measurements vary from procedure to procedure. Hence, direct assessment of lesion quality through endoscopic images may help improve distinguishing incomplete lesions and assessing ablation line continuity.

Several research groups have previously evaluated ablated cardiac tissue using experimental optical methods. Fiber based optical coherence tomography (OCT) enables visualization up to 1-mm imaging depth of treated myocardial tissue [17,18]. OCT with and without polarization contrast reliably distinguished ablation lesions and untreated tissue [18–21]. Recently, hyperspectral autofluorescence imaging was applied to analyze the reflected light from the endocardial and epicardial surface of left and right atrium [22–25]. Lesion contours were outlined using spectral changes under UV illumination. In Ahmed et al., visually guided RF ablation catheters directly showed discoloration of target tissue in vivo in patients with drug resistant CTI-dependent atrial flutter discoloration of the tissue [26]. These initial experiments laid the foundation of adapting endoscopic imaging for use during endocardial ablation procedures, in vivo. Other methods for evaluation of cardiac ablation transmurality include MRI, intracardiac ultrasound and endoscopic visualization. Several groups demonstrated real-time tracking of catheters using MRI [27–29]. This allows postprocedural visualization of lesion formation. Also, high frequency ultrasound was integrated into a catheter for real time analysis [30]. Alternatively, diffuse reflectance spectroscopy was studied to evaluate lesion quality [31–33]. They compare relative reflection spectra from changes in tissue composition. Since longer wavelengths penetrate deeper into the tissue, near-infrared spectroscopy can overcome depth limitations seen in OCT. Our group has previously proposed a method of real-time processing of wavelengths near the infrared range to reveal differences in ablated and unablated tissue, with estimated lesion depths up to 4 mm [32,33].

Optical spectroscopy has been widely utilized for characterization of pathological tissue on the basis that useful physiological information is reflected within tissue optical properties [34]. Figure 1 shows chromophore spectra of seven major cardiac chromophores from [34–36]. Absorption spectra of tissue can be expressed in a weighted sum [36,38,39]. The weighted sum of absorption spectra shifts after RF treatment since it changes tissue morphology and distribution of chromophore concentrations. Through inverse Monte Carlo simulations, absorption and scattering effects can be separated to reveal the composition of cardiac tissue [33,36,39]. RF-induced absorption changes have been linked to hemoglobin and myoglobin transforming into hemichromes, methemoglobin (metHb) and metmyoglobin (MMb) [40,41]. Reduced scattering spectra in ablated tissue is also elevated along the entire visible and near infrared range. Demos et al. analyzed spectral information of scattered light to show that ratio of spectral intensity at 910 nm over that at 710 nm monotonically changes with depth in bovine tissue [31]. While these methods have shown promise in lesion assessment, an endoscopic method may be better suited for identification of non-transmural lesions and gaps in linear ablation lines, a well-reported culprit for arrhythmia recurrence [16]. In this work, we present the development of an endoscopic multispectral reflectance imaging system (eMSI) for discriminating fully transmural lesions from normal and non-transmural ablation of the left atria porcine tissues. A pixel-based classification model is trained and validated in fresh swine samples ablated near the PV-left atrial wall junction.

 

Fig. 1 Dominant cardiac chromophores used to approximate a single absorption coefficient spectrum. All chromophores were found in published literature. Oxyhemoglobin (HbO2)a,  b&c; deoxyhemoglobin (Hb)a,  b&c; oxymyoglobin  (MbO2)a,  b&c; metmyoglobin  (MMb)a,  b&c; water  (H2O)a; hemichrome (HC)d and lipidb. .a obtained from [34]; .b obtained from [35]; .c obtained from [36].; .d obtained from [37].

Download Full Size | PPT Slide | PDF

2. Materials and methods

2.1 System design

The eMSI system mainly consists of a camera, endoscope, LED sources and a microcontroller. It uses a CMOS Camera (Hamamatsu Flash4.0LT, Hamamatsu City, Japan) and a USB3.0 interface board connection. A flexible fiber endoscope (Myriad Fiber Imaging Tech Inc, Dudley, Massachusetts) with 10,000 fibers and a viewing angle of 70° is connected to the camera. The camera can acquire images up to 2048 x 2048 pixels. Our data sets were binned by four to increase signal to noise ratio. When the camera is connected to the viewing port of the endoscope, the effective number of pixels are reduced to 172 x 172 pixels. The software instructs the camera to capture through USB connection. When the camera is directed to integrate, TTL exposure integration time signal is generated. This controls the timing for each image acquisition. The LEDs are controlled by the TTL signal sent to the microcontroller (Arduino UNO). At the falling edge of TTL signal, the microcontroller switches the LED to the next in the sequence.

LEDs are illuminated through the lighting port using a custom designed lens assembly. A plano-convex lens (LA1131-A, Thorlabs, NJ) was placed in front of collimated beam from the light source. The refracted beam is collimated back into the port of endoscope by a bi-convex lens (LB1494-A, Thorlabs, NJ) at 4.3cm away from the plano-convex lens. This lens assembly was designed through Zemax (Zemax LLC, Kirkland, WA) to maximize the throughput beam into the port of endoscope. Cagecubes with dichroic shortpass filters are used to align the beam paths to enable multispectral illumination. LED strobe pattern, TTL sequencing and image acquisition is controlled by a MATLAB graphical user interface.

Strong differences in biomolecular composition and ultrastructure has been shown in ablated myocardium [36,42]. Therefore, we selected wavelengths that showed largest variations in absorption while reducing scattering. For our system, wavelengths at 450 nm, 530 nm, 625 nm, 810 nm, and 940 nm were chosen. From Flock et al., we estimated penetration depth of each wavelengths selected in our system [43]. Approximate optical properties of μa and μ's were found from Swartling et al. μ's at 940 nm was estimated by interpolating and fitting the graph to a polynomial. μa at 940 nm was approximated by linearly decreased value from 900nm. 450nm was omitted since penetration depth is too small. As seen in Table 1, the longest wavelength penetrates approximately 3.42mm.

Tables Icon

Table 1. Optical depth penetration estimates from diffusion theory

Since the sampling depth of 450 nm is limited, the 450 nm channel is primary used to generate RGB images. Swartling et al. showed that the largest absorption coefficient (μa) differences between treated and untreated tissue was 40% and occurred near 630 nm and 490 nm bands. Additionally, the second largest μa difference was 20% centered at around 520 nm. Based on these differences, wavelength channels at 625 nm and 530 nm were selected to yield contrast between treated and untreated tissue, while constituting the red and green channels of the RGB image. Furthermore, the difference in reduced scattering coefficients show a constant difference in near-infrared range [36,42]. Also, in Fig. 1, 520 nm shows peaks of dominant chromophores, such as HbO2, MbO2, Mb, Hb and 630 nm exhibits second peak of MMb. Importance of these parameters are discussed in the introduction. Furthermore, approximately near 810nm is an isosbestic point for globin derivatives (HbO2, MbO2, Mb, Hb) and was selected to correspond roughly to sum globin contributions. Finally, 940 nm was selected due to a scattering dominated measurement as an alternative and additional contrast for distinguishing ablated tissue. From the acquired data, we analyzed the revealed features by comparing these major cardiac chromophores in Fig. 1.

2.2 Sample preparation

Total of 15 swine hearts from Green Village Packing Company (Green Village, New Jersey) were utilized. All the experiments were completed within 24 hours of sacrifice. In addition, a human heart was received from National Disease Research Interchange (NDRI): a donor with no known cardiovascular disease (66, Female). The heart was received within 24 hours of donor’s death and imaged within 48 hours of donor’s death. The purpose of the human heart is to show a proof-of-concept demonstration to showcase a potential for future clinical translation.

The dissected left atrium (LA) with PV intact is placed in a temperature-maintained phosphate buffered saline (PBS) bath at 37°sC with a pump to generate circulating and pulsatile flow. Each pulmonary vein was transected longitudinally and flattened to expose the veno-atrial junction. A set of non-irrigated lesions were delivered on the endocardial wall near the vein junction using a commercial 3.5mm radio-frequency catheter (Celsius Thermocool D curve uni-directional TC) and generator (Stockert 70, Biosense Webster, Diamond Bar, CA). To generate non-transmural and transmural lesions, the energy delivery duration was set between 15 and 60 seconds with constant target power set at 15W. A linear set of lesions with intentional gaps were created along the pulmonary vein. Bioelectrical impedance and delivered power were recorded for each lesion. For human heart sample, left atrium was ablated near the pulmonary vein using an irrigated catheter with normal saline under the same power setting as swine samples. The flow rate was at 30 ml/min.

The sample was placed 3.9 cm from the tip of the endoscope, as shown in Fig. 3. At this working distance, the diameter of field of view is 16.5 mm. After data acquisition, the center of each lesion was dissected in half. For swine hearts, one half was submerged in 1% triphenyltetrazolium chloride (TTC) vital stain for 40 minutes. TTC stains normal tissue in bright red and reveals damaged tissue, shown in Fig. 3(D). For histopathology assessment, the counter half of swine and all human samples were preserved in 10% formalin for 24 hours then transferred to 70% ethanol. They were stained with Hematoxylin and eosin and Masson’s Trichrome technique on adjacent 5μm sections. The samples were digitized using a digital microscope (Leica, Microsystems) and reviewed by a pathologist.

2.3 Data acquisition and processing

A reference datacube was taken on a spectrally flat 99% reflectance standard (AS-01161, Labsphere, NH) to account for system response and spatial distribution of light. Using the reflectance surface, exposure settings for each illumination is determined. The LED power is also tuned to avoid saturations. The peak quantum efficiency of CMOS camera is 83% at 600 nm and continues to decrease as wavelength increases. At 940 nm, quantum efficiency is 14%. Exposures are set to collect maximum reflectance signal without saturating the reference surface. Each image was predominantly aberrated by barrel distortion. The correction was applied to the distorted images as seen in Fig. 2(E) and 2(F) using digital image processing [44]. As magnification decreases with distance from the optical axis in barrel distortion, normalized scale is applied for distance away from center. Tissue samples were submerged in phosphate buffered saline (PBS) to reduce surface reflection. Although the system can acquire data up to 25Hz, the acquisition time was set at 6Hz for all experiments to maximize signal collection.

 

Fig. 2 A schematic diagram of endoscopic multispectral imaging system. The system is optically enclosed to block light interference during the experiment. A) shows reference data set of spectrally flat reflectance surface. B) displays raw data of ablated tissue with three lesions taken with the system. Two lesions are shown with light concentrated on the center but are hard to locate exactly all three lesions. In C), normalized image of swine left atrial tissue with three lesions is shown. D) shows distortion corrected image. Since it is difficult to see the correction, a sample grid is shown in E) and F). Image magnification decreases with distance from the center.

Download Full Size | PPT Slide | PDF

 

Fig. 3 Experiment procedure and sample preparation flow chart is shown. In A), Fresh swine hearts are retrieved and placed on ice prior to experiment. The pulmonary veins were dissected free from the rest of the heart B) shows experimental setup used for creating lesions using commercial radio-frequency ablation system under phosphate buffered saline. C) displays lesions with gaps created along the pulmonary vein. Image data set acquired from endoscopic multispectral imaging system. Tissue samples are submerged under warm PBS and laid flat as possible. One data set includes images from five specific wavelength channels: 450 nm, 550nm, 625 nm, 810 nm, and 940 nm. D) represents gross pathology of lesion cross-section stained in TTC vital stain and shows Masson’s Trichrome stating of transmural lesion. Dash line highlights the areas of tissue necrosis.

Download Full Size | PPT Slide | PDF

After barrel distortion correction, images were overlaid and stitched together to create large field-of-view mosaics of the ablated PV region. First, circular endoscopic images are squarely cropped. Then, the translated lesion location X and Y points are located and blended together using a previously published multiband blending algorithm [45,46]. Multiband blending is a technique that divides the original image into multiple bands with different weights. Overlapping bands are smoothed by linear combination of different weights. A motorized stage was placed underneath the sample container. The stage was translated in 5mm increments in both directions. The surface area of the stitched samples ranged from 75 to 375 cm2.The stitched images are again checked for any existing saturations from surface reflectance. Saturated pixels were omitted during data processing.

2.4 Classification of tissue types

From five spectral channels, our goal was to categorize tissue types and detect undertreated sites, including lesion gaps. In this work, quadratic discriminant analysis (QDA) was used to classify each pixel values into four classes: normal tissue, pulmonary vein, non-transmural and transmural lesions. Since the relative reflectance may have low variances between classes, quadratic decision boundary allowed less strict feature covariance matrices. The performance of the classifier was assessed using leave-one-out cross-validation (LOOCV) within MATLAB.

To label classes, RGB colored images were created by compositing 3 wavelength channels: 450 nm, 530 nm, 625 nm. Transmural and non-transmural ablated left atrial tissue, non-ablated left atrial tissue and pulmonary vein were manually segmented using the RGB reference image. Lesions were segmented in elliptical shapes since most ablations performed with radio-frequency catheter are oval shaped [47]. Normal tissue and pulmonary veins are parted in similar size to create consistent sample sets. Areas that were not part of atrial tissue were manually segmented out. The main data processing procedure is shown in Fig. 4.

 

Fig. 4 Flow chart of main data processing procedure. Images are first calibrated using reference data set and are corrected for barrel distortion and saturation. Images are stitched to create one full data set for each LA sample. Images are manually segmented for each tissue types using RGB image. Classifier is tested and validated using leave-one-out cross validation (LOOCV).

Download Full Size | PPT Slide | PDF

2.5 Statistical analysis

Analysis of variance (ANOVA) with multiple comparison test was used as statistical model to detect differences between the four tissue classes. P-values less than 0.05 were considered significant. The analysis was executed in Prism 7 (GraphPad Software, San Diego, California).

3. Results

3.1 Spectral analysis of acquired images

Swine data consisted of 79 lesion sets from 15 swine left atria (LA). 15 non-transmural and 64 transmural ablation lesions were created using commercial RF ablation system. Also, 61 different areas of normal tissue and 48 pulmonary vein samples were segmented. In Fig. 5, stitched left atrium data set with two lesions is shown. Figure 5(B) and 5(C) clearly highlights the pulmonary vein, thickened endocardium, and lesions with a dark core in the middle. We observed that the tissue surface shows a dark appearance in some ablated samples, which have previously been referred to as the lesion core [40,48]. This coagulum region is an area of acute, potentially irreversible damage. In Fig. 5(E) and 5(F), lesions show less contrast with surrounding tissue and the absence of the darker centers at longer wavelengths. Also, pulmonary vein does not show strong reflectance as seen in Fig. 5(B) and 5(C).

 

Fig. 5 Aberration corrected and stitched swine LA tissue sample. A) shows RGB composite image of swine sample with 2 ablated lesions: 1 transmural and 1 non-transmural lesions. B) and C) channel illuminates pulmonary vein and thick endocardium. Lesion contours show high reflectance, but the cores are heavily absorbent. D) shows contrast between the lesion core and the periphery but does not show significant contrast in PV. E) and F) channels reflect less around PV and lesions do not show cores. A full data set includes all five spectral data.

Download Full Size | PPT Slide | PDF

3.2 Statistical analysis of various tissue types and classification using quadratic discriminant analysis

Statistical comparisons of transmural (T), non-transmural (NT), normal (N) tissue and pulmonary vein (PV) in each wavelength channels are shown in Fig. 6. To reduce data redundancy, the mean values of segmented area were used to compare tissue types. In 450nm channel, PV showed significant differences between T, NT and N. In 530nm, only N, NT and T, NT pairs weren’t significant. 625 nm channel had the fewest statistically significant pairs. Both 810 nm and 940 nm channels showed identical significant pairs (T, PV and T, N pairs). In all wavelength channels, statistical differences in transmural and non-transmural data are not shown. The depth of treated tissue depends on myocardium thickness. Same depth may be transmural in one sample, but non-transmural in a thicker sample. Therefore, statistical analysis hints raw spectral data may be insufficient to differentiate between non-transmural and transmural.

 

Fig. 6 Statistical analysis of five wavelength-specific data. Mean relative reflectance values of each segmented normal tissue, pulmonary vein, transmural, and non-transmural lesions were analyzed using ANOVA with Turkey’s multiple comparison test. The number of samples for all tissue types are as follows: 64 transmural, 15 non-transmural lesions, 48 pulmonary vein, 61 normal regions. Boxes represent mean and standard deviations and whiskers indicate the range for each reflectance channel. ** (p < 0.01), *** (p < 0.001), **** (p < 0.0001)

Download Full Size | PPT Slide | PDF

Initially, the QDA classifier was used to distinguish tissue types based on five spectral features. Pixel values were classified as normal tissue, pulmonary vein, non-transmural or transmural lesions. Classification accuracy with leave-one out cross validation (LOOCV) is shown in Table 2. The classifier was capable of distinguishing normal tissue (93.7%), pulmonary vein (95.7%), and transmural (94.2%) with high accuracy. However, non-transmural lesions had low classification accuracy (58.41%) with highest error from mislabeled normal tissue.

Tables Icon

Table 2. Confusion matrix of QDA classifier based on reflectance

The purpose of our system is to improve the procedure outcome by reducing the possibility of Afib recurrences due to non-transmural lesions. Therefore, it is critical to identify the differences between non-transmural and transmural lesions. To improve the accuracy of non-transmural and transmural lesions, we statistically analyzed the ratios of all wavelength reflectance combinations. The two ratiometric reflectance maps at 625 nm over that at 940 nm and at 530 nm over that at 450 nm, generated the most significant pairs, shown in Fig. 7. Ratio of reflectance at 625 nm over that at 940nm, which we label as lesion optical index one (LOI1), generates p < 0.01 between NT and T, which was not seen previously in raw spectral data. Also, ratio of reflectance at 530 nm over that at 450 nm (LOI2) shows most significant pairs. Equations for LOI1 and LOI2 are shown below.

 

Fig. 7 Statistical analysis of LOI1 and LOI2 is shown at the top. Two pairs show the most significant pairs out of all ratiometric parameters. Boxes represent mean and standard deviations and whiskers indicate the range for each reflectance channel. ** (p < 0.01), *** (p < 0.001), **** (p < 0.0001). The ratiometric maps of LOI1 and LOI2 are presented at the bottom.

Download Full Size | PPT Slide | PDF

LOI1=625nm940nm#
LOI2=530nm450nm#

Significance of LOI1 is shown in our group’s previous work, where we established lesion optical indices (LOI) to define spectral differences ablated and unablated tissue and have shown real-time tissue spectra classification and lesion size estimation [33]. In Singh-Moon et al., LOI1 is described as the quotient given by spectral intensity at 964 nm divided by that at 616 nm [33]. Computing the ratio is a common practice. Demos et al. reported that spectral ratio method led to a parameter that monotonically changed with depth of RF ablation lesions on bovine hearts. In Fig. 7, ratiometric maps of LOI1 reveal all lesions along with pulmonary vein. Transmural lesions generally showed a distinctive darkened core surrounded by a bright halo, whereas non-transmural lesions are uniformly enhanced.

After training the QDA classifier with five spectral data along with two lesion optical indices, the classifier distinguished normal tissue (92.8%), pulmonary vein (95.9%), transmural (92.0%), and non-transmural (80.2%) with higher accuracy seen in Table 3. Most importantly, we saw significant improvements in non-transmural lesion classification accuracy by 22%. Also, misclassifications of non-transmural lesions to transmural lesions and normal tissue were reduced by 9% and 17%, respectively.

Tables Icon

Table 3. Confusion matrix of QDA classifier based on reflectance and LOI features

In Fig. 8, labeled tissue types of two LA samples are reconstructed. The algorithm detects gaps between two lesions in Fig. 8(G). Lesion gaps can potentially provide pathways for abnormal electrical activities. Therefore, identifying gaps is crucial for improving procedure success rate. Probability distributions of PV and N class in Fig. 8(B) and Fig. 8(C) display high confidence in the classified area. Also, normal tissue around the ablated regions have lower probability shown in Fig. 8(C). Transmural and non-transmural lesions are clearly identified in Fig. 8(D) and 8(E), respectively. Probability distribution of non-transmural lesions shows that lesion peripheries have a high likelihood of being non-transmural probability. This was confirmed through histological assessment.

 

Fig. 8 Reconstructed classified image with probability distributions from each tissue type. (A-F) shows an example set with lesion line formed along the PV. A) shows RGB image captured through the system with appropriate labels. B) Pixel by pixel QDA classifier identifies where pulmonary vein exists. C) illustrates normal tissue’s probability distribution of the classifier. D) and E) are probability distributions of transmural and non-transmural lesions respectively. In F), each pixel values are classified to a corresponding tissue type. (G-L) shows direct comparison study of transmural and non-transmural lesions.

Download Full Size | PPT Slide | PDF

An LA sample with transmural and non-transmural lesions is shown in Fig. 8(G). Figures 8(H-L) highlights the differences in non-transmural and transmural lesions. Generally, it was observed that permanently injured tissue exhibits a distinct core. However, non-transmural lesion also shows similar attributes in Fig. 8(G). This particular sample had a thicker myocardium layer, which was shown in histology. Although myocardium thickness varies in each sample, our classifier successfully identified this location as non-transmural lesion based on the provided spectral information.

In this work, all swine lesions were ablated using non-irrigated catheters. However, most RF ablations are now performed using irrigated catheters. As a preliminary data, a human heart from National Disease Research Interchange (NDRI) was imaged under our system. In Fig. 9, a heart of donor with no previous heart disease was imaged. The left atrium was ablated near the pulmonary vein using saline irrigated catheters. In Fig. 9(A), lesions are difficult to locate using only a camera image because of thick endocardium within the human left atrium. The contrast between ablated and unablated is low compared to swine samples. Spectral reflectance images of the PV region is shown in Fig. 10(B-D). In Fig. 10(G), LOI1 clearly unveiled the location of irrigated lesions, which were hard to visualize in the camera image (Fig. 9(A)). In the human sample, there is less distinction between the thick endocardium and myocardium as previously seen in swine samples in LOI2.

 

Fig. 9 A) shows a human left atrium captured with digital camera (Nikon). Three irrigated transmural lesions are generated using RF catheter with saline port. B) represents histology of transmural lesion. Ablated areas are more purple relative to normal tissue. C) shows histology of normal tissue. Thicker endocardium is shown in human sample.

Download Full Size | PPT Slide | PDF

 

Fig. 10 A) is an RGB composite image of human LA tissue sample with three irrigated lesions. B-F are the five spectral channels collected through our optical system. In all wavelength channels, irrigated lesions are difficult to locate without LOIs. In G), LOI1 parameter highlights the three irrigated lesions that weren’t visible within individual wavelength channels shown in B-F. Also, gap between two lesions is clearly viewed. In H), LOI2 map bears little to no lesion contrast.

Download Full Size | PPT Slide | PDF

4. Discussion

In this work, we show that direct visualization of cardiac lesions using an endoscope can effectively distinguish lesions, normal tissue and pulmonary vein with high accuracy (Table 3). By choosing specific wavelength channels for our system, collected reflectance spectra displayed significant spectral features, which classified transmural lesions with accuracy of 93.67%.

Previously, ex vivo rat heart samples were excited with UV illumination and imaged through hyperspectral benchtop system [22–24]. The sampling depth of UV light is limiting since lower wavelengths cannot penetrate more than a millimeter into the tissue. Therefore, deep lesions are difficult to analyze using surface reflectance. By using both visible and near-infrared wavelength channels, we demonstrated that distinctive features were revealed in different tissue types. From our relative reflectance measurements, the features are extracted from complex interaction between absorption and scattering properties. Both absorbing chromophores and increasing size of scattering structures influence the data collected through our optical system.

Reflectance collected by our system depends on the interplay between scattering, absorption, and our optical configuration. Prior studies report both an increase in tissue scattering as well as absorption in response to thermal treatment. In Celik et al, an iron assay was used to measure the concentration of ferric and ferrous iron in the lesion core and in untreated cardiac samples [40]. The authors detected a substantial increase in ferric iron which they attributed to the formation of MetHb and MMb species. Optically, this transition would cause an increase in spectral regions where Met derivatives are more absorbing then their ferrous counterparts. Because this change is more expressed within the core and less on the periphery, this leads to a darker appearance in the center of transmural lesions. In non- transmural lesions, this effect was similarly observed in some cases and not observed in more superficially treated cases. In Fig. 5, peripheral regions surrounding ablated tissue increased in reflectance compared to normal tissue in all five spectral channels. Shorter wavelength maps in Fig. 5B and 5C showed decreased reflectance in the center of ablated tissue. However, wavelengths near the infrared showed subtle contrast between the lesion core and lesion periphery as scattering remains the dominant transport parameter. In both Table 2 and Table 3, the classifier parted normal, pulmonary vein, and transmural lesions with high precision. However, with the addition of two ratiometric indices (LOIs), classification accuracy of non-transmural lesions increased significantly. LOI1 maps (Fig. 7) help to differentiate lesions from other tissue types. On the other hand, LOI2 reduces lesion contrast and highlights complex myocardial and endocardial features in the left atrium.

LOI1 ratiometric maps show contrast between ablated and normal tissue. In these maps, heavily treated tissues generally displayed lower values in the core. This phenomenon may be attributed to increased absorption in the ablated tissue divided by increased scattering in both ablated and normal tissue. Number of groups have observed changes in the underlying physiological and molecular properties during ablation therapy. Biomolecular properties, such as absorption and scattering coefficients, are complex parameters that interact with light. In Swartling et al., absorption spectra of ablated tissue was reported higher in 500~600 nm range and also in at 635 nm [36]. This phenomenon can be explained through increase in MMb concentration. Extracted concentration of MMb in normal tissue increased from 32 μmol dm3 to 137 μmol dm3 after ablation [36]. It was also found that there was an increase of Fe(III) concentration in ablated tissue compared to normal tissue, which is related to Mb and MMb presence [40]. In our setup, scattering is likely to increase reflectance proportionally. In Thomsen et al, reduced scattering increased in heated tissue compared to normal tissue under yellow (594 nm) and red (634 nm) light. It was also reported that the reduced scattering of ablated tissue was higher than non-ablated tissue throughout the visible and near infrared regions [36,38,49].

Given the small sample size of non-transmural lesions (n = 15) and the variation in reflectance observed within the normal tissue class (transparent vs opaque endocardium), classification accuracy may further improve by increasing the number of non-transmural lesions. Additionally, since we generalize ablated area as non-transmural or transmural based on a single lesion cross-section, histology of multiple lesion cross-sections may help to more accurately assess treatment severity.

By limiting the number of wavelengths, our system can acquire spectral datacubes at 6 Hz and can potentially acquire up to 25 Hz with lower exposure settings. Although a full bandwidth of spectral data may provide more information, the added acquisition time is not feasible for in vivo implementation. Since heart rate can vary widely, quick acquisition is crucial to capture motionless data sets in vivo. Yet, the current data acquisition speed is prone to severe motion artifacts in vivo. One way to improve acquisition speed closer to real-time operation is to use a faster microcontroller. To accomplish this, an optimization of exposure time and illumination power will need to be conducted to ensure adequate signal intensity.

Currently, the majority of data were collected from swine heart samples. Although normal swine samples show similar anatomy to human hearts, left atrial samples from human donors with prior cardiovascular disease show complex fibrosis and increased endocardial thickness [20,46]. Also, relative reflectance measurements from swine samples have different values compared to those from human. When human samples are classified using the same classifier trained on swine samples, most normal tissue sites were thus labeled as pulmonary vein, likely due to the thicker endocardium. Trichrome histology of the human sample also confirmed a thicker endocardium compared to swine samples. Nonetheless, in Fig. 10G, LOI1 showed promise in distinguishing lesions from the rest in human atrial sample. Although human and porcine hearts are inherently different, the same lesion optical index displayed significant contrast by decreasing intensity values in treated areas. Further studies are aimed at collecting more human data to characterize the thick endocardium, fibrosis, and adipose sites. In vivo translation will require displacement of blood between the tissue surface and endoscopic fibers. The technical feasibilities for these modifications have been demonstrated in endoscopic systems designed to guide laser ablation therapy utilizing a balloon for blood displacement [10,50]. A model based on ex vivo human samples will help build a platform for initial in vivo deployment.

5. Conclusion

In closing, an optical system and methods to discern endocardial lesions were presented based on endoscopic multispectral imaging. A QDA classifier was developed which showed strong accuracies in distinguishing between four cardiac tissue types (normal tissue, PV, non-transmural and transmural lesions) given inputs of wavelength-specific reflectance and ratiometric maps. Accurate assessment of transmural lesions could aid in uncovering areas that require further treatment or targeting discontinuities in ablation lines to improve the procedural efficacy of cardiac ablation therapy.

Funding

National Institute of Health (NIH 1DP2HL127776-01); National Science Foundation (1454365).

Disclosures

The authors declare that there are no conflicts of interest related to this article.

References

1. W. M. Feinberg, J. L. Blackshear, A. Laupacis, R. Kronmal, and R. G. Hart, “Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications,” Arch. Intern. Med. 155(5), 469–473 (1995). [CrossRef]   [PubMed]  

2. P. A. Wolf, R. D. Abbott, and W. B. Kannel, “Atrial fibrillation as an independent risk factor for stroke: the Framingham Study,” Stroke 22(8), 983–988 (1991). [CrossRef]   [PubMed]  

3. E. J. Benjamin, P. A. Wolf, R. B. D’Agostino, H. Silbershatz, W. B. Kannel, and D. Levy, “Impact of atrial fibrillation on the risk of death: the Framingham Heart Study,” Circulation 98(10), 946–952 (1998). [CrossRef]   [PubMed]  

4. “Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials,” Arch. Intern. Med.154(13), 1449–1457 (1994). [CrossRef]   [PubMed]  

5. A. S. Go, E. M. Hylek, K. A. Phillips, Y. Chang, L. E. Henault, J. V. Selby, and D. E. Singer, “Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study,” JAMA 285(18), 2370–2375 (2001). [CrossRef]   [PubMed]  

6. P. Jaïs, D. C. Shah, M. Haïssaguerre, A. Takahashi, T. Lavergne, M. Hocini, S. Garrigue, S. S. Barold, P. Le Métayer, and J. Clémenty, “Efficacy and safety of septal and left-atrial linear ablation for atrial fibrillation,” Am. J. Cardiol. 84(9), 139R–146R (1999). [CrossRef]   [PubMed]  

7. E. Pokushalov, A. Romanov, G. Corbucci, S. Artyomenko, V. Baranova, A. Turov, N. Shirokova, A. Karaskov, S. Mittal, and J. S. Steinberg, “A randomized comparison of pulmonary vein isolation with versus without concomitant renal artery denervation in patients with refractory symptomatic atrial fibrillation and resistant hypertension,” J. Am. Coll. Cardiol. 60(13), 1163–1170 (2012). [CrossRef]   [PubMed]  

8. N. Pérez-Castellano, J. Villacastín, J. Salinas, M. Vega, J. Moreno, M. Doblado, E. Ruiz, and C. Macaya, “Epicardial connections between the pulmonary veins and left atrium: relevance for atrial fibrillation ablation,” J. Cardiovasc. Electrophysiol. 22(2), 149–159 (2011). [PubMed]  

9. M. Antz, K. R. Chun, F. Ouyang, and K. H. Kuck, “Ablation of atrial fibrillation in humans using a balloon-based ablation system: identification of the site of phrenic nerve damage using pacing maneuvers and CARTO,” J. Cardiovasc. Electrophysiol. 17(11), 1242–1245 (2006). [CrossRef]   [PubMed]  

10. A. Garan, A. Al-Ahmad, T. Mihalik, C. Cartier, L. Capuano, D. Holtan, C. Song, M. K. Homoud, M. S. Link, N. A. Estes 3rd, and P. J. Wang, “Cryoablation of the pulmonary veins using a novel balloon catheter,” J. Interv. Card. Electrophysiol. 15(2), 79–81 (2006). [CrossRef]   [PubMed]  

11. V. Y. Reddy, C. Houghtaling, J. Fallon, G. Fischer, N. Farr, J. Clarke, J. McIntyre, E. Sinofsky, J. N. Ruskin, and D. Keane, “Use of a diode laser balloon ablation catheter to generate circumferential pulmonary venous lesions in an open-thoracotomy caprine model,” Pacing Clin. Electrophysiol. 27(1), 52–57 (2004). [CrossRef]   [PubMed]  

12. E. Leshem, I. Zilberman, C. M. Tschabrunn, M. Barkagan, F. M. Contreras-Valdes, A. Govari, and E. Anter, “High-Power and Short-Duration Ablation for Pulmonary Vein Isolation: Biophysical Characterization,” JACC Clin. Electrophysiol. 4(4), 467–479 (2018). [CrossRef]   [PubMed]  

13. M. A. Mitchell, I. D. McRury, T. H. Everett, H. Li, J. M. Mangrum, and D. E. Haines, “Morphological and physiological characteristics of discontinuous linear atrial ablations during atrial pacing and atrial fibrillation,” J. Cardiovasc. Electrophysiol. 10(3), 378–386 (1999). [CrossRef]   [PubMed]  

14. A. Verma, C. Y. Jiang, T. R. Betts, J. Chen, I. Deisenhofer, R. Mantovan, L. Macle, C. A. Morillo, W. Haverkamp, R. Weerasooriya, J. P. Albenque, S. Nardi, E. Menardi, P. Novak, P. Sanders, and STAR AF II Investigators, “Approaches to catheter ablation for persistent atrial fibrillation,” N. Engl. J. Med. 372(19), 1812–1822 (2015). [CrossRef]   [PubMed]  

15. A. N. Ganesan, N. J. Shipp, A. G. Brooks, P. Kuklik, D. H. Lau, H. S. Lim, T. Sullivan, K. C. Roberts-Thomson, and P. Sanders, “Long-term outcomes of catheter ablation of atrial fibrillation: a systematic review and meta-analysis,” J. Am. Heart Assoc. 2(2), e004549 (2013). [CrossRef]   [PubMed]  

16. M. A. Wood, “Exposing gaps in linear radiofrequency lesions: form before function,” Circ Arrhythm Electrophysiol 4(3), 257–259 (2011). [CrossRef]   [PubMed]  

17. C. P. Fleming, K. J. Quan, H. Wang, G. Amit, and A. M. Rollins, “In vitro characterization of cardiac radiofrequency ablation lesions using optical coherence tomography,” Opt. Express 18(3), 3079–3092 (2010). [CrossRef]   [PubMed]  

18. X. Yao, Y. Gan, Y. Ling, C. C. Marboe, and C. P. Hendon, “Multicontrast endomyocardial imaging by single-channel high-resolution cross-polarization optical coherence tomography,” J. Biophotonics 11(4), e201700204 (2018). [CrossRef]   [PubMed]  

19. X. Fu, Z. Wang, H. Wang, Y. T. Wang, M. W. Jenkins, and A. M. Rollins, “Fiber-optic catheter-based polarization-sensitive OCT for radio-frequency ablation monitoring,” Opt. Lett. 39(17), 5066–5069 (2014). [CrossRef]   [PubMed]  

20. Y. Gan, D. Tsay, S. B. Amir, C. C. Marboe, and C. P. Hendon, “Automated classification of optical coherence tomography images of human atrial tissue,” J. Biomed. Opt. 21(10), 101407 (2016). [CrossRef]   [PubMed]  

21. C. P. Fleming, N. Rosenthal, A. M. Rollins, and M. M. Arruda, “First in vivo real-time imaging of endocardial radiofrequency ablation by optical coherence tomography: Implications on safety and the birth of “electrostructuralsubstrate-guided ablation”,” Innovations in Cardiac Rhythm Management 2, 199–201 (2011).

22. D. A. Gil, L. M. Swift, H. Asfour, N. Muselimyan, M. A. Mercader, and N. A. Sarvazyan, “Autofluorescence hyperspectral imaging of radiofrequency ablation lesions in porcine cardiac tissue,” J. Biophotonics 10(8), 1008–1017 (2017). [CrossRef]   [PubMed]  

23. N. Muselimyan, L. M. Swift, H. Asfour, T. Chahbazian, R. Mazhari, M. A. Mercader, and N. A. Sarvazyan, “Seeing the Invisible: Revealing Atrial Ablation Lesions Using Hyperspectral Imaging Approach,” PLoS One 11(12), e0167760 (2016). [CrossRef]   [PubMed]  

24. L. M. Swift, H. Asfour, N. Muselimyan, C. Larson, K. Armstrong, and N. A. Sarvazyan, “Hyperspectral imaging for label-free in vivo identification of myocardial scars and sites of radiofrequency ablation lesions,” Heart Rhythm 15(4), 564–575 (2018). [CrossRef]   [PubMed]  

25. M. Mercader, L. Swift, S. Sood, H. Asfour, M. Kay, and N. Sarvazyan, “Use of endogenous NADH fluorescence for real-time in situ visualization of epicardial radiofrequency ablation lesions and gaps,” Am. J. Physiol. Heart Circ. Physiol. 302(10), H2131–H2138 (2012). [CrossRef]   [PubMed]  

26. H. Ahmed, P. Neuzil, J. Skoda, J. Petru, L. Sediva, S. Kralovec, and V. Y. Reddy, “Initial clinical experience with a novel visualization and virtual electrode radiofrequency ablation catheter to treat atrial flutter,” Heart Rhythm 8(3), 361–367 (2011). [CrossRef]   [PubMed]  

27. R. J. Lederman, M. A. Guttman, D. C. Peters, R. B. Thompson, J. M. Sorger, A. J. Dick, V. K. Raman, and E. R. McVeigh, “Catheter-based endomyocardial injection with real-time magnetic resonance imaging,” Circulation 105(11), 1282–1284 (2002). [CrossRef]   [PubMed]  

28. S. Nazarian, A. Kolandaivelu, M. M. Zviman, G. R. Meininger, R. Kato, R. C. Susil, A. Roguin, T. L. Dickfeld, H. Ashikaga, H. Calkins, R. D. Berger, D. A. Bluemke, A. C. Lardo, and H. R. Halperin, “Feasibility of real-time magnetic resonance imaging for catheter guidance in electrophysiology studies,” Circulation 118(3), 223–229 (2008). [CrossRef]   [PubMed]  

29. G. R. Vergara, S. Vijayakumar, E. G. Kholmovski, J. J. Blauer, M. A. Guttman, C. Gloschat, G. Payne, K. Vij, N. W. Akoum, M. Daccarett, C. J. McGann, R. S. Macleod, and N. F. Marrouche, “Real-time magnetic resonance imaging-guided radiofrequency atrial ablation and visualization of lesion formation at 3 Tesla,” Heart Rhythm 8(2), 295–303 (2011). [CrossRef]   [PubMed]  

30. M. Wright, E. Harks, S. Deladi, F. Suijver, M. Barley, A. van Dusschoten, S. Fokkenrood, F. Zuo, F. Sacher, M. Hocini, M. Haïssaguerre, and P. Jaïs, “Real-time lesion assessment using a novel combined ultrasound and radiofrequency ablation catheter,” Heart Rhythm 8(2), 304–312 (2011). [CrossRef]   [PubMed]  

31. S. G. Demos and S. Sharareh, “Real time assessment of RF cardiac tissue ablation with optical spectroscopy,” Opt. Express 16(19), 15286–15296 (2008). [CrossRef]   [PubMed]  

32. R. P. Singh-Moon, C. C. Marboe, and C. P. Hendon, “Near-infrared spectroscopy integrated catheter for characterization of myocardial tissues: preliminary demonstrations to radiofrequency ablation therapy for atrial fibrillation,” Biomed. Opt. Express 6(7), 2494–2511 (2015). [CrossRef]   [PubMed]  

33. R. P. Singh-Moon, X. Yao, V. Iyer, C. Marboe, W. Whang, and C. P. Hendon, “Real-time optical spectroscopic monitoring of non-irrigated lesion progression within atrial and ventricular tissues,” J. Biophotonics 12, 201800144 (2018). [PubMed]  

34. S. L. Jacques, “Optical properties of biological tissues: a review,” Phys. Med. Biol. 58(11), R37–R61 (2013). [CrossRef]   [PubMed]  

35. W. J. Bowen, “The absorption spectra and extinction coefficients of myoglobin,” J. Biol. Chem. 179(1), 235–245 (1949). [PubMed]  

36. J. Swartling, S. Pålsson, P. Platonov, S. B. Olsson, and S. Andersson-Engels, “Changes in tissue optical properties due to radio-frequency ablation of myocardium,” Med. Biol. Eng. Comput. 41(4), 403–409 (2003). [CrossRef]   [PubMed]  

37. R. H. Bremmer, A. Nadort, T. G. van Leeuwen, M. J. van Gemert, and M. C. Aalders, “Age estimation of blood stains by hemoglobin derivative determination using reflectance spectroscopy,” Forensic Sci. Int. 206(1-3), 166–171 (2011). [CrossRef]   [PubMed]  

38. A. M. Nilsson, G. W. Lucassen, W. Verkruysse, S. Andersson-Engels, and M. J. van Gemert, “Changes in optical properties of human whole blood in vitro due to slow heating,” Photochem. Photobiol. 65(2), 366–373 (1997). [CrossRef]   [PubMed]  

39. A. M. Nilsson, C. Sturesson, D. L. Liu, and S. Andersson-Engels, “Changes in spectral shape of tissue optical properties in conjunction with laser-induced thermotherapy,” Appl. Opt. 37(7), 1256–1267 (1998). [CrossRef]   [PubMed]  

40. H. Celik, V. Ramanan, J. Barry, S. Ghate, V. Leber, S. Oduneye, Y. Gu, M. Jamali, N. Ghugre, J. A. Stainsby, M. Shurrab, E. Crystal, and G. A. Wright, “Intrinsic contrast for characterization of acute radiofrequency ablation lesions,” Circ Arrhythm Electrophysiol 7(4), 718–727 (2014). [CrossRef]   [PubMed]  

41. S. Iskander-Rizk, P. Kruizinga, A. F. W. van der Steen, and G. van Soest, “Spectroscopic photoacoustic imaging of radiofrequency ablation in the left atrium,” Biomed. Opt. Express 9(3), 1309–1322 (2018). [CrossRef]   [PubMed]  

42. S. Thomsen, “Microscopic correlates of macroscopic optical property changes during thermal coagulation of myocardium,” Proc. Soc. Photo-Opt 1202, 2–10 (1990).

43. S. T. Flock, M. S. Patterson, B. C. Wilson, and D. R. Wyman, “Monte Carlo modeling of light propagation in highly scattering tissue--I: Model predictions and comparison with diffusion theory,” IEEE Trans. Biomed. Eng. 36(12), 1162–1168 (1989). [CrossRef]   [PubMed]  

44. J. de Vries, “Barrel and pincushion lens distortion correction,” MATLAB Central File Exchange (2012).

45. Y. Gan, W. Yao, K. M. Myers, J. Y. Vink, R. J. Wapner, and C. P. Hendon, “Analyzing three-dimensional ultrastructure of human cervical tissue using optical coherence tomography,” Biomed. Opt. Express 6(4), 1090–1108 (2015). [CrossRef]   [PubMed]  

46. T. H. Lye, V. Iyer, C. C. Marboe, and C. P. Hendon, “Mapping the human pulmonary venoatrial junction with optical coherence tomography,” Biomed. Opt. Express 10(2), 434–448 (2019). [CrossRef]   [PubMed]  

47. S. N. Goldberg, G. S. Gazelle, E. F. Halpern, W. J. Rittman, P. R. Mueller, and D. I. Rosenthal, “Radiofrequency tissue ablation: importance of local temperature along the electrode tip exposure in determining lesion shape and size,” Acad. Radiol. 3(3), 212–218 (1996). [CrossRef]   [PubMed]  

48. S. Nath, J. P. DiMarco, and D. E. Haines, “Basic aspects of radiofrequency catheter ablation,” J. Cardiovasc. Electrophysiol. 5(10), 863–876 (1994). [CrossRef]   [PubMed]  

49. R. Splinter, R. H. Svenson, L. Littmann, J. R. Tuntelder, C. H. Chuang, G. P. Tatsis, and M. Thompson, “Optical properties of normal, diseased, and laser photocoagulated myocardium at the Nd: YAG wavelength,” Lasers Surg. Med. 11(2), 117–124 (1991). [CrossRef]   [PubMed]  

50. S. R. Dukkipati, F. Cuoco, I. Kutinsky, A. Aryana, T. D. Bahnson, D. Lakkireddy, I. Woollett, Z. F. Issa, A. Natale, V. Y. Reddy, and HeartLight Study Investigators, “Pulmonary Vein Isolation Using the Visually Guided Laser Balloon: A Prospective, Multicenter, and Randomized Comparison to Standard Radiofrequency Ablation,” J. Am. Coll. Cardiol. 66(12), 1350–1360 (2015). [CrossRef]   [PubMed]  

References

  • View by:
  • |
  • |
  • |

  1. W. M. Feinberg, J. L. Blackshear, A. Laupacis, R. Kronmal, and R. G. Hart, “Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications,” Arch. Intern. Med. 155(5), 469–473 (1995).
    [Crossref] [PubMed]
  2. P. A. Wolf, R. D. Abbott, and W. B. Kannel, “Atrial fibrillation as an independent risk factor for stroke: the Framingham Study,” Stroke 22(8), 983–988 (1991).
    [Crossref] [PubMed]
  3. E. J. Benjamin, P. A. Wolf, R. B. D’Agostino, H. Silbershatz, W. B. Kannel, and D. Levy, “Impact of atrial fibrillation on the risk of death: the Framingham Heart Study,” Circulation 98(10), 946–952 (1998).
    [Crossref] [PubMed]
  4. “Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials,” Arch. Intern. Med.154(13), 1449–1457 (1994).
    [Crossref] [PubMed]
  5. A. S. Go, E. M. Hylek, K. A. Phillips, Y. Chang, L. E. Henault, J. V. Selby, and D. E. Singer, “Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study,” JAMA 285(18), 2370–2375 (2001).
    [Crossref] [PubMed]
  6. P. Jaïs, D. C. Shah, M. Haïssaguerre, A. Takahashi, T. Lavergne, M. Hocini, S. Garrigue, S. S. Barold, P. Le Métayer, and J. Clémenty, “Efficacy and safety of septal and left-atrial linear ablation for atrial fibrillation,” Am. J. Cardiol. 84(9), 139R–146R (1999).
    [Crossref] [PubMed]
  7. E. Pokushalov, A. Romanov, G. Corbucci, S. Artyomenko, V. Baranova, A. Turov, N. Shirokova, A. Karaskov, S. Mittal, and J. S. Steinberg, “A randomized comparison of pulmonary vein isolation with versus without concomitant renal artery denervation in patients with refractory symptomatic atrial fibrillation and resistant hypertension,” J. Am. Coll. Cardiol. 60(13), 1163–1170 (2012).
    [Crossref] [PubMed]
  8. N. Pérez-Castellano, J. Villacastín, J. Salinas, M. Vega, J. Moreno, M. Doblado, E. Ruiz, and C. Macaya, “Epicardial connections between the pulmonary veins and left atrium: relevance for atrial fibrillation ablation,” J. Cardiovasc. Electrophysiol. 22(2), 149–159 (2011).
    [PubMed]
  9. M. Antz, K. R. Chun, F. Ouyang, and K. H. Kuck, “Ablation of atrial fibrillation in humans using a balloon-based ablation system: identification of the site of phrenic nerve damage using pacing maneuvers and CARTO,” J. Cardiovasc. Electrophysiol. 17(11), 1242–1245 (2006).
    [Crossref] [PubMed]
  10. A. Garan, A. Al-Ahmad, T. Mihalik, C. Cartier, L. Capuano, D. Holtan, C. Song, M. K. Homoud, M. S. Link, N. A. Estes, and P. J. Wang, “Cryoablation of the pulmonary veins using a novel balloon catheter,” J. Interv. Card. Electrophysiol. 15(2), 79–81 (2006).
    [Crossref] [PubMed]
  11. V. Y. Reddy, C. Houghtaling, J. Fallon, G. Fischer, N. Farr, J. Clarke, J. McIntyre, E. Sinofsky, J. N. Ruskin, and D. Keane, “Use of a diode laser balloon ablation catheter to generate circumferential pulmonary venous lesions in an open-thoracotomy caprine model,” Pacing Clin. Electrophysiol. 27(1), 52–57 (2004).
    [Crossref] [PubMed]
  12. E. Leshem, I. Zilberman, C. M. Tschabrunn, M. Barkagan, F. M. Contreras-Valdes, A. Govari, and E. Anter, “High-Power and Short-Duration Ablation for Pulmonary Vein Isolation: Biophysical Characterization,” JACC Clin. Electrophysiol. 4(4), 467–479 (2018).
    [Crossref] [PubMed]
  13. M. A. Mitchell, I. D. McRury, T. H. Everett, H. Li, J. M. Mangrum, and D. E. Haines, “Morphological and physiological characteristics of discontinuous linear atrial ablations during atrial pacing and atrial fibrillation,” J. Cardiovasc. Electrophysiol. 10(3), 378–386 (1999).
    [Crossref] [PubMed]
  14. A. Verma, C. Y. Jiang, T. R. Betts, J. Chen, I. Deisenhofer, R. Mantovan, L. Macle, C. A. Morillo, W. Haverkamp, R. Weerasooriya, J. P. Albenque, S. Nardi, E. Menardi, P. Novak, P. Sanders, and STAR AF II Investigators, “Approaches to catheter ablation for persistent atrial fibrillation,” N. Engl. J. Med. 372(19), 1812–1822 (2015).
    [Crossref] [PubMed]
  15. A. N. Ganesan, N. J. Shipp, A. G. Brooks, P. Kuklik, D. H. Lau, H. S. Lim, T. Sullivan, K. C. Roberts-Thomson, and P. Sanders, “Long-term outcomes of catheter ablation of atrial fibrillation: a systematic review and meta-analysis,” J. Am. Heart Assoc. 2(2), e004549 (2013).
    [Crossref] [PubMed]
  16. M. A. Wood, “Exposing gaps in linear radiofrequency lesions: form before function,” Circ Arrhythm Electrophysiol 4(3), 257–259 (2011).
    [Crossref] [PubMed]
  17. C. P. Fleming, K. J. Quan, H. Wang, G. Amit, and A. M. Rollins, “In vitro characterization of cardiac radiofrequency ablation lesions using optical coherence tomography,” Opt. Express 18(3), 3079–3092 (2010).
    [Crossref] [PubMed]
  18. X. Yao, Y. Gan, Y. Ling, C. C. Marboe, and C. P. Hendon, “Multicontrast endomyocardial imaging by single-channel high-resolution cross-polarization optical coherence tomography,” J. Biophotonics 11(4), e201700204 (2018).
    [Crossref] [PubMed]
  19. X. Fu, Z. Wang, H. Wang, Y. T. Wang, M. W. Jenkins, and A. M. Rollins, “Fiber-optic catheter-based polarization-sensitive OCT for radio-frequency ablation monitoring,” Opt. Lett. 39(17), 5066–5069 (2014).
    [Crossref] [PubMed]
  20. Y. Gan, D. Tsay, S. B. Amir, C. C. Marboe, and C. P. Hendon, “Automated classification of optical coherence tomography images of human atrial tissue,” J. Biomed. Opt. 21(10), 101407 (2016).
    [Crossref] [PubMed]
  21. C. P. Fleming, N. Rosenthal, A. M. Rollins, and M. M. Arruda, “First in vivo real-time imaging of endocardial radiofrequency ablation by optical coherence tomography: Implications on safety and the birth of “electrostructuralsubstrate-guided ablation”,” Innovations in Cardiac Rhythm Management 2, 199–201 (2011).
  22. D. A. Gil, L. M. Swift, H. Asfour, N. Muselimyan, M. A. Mercader, and N. A. Sarvazyan, “Autofluorescence hyperspectral imaging of radiofrequency ablation lesions in porcine cardiac tissue,” J. Biophotonics 10(8), 1008–1017 (2017).
    [Crossref] [PubMed]
  23. N. Muselimyan, L. M. Swift, H. Asfour, T. Chahbazian, R. Mazhari, M. A. Mercader, and N. A. Sarvazyan, “Seeing the Invisible: Revealing Atrial Ablation Lesions Using Hyperspectral Imaging Approach,” PLoS One 11(12), e0167760 (2016).
    [Crossref] [PubMed]
  24. L. M. Swift, H. Asfour, N. Muselimyan, C. Larson, K. Armstrong, and N. A. Sarvazyan, “Hyperspectral imaging for label-free in vivo identification of myocardial scars and sites of radiofrequency ablation lesions,” Heart Rhythm 15(4), 564–575 (2018).
    [Crossref] [PubMed]
  25. M. Mercader, L. Swift, S. Sood, H. Asfour, M. Kay, and N. Sarvazyan, “Use of endogenous NADH fluorescence for real-time in situ visualization of epicardial radiofrequency ablation lesions and gaps,” Am. J. Physiol. Heart Circ. Physiol. 302(10), H2131–H2138 (2012).
    [Crossref] [PubMed]
  26. H. Ahmed, P. Neuzil, J. Skoda, J. Petru, L. Sediva, S. Kralovec, and V. Y. Reddy, “Initial clinical experience with a novel visualization and virtual electrode radiofrequency ablation catheter to treat atrial flutter,” Heart Rhythm 8(3), 361–367 (2011).
    [Crossref] [PubMed]
  27. R. J. Lederman, M. A. Guttman, D. C. Peters, R. B. Thompson, J. M. Sorger, A. J. Dick, V. K. Raman, and E. R. McVeigh, “Catheter-based endomyocardial injection with real-time magnetic resonance imaging,” Circulation 105(11), 1282–1284 (2002).
    [Crossref] [PubMed]
  28. S. Nazarian, A. Kolandaivelu, M. M. Zviman, G. R. Meininger, R. Kato, R. C. Susil, A. Roguin, T. L. Dickfeld, H. Ashikaga, H. Calkins, R. D. Berger, D. A. Bluemke, A. C. Lardo, and H. R. Halperin, “Feasibility of real-time magnetic resonance imaging for catheter guidance in electrophysiology studies,” Circulation 118(3), 223–229 (2008).
    [Crossref] [PubMed]
  29. G. R. Vergara, S. Vijayakumar, E. G. Kholmovski, J. J. Blauer, M. A. Guttman, C. Gloschat, G. Payne, K. Vij, N. W. Akoum, M. Daccarett, C. J. McGann, R. S. Macleod, and N. F. Marrouche, “Real-time magnetic resonance imaging-guided radiofrequency atrial ablation and visualization of lesion formation at 3 Tesla,” Heart Rhythm 8(2), 295–303 (2011).
    [Crossref] [PubMed]
  30. M. Wright, E. Harks, S. Deladi, F. Suijver, M. Barley, A. van Dusschoten, S. Fokkenrood, F. Zuo, F. Sacher, M. Hocini, M. Haïssaguerre, and P. Jaïs, “Real-time lesion assessment using a novel combined ultrasound and radiofrequency ablation catheter,” Heart Rhythm 8(2), 304–312 (2011).
    [Crossref] [PubMed]
  31. S. G. Demos and S. Sharareh, “Real time assessment of RF cardiac tissue ablation with optical spectroscopy,” Opt. Express 16(19), 15286–15296 (2008).
    [Crossref] [PubMed]
  32. R. P. Singh-Moon, C. C. Marboe, and C. P. Hendon, “Near-infrared spectroscopy integrated catheter for characterization of myocardial tissues: preliminary demonstrations to radiofrequency ablation therapy for atrial fibrillation,” Biomed. Opt. Express 6(7), 2494–2511 (2015).
    [Crossref] [PubMed]
  33. R. P. Singh-Moon, X. Yao, V. Iyer, C. Marboe, W. Whang, and C. P. Hendon, “Real-time optical spectroscopic monitoring of non-irrigated lesion progression within atrial and ventricular tissues,” J. Biophotonics 12, 201800144 (2018).
    [PubMed]
  34. S. L. Jacques, “Optical properties of biological tissues: a review,” Phys. Med. Biol. 58(11), R37–R61 (2013).
    [Crossref] [PubMed]
  35. W. J. Bowen, “The absorption spectra and extinction coefficients of myoglobin,” J. Biol. Chem. 179(1), 235–245 (1949).
    [PubMed]
  36. J. Swartling, S. Pålsson, P. Platonov, S. B. Olsson, and S. Andersson-Engels, “Changes in tissue optical properties due to radio-frequency ablation of myocardium,” Med. Biol. Eng. Comput. 41(4), 403–409 (2003).
    [Crossref] [PubMed]
  37. R. H. Bremmer, A. Nadort, T. G. van Leeuwen, M. J. van Gemert, and M. C. Aalders, “Age estimation of blood stains by hemoglobin derivative determination using reflectance spectroscopy,” Forensic Sci. Int. 206(1-3), 166–171 (2011).
    [Crossref] [PubMed]
  38. A. M. Nilsson, G. W. Lucassen, W. Verkruysse, S. Andersson-Engels, and M. J. van Gemert, “Changes in optical properties of human whole blood in vitro due to slow heating,” Photochem. Photobiol. 65(2), 366–373 (1997).
    [Crossref] [PubMed]
  39. A. M. Nilsson, C. Sturesson, D. L. Liu, and S. Andersson-Engels, “Changes in spectral shape of tissue optical properties in conjunction with laser-induced thermotherapy,” Appl. Opt. 37(7), 1256–1267 (1998).
    [Crossref] [PubMed]
  40. H. Celik, V. Ramanan, J. Barry, S. Ghate, V. Leber, S. Oduneye, Y. Gu, M. Jamali, N. Ghugre, J. A. Stainsby, M. Shurrab, E. Crystal, and G. A. Wright, “Intrinsic contrast for characterization of acute radiofrequency ablation lesions,” Circ Arrhythm Electrophysiol 7(4), 718–727 (2014).
    [Crossref] [PubMed]
  41. S. Iskander-Rizk, P. Kruizinga, A. F. W. van der Steen, and G. van Soest, “Spectroscopic photoacoustic imaging of radiofrequency ablation in the left atrium,” Biomed. Opt. Express 9(3), 1309–1322 (2018).
    [Crossref] [PubMed]
  42. S. Thomsen, “Microscopic correlates of macroscopic optical property changes during thermal coagulation of myocardium,” Proc. Soc. Photo-Opt 1202, 2–10 (1990).
  43. S. T. Flock, M. S. Patterson, B. C. Wilson, and D. R. Wyman, “Monte Carlo modeling of light propagation in highly scattering tissue--I: Model predictions and comparison with diffusion theory,” IEEE Trans. Biomed. Eng. 36(12), 1162–1168 (1989).
    [Crossref] [PubMed]
  44. J. de Vries, “Barrel and pincushion lens distortion correction,” MATLAB Central File Exchange (2012).
  45. Y. Gan, W. Yao, K. M. Myers, J. Y. Vink, R. J. Wapner, and C. P. Hendon, “Analyzing three-dimensional ultrastructure of human cervical tissue using optical coherence tomography,” Biomed. Opt. Express 6(4), 1090–1108 (2015).
    [Crossref] [PubMed]
  46. T. H. Lye, V. Iyer, C. C. Marboe, and C. P. Hendon, “Mapping the human pulmonary venoatrial junction with optical coherence tomography,” Biomed. Opt. Express 10(2), 434–448 (2019).
    [Crossref] [PubMed]
  47. S. N. Goldberg, G. S. Gazelle, E. F. Halpern, W. J. Rittman, P. R. Mueller, and D. I. Rosenthal, “Radiofrequency tissue ablation: importance of local temperature along the electrode tip exposure in determining lesion shape and size,” Acad. Radiol. 3(3), 212–218 (1996).
    [Crossref] [PubMed]
  48. S. Nath, J. P. DiMarco, and D. E. Haines, “Basic aspects of radiofrequency catheter ablation,” J. Cardiovasc. Electrophysiol. 5(10), 863–876 (1994).
    [Crossref] [PubMed]
  49. R. Splinter, R. H. Svenson, L. Littmann, J. R. Tuntelder, C. H. Chuang, G. P. Tatsis, and M. Thompson, “Optical properties of normal, diseased, and laser photocoagulated myocardium at the Nd: YAG wavelength,” Lasers Surg. Med. 11(2), 117–124 (1991).
    [Crossref] [PubMed]
  50. S. R. Dukkipati, F. Cuoco, I. Kutinsky, A. Aryana, T. D. Bahnson, D. Lakkireddy, I. Woollett, Z. F. Issa, A. Natale, V. Y. Reddy, and HeartLight Study Investigators, “Pulmonary Vein Isolation Using the Visually Guided Laser Balloon: A Prospective, Multicenter, and Randomized Comparison to Standard Radiofrequency Ablation,” J. Am. Coll. Cardiol. 66(12), 1350–1360 (2015).
    [Crossref] [PubMed]

2019 (1)

2018 (5)

X. Yao, Y. Gan, Y. Ling, C. C. Marboe, and C. P. Hendon, “Multicontrast endomyocardial imaging by single-channel high-resolution cross-polarization optical coherence tomography,” J. Biophotonics 11(4), e201700204 (2018).
[Crossref] [PubMed]

E. Leshem, I. Zilberman, C. M. Tschabrunn, M. Barkagan, F. M. Contreras-Valdes, A. Govari, and E. Anter, “High-Power and Short-Duration Ablation for Pulmonary Vein Isolation: Biophysical Characterization,” JACC Clin. Electrophysiol. 4(4), 467–479 (2018).
[Crossref] [PubMed]

R. P. Singh-Moon, X. Yao, V. Iyer, C. Marboe, W. Whang, and C. P. Hendon, “Real-time optical spectroscopic monitoring of non-irrigated lesion progression within atrial and ventricular tissues,” J. Biophotonics 12, 201800144 (2018).
[PubMed]

L. M. Swift, H. Asfour, N. Muselimyan, C. Larson, K. Armstrong, and N. A. Sarvazyan, “Hyperspectral imaging for label-free in vivo identification of myocardial scars and sites of radiofrequency ablation lesions,” Heart Rhythm 15(4), 564–575 (2018).
[Crossref] [PubMed]

S. Iskander-Rizk, P. Kruizinga, A. F. W. van der Steen, and G. van Soest, “Spectroscopic photoacoustic imaging of radiofrequency ablation in the left atrium,” Biomed. Opt. Express 9(3), 1309–1322 (2018).
[Crossref] [PubMed]

2017 (1)

D. A. Gil, L. M. Swift, H. Asfour, N. Muselimyan, M. A. Mercader, and N. A. Sarvazyan, “Autofluorescence hyperspectral imaging of radiofrequency ablation lesions in porcine cardiac tissue,” J. Biophotonics 10(8), 1008–1017 (2017).
[Crossref] [PubMed]

2016 (2)

Y. Gan, D. Tsay, S. B. Amir, C. C. Marboe, and C. P. Hendon, “Automated classification of optical coherence tomography images of human atrial tissue,” J. Biomed. Opt. 21(10), 101407 (2016).
[Crossref] [PubMed]

N. Muselimyan, L. M. Swift, H. Asfour, T. Chahbazian, R. Mazhari, M. A. Mercader, and N. A. Sarvazyan, “Seeing the Invisible: Revealing Atrial Ablation Lesions Using Hyperspectral Imaging Approach,” PLoS One 11(12), e0167760 (2016).
[Crossref] [PubMed]

2015 (4)

Y. Gan, W. Yao, K. M. Myers, J. Y. Vink, R. J. Wapner, and C. P. Hendon, “Analyzing three-dimensional ultrastructure of human cervical tissue using optical coherence tomography,” Biomed. Opt. Express 6(4), 1090–1108 (2015).
[Crossref] [PubMed]

S. R. Dukkipati, F. Cuoco, I. Kutinsky, A. Aryana, T. D. Bahnson, D. Lakkireddy, I. Woollett, Z. F. Issa, A. Natale, V. Y. Reddy, and HeartLight Study Investigators, “Pulmonary Vein Isolation Using the Visually Guided Laser Balloon: A Prospective, Multicenter, and Randomized Comparison to Standard Radiofrequency Ablation,” J. Am. Coll. Cardiol. 66(12), 1350–1360 (2015).
[Crossref] [PubMed]

A. Verma, C. Y. Jiang, T. R. Betts, J. Chen, I. Deisenhofer, R. Mantovan, L. Macle, C. A. Morillo, W. Haverkamp, R. Weerasooriya, J. P. Albenque, S. Nardi, E. Menardi, P. Novak, P. Sanders, and STAR AF II Investigators, “Approaches to catheter ablation for persistent atrial fibrillation,” N. Engl. J. Med. 372(19), 1812–1822 (2015).
[Crossref] [PubMed]

R. P. Singh-Moon, C. C. Marboe, and C. P. Hendon, “Near-infrared spectroscopy integrated catheter for characterization of myocardial tissues: preliminary demonstrations to radiofrequency ablation therapy for atrial fibrillation,” Biomed. Opt. Express 6(7), 2494–2511 (2015).
[Crossref] [PubMed]

2014 (2)

H. Celik, V. Ramanan, J. Barry, S. Ghate, V. Leber, S. Oduneye, Y. Gu, M. Jamali, N. Ghugre, J. A. Stainsby, M. Shurrab, E. Crystal, and G. A. Wright, “Intrinsic contrast for characterization of acute radiofrequency ablation lesions,” Circ Arrhythm Electrophysiol 7(4), 718–727 (2014).
[Crossref] [PubMed]

X. Fu, Z. Wang, H. Wang, Y. T. Wang, M. W. Jenkins, and A. M. Rollins, “Fiber-optic catheter-based polarization-sensitive OCT for radio-frequency ablation monitoring,” Opt. Lett. 39(17), 5066–5069 (2014).
[Crossref] [PubMed]

2013 (2)

S. L. Jacques, “Optical properties of biological tissues: a review,” Phys. Med. Biol. 58(11), R37–R61 (2013).
[Crossref] [PubMed]

A. N. Ganesan, N. J. Shipp, A. G. Brooks, P. Kuklik, D. H. Lau, H. S. Lim, T. Sullivan, K. C. Roberts-Thomson, and P. Sanders, “Long-term outcomes of catheter ablation of atrial fibrillation: a systematic review and meta-analysis,” J. Am. Heart Assoc. 2(2), e004549 (2013).
[Crossref] [PubMed]

2012 (2)

M. Mercader, L. Swift, S. Sood, H. Asfour, M. Kay, and N. Sarvazyan, “Use of endogenous NADH fluorescence for real-time in situ visualization of epicardial radiofrequency ablation lesions and gaps,” Am. J. Physiol. Heart Circ. Physiol. 302(10), H2131–H2138 (2012).
[Crossref] [PubMed]

E. Pokushalov, A. Romanov, G. Corbucci, S. Artyomenko, V. Baranova, A. Turov, N. Shirokova, A. Karaskov, S. Mittal, and J. S. Steinberg, “A randomized comparison of pulmonary vein isolation with versus without concomitant renal artery denervation in patients with refractory symptomatic atrial fibrillation and resistant hypertension,” J. Am. Coll. Cardiol. 60(13), 1163–1170 (2012).
[Crossref] [PubMed]

2011 (7)

C. P. Fleming, N. Rosenthal, A. M. Rollins, and M. M. Arruda, “First in vivo real-time imaging of endocardial radiofrequency ablation by optical coherence tomography: Implications on safety and the birth of “electrostructuralsubstrate-guided ablation”,” Innovations in Cardiac Rhythm Management 2, 199–201 (2011).

N. Pérez-Castellano, J. Villacastín, J. Salinas, M. Vega, J. Moreno, M. Doblado, E. Ruiz, and C. Macaya, “Epicardial connections between the pulmonary veins and left atrium: relevance for atrial fibrillation ablation,” J. Cardiovasc. Electrophysiol. 22(2), 149–159 (2011).
[PubMed]

G. R. Vergara, S. Vijayakumar, E. G. Kholmovski, J. J. Blauer, M. A. Guttman, C. Gloschat, G. Payne, K. Vij, N. W. Akoum, M. Daccarett, C. J. McGann, R. S. Macleod, and N. F. Marrouche, “Real-time magnetic resonance imaging-guided radiofrequency atrial ablation and visualization of lesion formation at 3 Tesla,” Heart Rhythm 8(2), 295–303 (2011).
[Crossref] [PubMed]

H. Ahmed, P. Neuzil, J. Skoda, J. Petru, L. Sediva, S. Kralovec, and V. Y. Reddy, “Initial clinical experience with a novel visualization and virtual electrode radiofrequency ablation catheter to treat atrial flutter,” Heart Rhythm 8(3), 361–367 (2011).
[Crossref] [PubMed]

M. A. Wood, “Exposing gaps in linear radiofrequency lesions: form before function,” Circ Arrhythm Electrophysiol 4(3), 257–259 (2011).
[Crossref] [PubMed]

R. H. Bremmer, A. Nadort, T. G. van Leeuwen, M. J. van Gemert, and M. C. Aalders, “Age estimation of blood stains by hemoglobin derivative determination using reflectance spectroscopy,” Forensic Sci. Int. 206(1-3), 166–171 (2011).
[Crossref] [PubMed]

M. Wright, E. Harks, S. Deladi, F. Suijver, M. Barley, A. van Dusschoten, S. Fokkenrood, F. Zuo, F. Sacher, M. Hocini, M. Haïssaguerre, and P. Jaïs, “Real-time lesion assessment using a novel combined ultrasound and radiofrequency ablation catheter,” Heart Rhythm 8(2), 304–312 (2011).
[Crossref] [PubMed]

2010 (1)

2008 (2)

S. G. Demos and S. Sharareh, “Real time assessment of RF cardiac tissue ablation with optical spectroscopy,” Opt. Express 16(19), 15286–15296 (2008).
[Crossref] [PubMed]

S. Nazarian, A. Kolandaivelu, M. M. Zviman, G. R. Meininger, R. Kato, R. C. Susil, A. Roguin, T. L. Dickfeld, H. Ashikaga, H. Calkins, R. D. Berger, D. A. Bluemke, A. C. Lardo, and H. R. Halperin, “Feasibility of real-time magnetic resonance imaging for catheter guidance in electrophysiology studies,” Circulation 118(3), 223–229 (2008).
[Crossref] [PubMed]

2006 (2)

M. Antz, K. R. Chun, F. Ouyang, and K. H. Kuck, “Ablation of atrial fibrillation in humans using a balloon-based ablation system: identification of the site of phrenic nerve damage using pacing maneuvers and CARTO,” J. Cardiovasc. Electrophysiol. 17(11), 1242–1245 (2006).
[Crossref] [PubMed]

A. Garan, A. Al-Ahmad, T. Mihalik, C. Cartier, L. Capuano, D. Holtan, C. Song, M. K. Homoud, M. S. Link, N. A. Estes, and P. J. Wang, “Cryoablation of the pulmonary veins using a novel balloon catheter,” J. Interv. Card. Electrophysiol. 15(2), 79–81 (2006).
[Crossref] [PubMed]

2004 (1)

V. Y. Reddy, C. Houghtaling, J. Fallon, G. Fischer, N. Farr, J. Clarke, J. McIntyre, E. Sinofsky, J. N. Ruskin, and D. Keane, “Use of a diode laser balloon ablation catheter to generate circumferential pulmonary venous lesions in an open-thoracotomy caprine model,” Pacing Clin. Electrophysiol. 27(1), 52–57 (2004).
[Crossref] [PubMed]

2003 (1)

J. Swartling, S. Pålsson, P. Platonov, S. B. Olsson, and S. Andersson-Engels, “Changes in tissue optical properties due to radio-frequency ablation of myocardium,” Med. Biol. Eng. Comput. 41(4), 403–409 (2003).
[Crossref] [PubMed]

2002 (1)

R. J. Lederman, M. A. Guttman, D. C. Peters, R. B. Thompson, J. M. Sorger, A. J. Dick, V. K. Raman, and E. R. McVeigh, “Catheter-based endomyocardial injection with real-time magnetic resonance imaging,” Circulation 105(11), 1282–1284 (2002).
[Crossref] [PubMed]

2001 (1)

A. S. Go, E. M. Hylek, K. A. Phillips, Y. Chang, L. E. Henault, J. V. Selby, and D. E. Singer, “Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study,” JAMA 285(18), 2370–2375 (2001).
[Crossref] [PubMed]

1999 (2)

M. A. Mitchell, I. D. McRury, T. H. Everett, H. Li, J. M. Mangrum, and D. E. Haines, “Morphological and physiological characteristics of discontinuous linear atrial ablations during atrial pacing and atrial fibrillation,” J. Cardiovasc. Electrophysiol. 10(3), 378–386 (1999).
[Crossref] [PubMed]

P. Jaïs, D. C. Shah, M. Haïssaguerre, A. Takahashi, T. Lavergne, M. Hocini, S. Garrigue, S. S. Barold, P. Le Métayer, and J. Clémenty, “Efficacy and safety of septal and left-atrial linear ablation for atrial fibrillation,” Am. J. Cardiol. 84(9), 139R–146R (1999).
[Crossref] [PubMed]

1998 (2)

E. J. Benjamin, P. A. Wolf, R. B. D’Agostino, H. Silbershatz, W. B. Kannel, and D. Levy, “Impact of atrial fibrillation on the risk of death: the Framingham Heart Study,” Circulation 98(10), 946–952 (1998).
[Crossref] [PubMed]

A. M. Nilsson, C. Sturesson, D. L. Liu, and S. Andersson-Engels, “Changes in spectral shape of tissue optical properties in conjunction with laser-induced thermotherapy,” Appl. Opt. 37(7), 1256–1267 (1998).
[Crossref] [PubMed]

1997 (1)

A. M. Nilsson, G. W. Lucassen, W. Verkruysse, S. Andersson-Engels, and M. J. van Gemert, “Changes in optical properties of human whole blood in vitro due to slow heating,” Photochem. Photobiol. 65(2), 366–373 (1997).
[Crossref] [PubMed]

1996 (1)

S. N. Goldberg, G. S. Gazelle, E. F. Halpern, W. J. Rittman, P. R. Mueller, and D. I. Rosenthal, “Radiofrequency tissue ablation: importance of local temperature along the electrode tip exposure in determining lesion shape and size,” Acad. Radiol. 3(3), 212–218 (1996).
[Crossref] [PubMed]

1995 (1)

W. M. Feinberg, J. L. Blackshear, A. Laupacis, R. Kronmal, and R. G. Hart, “Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications,” Arch. Intern. Med. 155(5), 469–473 (1995).
[Crossref] [PubMed]

1994 (1)

S. Nath, J. P. DiMarco, and D. E. Haines, “Basic aspects of radiofrequency catheter ablation,” J. Cardiovasc. Electrophysiol. 5(10), 863–876 (1994).
[Crossref] [PubMed]

1991 (2)

P. A. Wolf, R. D. Abbott, and W. B. Kannel, “Atrial fibrillation as an independent risk factor for stroke: the Framingham Study,” Stroke 22(8), 983–988 (1991).
[Crossref] [PubMed]

R. Splinter, R. H. Svenson, L. Littmann, J. R. Tuntelder, C. H. Chuang, G. P. Tatsis, and M. Thompson, “Optical properties of normal, diseased, and laser photocoagulated myocardium at the Nd: YAG wavelength,” Lasers Surg. Med. 11(2), 117–124 (1991).
[Crossref] [PubMed]

1990 (1)

S. Thomsen, “Microscopic correlates of macroscopic optical property changes during thermal coagulation of myocardium,” Proc. Soc. Photo-Opt 1202, 2–10 (1990).

1989 (1)

S. T. Flock, M. S. Patterson, B. C. Wilson, and D. R. Wyman, “Monte Carlo modeling of light propagation in highly scattering tissue--I: Model predictions and comparison with diffusion theory,” IEEE Trans. Biomed. Eng. 36(12), 1162–1168 (1989).
[Crossref] [PubMed]

1949 (1)

W. J. Bowen, “The absorption spectra and extinction coefficients of myoglobin,” J. Biol. Chem. 179(1), 235–245 (1949).
[PubMed]

Aalders, M. C.

R. H. Bremmer, A. Nadort, T. G. van Leeuwen, M. J. van Gemert, and M. C. Aalders, “Age estimation of blood stains by hemoglobin derivative determination using reflectance spectroscopy,” Forensic Sci. Int. 206(1-3), 166–171 (2011).
[Crossref] [PubMed]

Abbott, R. D.

P. A. Wolf, R. D. Abbott, and W. B. Kannel, “Atrial fibrillation as an independent risk factor for stroke: the Framingham Study,” Stroke 22(8), 983–988 (1991).
[Crossref] [PubMed]

Ahmed, H.

H. Ahmed, P. Neuzil, J. Skoda, J. Petru, L. Sediva, S. Kralovec, and V. Y. Reddy, “Initial clinical experience with a novel visualization and virtual electrode radiofrequency ablation catheter to treat atrial flutter,” Heart Rhythm 8(3), 361–367 (2011).
[Crossref] [PubMed]

Akoum, N. W.

G. R. Vergara, S. Vijayakumar, E. G. Kholmovski, J. J. Blauer, M. A. Guttman, C. Gloschat, G. Payne, K. Vij, N. W. Akoum, M. Daccarett, C. J. McGann, R. S. Macleod, and N. F. Marrouche, “Real-time magnetic resonance imaging-guided radiofrequency atrial ablation and visualization of lesion formation at 3 Tesla,” Heart Rhythm 8(2), 295–303 (2011).
[Crossref] [PubMed]

Al-Ahmad, A.

A. Garan, A. Al-Ahmad, T. Mihalik, C. Cartier, L. Capuano, D. Holtan, C. Song, M. K. Homoud, M. S. Link, N. A. Estes, and P. J. Wang, “Cryoablation of the pulmonary veins using a novel balloon catheter,” J. Interv. Card. Electrophysiol. 15(2), 79–81 (2006).
[Crossref] [PubMed]

Albenque, J. P.

A. Verma, C. Y. Jiang, T. R. Betts, J. Chen, I. Deisenhofer, R. Mantovan, L. Macle, C. A. Morillo, W. Haverkamp, R. Weerasooriya, J. P. Albenque, S. Nardi, E. Menardi, P. Novak, P. Sanders, and STAR AF II Investigators, “Approaches to catheter ablation for persistent atrial fibrillation,” N. Engl. J. Med. 372(19), 1812–1822 (2015).
[Crossref] [PubMed]

Amir, S. B.

Y. Gan, D. Tsay, S. B. Amir, C. C. Marboe, and C. P. Hendon, “Automated classification of optical coherence tomography images of human atrial tissue,” J. Biomed. Opt. 21(10), 101407 (2016).
[Crossref] [PubMed]

Amit, G.

Andersson-Engels, S.

J. Swartling, S. Pålsson, P. Platonov, S. B. Olsson, and S. Andersson-Engels, “Changes in tissue optical properties due to radio-frequency ablation of myocardium,” Med. Biol. Eng. Comput. 41(4), 403–409 (2003).
[Crossref] [PubMed]

A. M. Nilsson, C. Sturesson, D. L. Liu, and S. Andersson-Engels, “Changes in spectral shape of tissue optical properties in conjunction with laser-induced thermotherapy,” Appl. Opt. 37(7), 1256–1267 (1998).
[Crossref] [PubMed]

A. M. Nilsson, G. W. Lucassen, W. Verkruysse, S. Andersson-Engels, and M. J. van Gemert, “Changes in optical properties of human whole blood in vitro due to slow heating,” Photochem. Photobiol. 65(2), 366–373 (1997).
[Crossref] [PubMed]

Anter, E.

E. Leshem, I. Zilberman, C. M. Tschabrunn, M. Barkagan, F. M. Contreras-Valdes, A. Govari, and E. Anter, “High-Power and Short-Duration Ablation for Pulmonary Vein Isolation: Biophysical Characterization,” JACC Clin. Electrophysiol. 4(4), 467–479 (2018).
[Crossref] [PubMed]

Antz, M.

M. Antz, K. R. Chun, F. Ouyang, and K. H. Kuck, “Ablation of atrial fibrillation in humans using a balloon-based ablation system: identification of the site of phrenic nerve damage using pacing maneuvers and CARTO,” J. Cardiovasc. Electrophysiol. 17(11), 1242–1245 (2006).
[Crossref] [PubMed]

Armstrong, K.

L. M. Swift, H. Asfour, N. Muselimyan, C. Larson, K. Armstrong, and N. A. Sarvazyan, “Hyperspectral imaging for label-free in vivo identification of myocardial scars and sites of radiofrequency ablation lesions,” Heart Rhythm 15(4), 564–575 (2018).
[Crossref] [PubMed]

Arruda, M. M.

C. P. Fleming, N. Rosenthal, A. M. Rollins, and M. M. Arruda, “First in vivo real-time imaging of endocardial radiofrequency ablation by optical coherence tomography: Implications on safety and the birth of “electrostructuralsubstrate-guided ablation”,” Innovations in Cardiac Rhythm Management 2, 199–201 (2011).

Artyomenko, S.

E. Pokushalov, A. Romanov, G. Corbucci, S. Artyomenko, V. Baranova, A. Turov, N. Shirokova, A. Karaskov, S. Mittal, and J. S. Steinberg, “A randomized comparison of pulmonary vein isolation with versus without concomitant renal artery denervation in patients with refractory symptomatic atrial fibrillation and resistant hypertension,” J. Am. Coll. Cardiol. 60(13), 1163–1170 (2012).
[Crossref] [PubMed]

Aryana, A.

S. R. Dukkipati, F. Cuoco, I. Kutinsky, A. Aryana, T. D. Bahnson, D. Lakkireddy, I. Woollett, Z. F. Issa, A. Natale, V. Y. Reddy, and HeartLight Study Investigators, “Pulmonary Vein Isolation Using the Visually Guided Laser Balloon: A Prospective, Multicenter, and Randomized Comparison to Standard Radiofrequency Ablation,” J. Am. Coll. Cardiol. 66(12), 1350–1360 (2015).
[Crossref] [PubMed]

Asfour, H.

L. M. Swift, H. Asfour, N. Muselimyan, C. Larson, K. Armstrong, and N. A. Sarvazyan, “Hyperspectral imaging for label-free in vivo identification of myocardial scars and sites of radiofrequency ablation lesions,” Heart Rhythm 15(4), 564–575 (2018).
[Crossref] [PubMed]

D. A. Gil, L. M. Swift, H. Asfour, N. Muselimyan, M. A. Mercader, and N. A. Sarvazyan, “Autofluorescence hyperspectral imaging of radiofrequency ablation lesions in porcine cardiac tissue,” J. Biophotonics 10(8), 1008–1017 (2017).
[Crossref] [PubMed]

N. Muselimyan, L. M. Swift, H. Asfour, T. Chahbazian, R. Mazhari, M. A. Mercader, and N. A. Sarvazyan, “Seeing the Invisible: Revealing Atrial Ablation Lesions Using Hyperspectral Imaging Approach,” PLoS One 11(12), e0167760 (2016).
[Crossref] [PubMed]

M. Mercader, L. Swift, S. Sood, H. Asfour, M. Kay, and N. Sarvazyan, “Use of endogenous NADH fluorescence for real-time in situ visualization of epicardial radiofrequency ablation lesions and gaps,” Am. J. Physiol. Heart Circ. Physiol. 302(10), H2131–H2138 (2012).
[Crossref] [PubMed]

Ashikaga, H.

S. Nazarian, A. Kolandaivelu, M. M. Zviman, G. R. Meininger, R. Kato, R. C. Susil, A. Roguin, T. L. Dickfeld, H. Ashikaga, H. Calkins, R. D. Berger, D. A. Bluemke, A. C. Lardo, and H. R. Halperin, “Feasibility of real-time magnetic resonance imaging for catheter guidance in electrophysiology studies,” Circulation 118(3), 223–229 (2008).
[Crossref] [PubMed]

Bahnson, T. D.

S. R. Dukkipati, F. Cuoco, I. Kutinsky, A. Aryana, T. D. Bahnson, D. Lakkireddy, I. Woollett, Z. F. Issa, A. Natale, V. Y. Reddy, and HeartLight Study Investigators, “Pulmonary Vein Isolation Using the Visually Guided Laser Balloon: A Prospective, Multicenter, and Randomized Comparison to Standard Radiofrequency Ablation,” J. Am. Coll. Cardiol. 66(12), 1350–1360 (2015).
[Crossref] [PubMed]

Baranova, V.

E. Pokushalov, A. Romanov, G. Corbucci, S. Artyomenko, V. Baranova, A. Turov, N. Shirokova, A. Karaskov, S. Mittal, and J. S. Steinberg, “A randomized comparison of pulmonary vein isolation with versus without concomitant renal artery denervation in patients with refractory symptomatic atrial fibrillation and resistant hypertension,” J. Am. Coll. Cardiol. 60(13), 1163–1170 (2012).
[Crossref] [PubMed]

Barkagan, M.

E. Leshem, I. Zilberman, C. M. Tschabrunn, M. Barkagan, F. M. Contreras-Valdes, A. Govari, and E. Anter, “High-Power and Short-Duration Ablation for Pulmonary Vein Isolation: Biophysical Characterization,” JACC Clin. Electrophysiol. 4(4), 467–479 (2018).
[Crossref] [PubMed]

Barley, M.

M. Wright, E. Harks, S. Deladi, F. Suijver, M. Barley, A. van Dusschoten, S. Fokkenrood, F. Zuo, F. Sacher, M. Hocini, M. Haïssaguerre, and P. Jaïs, “Real-time lesion assessment using a novel combined ultrasound and radiofrequency ablation catheter,” Heart Rhythm 8(2), 304–312 (2011).
[Crossref] [PubMed]

Barold, S. S.

P. Jaïs, D. C. Shah, M. Haïssaguerre, A. Takahashi, T. Lavergne, M. Hocini, S. Garrigue, S. S. Barold, P. Le Métayer, and J. Clémenty, “Efficacy and safety of septal and left-atrial linear ablation for atrial fibrillation,” Am. J. Cardiol. 84(9), 139R–146R (1999).
[Crossref] [PubMed]

Barry, J.

H. Celik, V. Ramanan, J. Barry, S. Ghate, V. Leber, S. Oduneye, Y. Gu, M. Jamali, N. Ghugre, J. A. Stainsby, M. Shurrab, E. Crystal, and G. A. Wright, “Intrinsic contrast for characterization of acute radiofrequency ablation lesions,” Circ Arrhythm Electrophysiol 7(4), 718–727 (2014).
[Crossref] [PubMed]

Benjamin, E. J.

E. J. Benjamin, P. A. Wolf, R. B. D’Agostino, H. Silbershatz, W. B. Kannel, and D. Levy, “Impact of atrial fibrillation on the risk of death: the Framingham Heart Study,” Circulation 98(10), 946–952 (1998).
[Crossref] [PubMed]

Berger, R. D.

S. Nazarian, A. Kolandaivelu, M. M. Zviman, G. R. Meininger, R. Kato, R. C. Susil, A. Roguin, T. L. Dickfeld, H. Ashikaga, H. Calkins, R. D. Berger, D. A. Bluemke, A. C. Lardo, and H. R. Halperin, “Feasibility of real-time magnetic resonance imaging for catheter guidance in electrophysiology studies,” Circulation 118(3), 223–229 (2008).
[Crossref] [PubMed]

Betts, T. R.

A. Verma, C. Y. Jiang, T. R. Betts, J. Chen, I. Deisenhofer, R. Mantovan, L. Macle, C. A. Morillo, W. Haverkamp, R. Weerasooriya, J. P. Albenque, S. Nardi, E. Menardi, P. Novak, P. Sanders, and STAR AF II Investigators, “Approaches to catheter ablation for persistent atrial fibrillation,” N. Engl. J. Med. 372(19), 1812–1822 (2015).
[Crossref] [PubMed]

Blackshear, J. L.

W. M. Feinberg, J. L. Blackshear, A. Laupacis, R. Kronmal, and R. G. Hart, “Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications,” Arch. Intern. Med. 155(5), 469–473 (1995).
[Crossref] [PubMed]

Blauer, J. J.

G. R. Vergara, S. Vijayakumar, E. G. Kholmovski, J. J. Blauer, M. A. Guttman, C. Gloschat, G. Payne, K. Vij, N. W. Akoum, M. Daccarett, C. J. McGann, R. S. Macleod, and N. F. Marrouche, “Real-time magnetic resonance imaging-guided radiofrequency atrial ablation and visualization of lesion formation at 3 Tesla,” Heart Rhythm 8(2), 295–303 (2011).
[Crossref] [PubMed]

Bluemke, D. A.

S. Nazarian, A. Kolandaivelu, M. M. Zviman, G. R. Meininger, R. Kato, R. C. Susil, A. Roguin, T. L. Dickfeld, H. Ashikaga, H. Calkins, R. D. Berger, D. A. Bluemke, A. C. Lardo, and H. R. Halperin, “Feasibility of real-time magnetic resonance imaging for catheter guidance in electrophysiology studies,” Circulation 118(3), 223–229 (2008).
[Crossref] [PubMed]

Bowen, W. J.

W. J. Bowen, “The absorption spectra and extinction coefficients of myoglobin,” J. Biol. Chem. 179(1), 235–245 (1949).
[PubMed]

Bremmer, R. H.

R. H. Bremmer, A. Nadort, T. G. van Leeuwen, M. J. van Gemert, and M. C. Aalders, “Age estimation of blood stains by hemoglobin derivative determination using reflectance spectroscopy,” Forensic Sci. Int. 206(1-3), 166–171 (2011).
[Crossref] [PubMed]

Brooks, A. G.

A. N. Ganesan, N. J. Shipp, A. G. Brooks, P. Kuklik, D. H. Lau, H. S. Lim, T. Sullivan, K. C. Roberts-Thomson, and P. Sanders, “Long-term outcomes of catheter ablation of atrial fibrillation: a systematic review and meta-analysis,” J. Am. Heart Assoc. 2(2), e004549 (2013).
[Crossref] [PubMed]

Calkins, H.

S. Nazarian, A. Kolandaivelu, M. M. Zviman, G. R. Meininger, R. Kato, R. C. Susil, A. Roguin, T. L. Dickfeld, H. Ashikaga, H. Calkins, R. D. Berger, D. A. Bluemke, A. C. Lardo, and H. R. Halperin, “Feasibility of real-time magnetic resonance imaging for catheter guidance in electrophysiology studies,” Circulation 118(3), 223–229 (2008).
[Crossref] [PubMed]

Capuano, L.

A. Garan, A. Al-Ahmad, T. Mihalik, C. Cartier, L. Capuano, D. Holtan, C. Song, M. K. Homoud, M. S. Link, N. A. Estes, and P. J. Wang, “Cryoablation of the pulmonary veins using a novel balloon catheter,” J. Interv. Card. Electrophysiol. 15(2), 79–81 (2006).
[Crossref] [PubMed]

Cartier, C.

A. Garan, A. Al-Ahmad, T. Mihalik, C. Cartier, L. Capuano, D. Holtan, C. Song, M. K. Homoud, M. S. Link, N. A. Estes, and P. J. Wang, “Cryoablation of the pulmonary veins using a novel balloon catheter,” J. Interv. Card. Electrophysiol. 15(2), 79–81 (2006).
[Crossref] [PubMed]

Celik, H.

H. Celik, V. Ramanan, J. Barry, S. Ghate, V. Leber, S. Oduneye, Y. Gu, M. Jamali, N. Ghugre, J. A. Stainsby, M. Shurrab, E. Crystal, and G. A. Wright, “Intrinsic contrast for characterization of acute radiofrequency ablation lesions,” Circ Arrhythm Electrophysiol 7(4), 718–727 (2014).
[Crossref] [PubMed]

Chahbazian, T.

N. Muselimyan, L. M. Swift, H. Asfour, T. Chahbazian, R. Mazhari, M. A. Mercader, and N. A. Sarvazyan, “Seeing the Invisible: Revealing Atrial Ablation Lesions Using Hyperspectral Imaging Approach,” PLoS One 11(12), e0167760 (2016).
[Crossref] [PubMed]

Chang, Y.

A. S. Go, E. M. Hylek, K. A. Phillips, Y. Chang, L. E. Henault, J. V. Selby, and D. E. Singer, “Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study,” JAMA 285(18), 2370–2375 (2001).
[Crossref] [PubMed]

Chen, J.

A. Verma, C. Y. Jiang, T. R. Betts, J. Chen, I. Deisenhofer, R. Mantovan, L. Macle, C. A. Morillo, W. Haverkamp, R. Weerasooriya, J. P. Albenque, S. Nardi, E. Menardi, P. Novak, P. Sanders, and STAR AF II Investigators, “Approaches to catheter ablation for persistent atrial fibrillation,” N. Engl. J. Med. 372(19), 1812–1822 (2015).
[Crossref] [PubMed]

Chuang, C. H.

R. Splinter, R. H. Svenson, L. Littmann, J. R. Tuntelder, C. H. Chuang, G. P. Tatsis, and M. Thompson, “Optical properties of normal, diseased, and laser photocoagulated myocardium at the Nd: YAG wavelength,” Lasers Surg. Med. 11(2), 117–124 (1991).
[Crossref] [PubMed]

Chun, K. R.

M. Antz, K. R. Chun, F. Ouyang, and K. H. Kuck, “Ablation of atrial fibrillation in humans using a balloon-based ablation system: identification of the site of phrenic nerve damage using pacing maneuvers and CARTO,” J. Cardiovasc. Electrophysiol. 17(11), 1242–1245 (2006).
[Crossref] [PubMed]

Clarke, J.

V. Y. Reddy, C. Houghtaling, J. Fallon, G. Fischer, N. Farr, J. Clarke, J. McIntyre, E. Sinofsky, J. N. Ruskin, and D. Keane, “Use of a diode laser balloon ablation catheter to generate circumferential pulmonary venous lesions in an open-thoracotomy caprine model,” Pacing Clin. Electrophysiol. 27(1), 52–57 (2004).
[Crossref] [PubMed]

Clémenty, J.

P. Jaïs, D. C. Shah, M. Haïssaguerre, A. Takahashi, T. Lavergne, M. Hocini, S. Garrigue, S. S. Barold, P. Le Métayer, and J. Clémenty, “Efficacy and safety of septal and left-atrial linear ablation for atrial fibrillation,” Am. J. Cardiol. 84(9), 139R–146R (1999).
[Crossref] [PubMed]

Contreras-Valdes, F. M.

E. Leshem, I. Zilberman, C. M. Tschabrunn, M. Barkagan, F. M. Contreras-Valdes, A. Govari, and E. Anter, “High-Power and Short-Duration Ablation for Pulmonary Vein Isolation: Biophysical Characterization,” JACC Clin. Electrophysiol. 4(4), 467–479 (2018).
[Crossref] [PubMed]

Corbucci, G.

E. Pokushalov, A. Romanov, G. Corbucci, S. Artyomenko, V. Baranova, A. Turov, N. Shirokova, A. Karaskov, S. Mittal, and J. S. Steinberg, “A randomized comparison of pulmonary vein isolation with versus without concomitant renal artery denervation in patients with refractory symptomatic atrial fibrillation and resistant hypertension,” J. Am. Coll. Cardiol. 60(13), 1163–1170 (2012).
[Crossref] [PubMed]

Crystal, E.

H. Celik, V. Ramanan, J. Barry, S. Ghate, V. Leber, S. Oduneye, Y. Gu, M. Jamali, N. Ghugre, J. A. Stainsby, M. Shurrab, E. Crystal, and G. A. Wright, “Intrinsic contrast for characterization of acute radiofrequency ablation lesions,” Circ Arrhythm Electrophysiol 7(4), 718–727 (2014).
[Crossref] [PubMed]

Cuoco, F.

S. R. Dukkipati, F. Cuoco, I. Kutinsky, A. Aryana, T. D. Bahnson, D. Lakkireddy, I. Woollett, Z. F. Issa, A. Natale, V. Y. Reddy, and HeartLight Study Investigators, “Pulmonary Vein Isolation Using the Visually Guided Laser Balloon: A Prospective, Multicenter, and Randomized Comparison to Standard Radiofrequency Ablation,” J. Am. Coll. Cardiol. 66(12), 1350–1360 (2015).
[Crossref] [PubMed]

D’Agostino, R. B.

E. J. Benjamin, P. A. Wolf, R. B. D’Agostino, H. Silbershatz, W. B. Kannel, and D. Levy, “Impact of atrial fibrillation on the risk of death: the Framingham Heart Study,” Circulation 98(10), 946–952 (1998).
[Crossref] [PubMed]

Daccarett, M.

G. R. Vergara, S. Vijayakumar, E. G. Kholmovski, J. J. Blauer, M. A. Guttman, C. Gloschat, G. Payne, K. Vij, N. W. Akoum, M. Daccarett, C. J. McGann, R. S. Macleod, and N. F. Marrouche, “Real-time magnetic resonance imaging-guided radiofrequency atrial ablation and visualization of lesion formation at 3 Tesla,” Heart Rhythm 8(2), 295–303 (2011).
[Crossref] [PubMed]

Deisenhofer, I.

A. Verma, C. Y. Jiang, T. R. Betts, J. Chen, I. Deisenhofer, R. Mantovan, L. Macle, C. A. Morillo, W. Haverkamp, R. Weerasooriya, J. P. Albenque, S. Nardi, E. Menardi, P. Novak, P. Sanders, and STAR AF II Investigators, “Approaches to catheter ablation for persistent atrial fibrillation,” N. Engl. J. Med. 372(19), 1812–1822 (2015).
[Crossref] [PubMed]

Deladi, S.

M. Wright, E. Harks, S. Deladi, F. Suijver, M. Barley, A. van Dusschoten, S. Fokkenrood, F. Zuo, F. Sacher, M. Hocini, M. Haïssaguerre, and P. Jaïs, “Real-time lesion assessment using a novel combined ultrasound and radiofrequency ablation catheter,” Heart Rhythm 8(2), 304–312 (2011).
[Crossref] [PubMed]

Demos, S. G.

Dick, A. J.

R. J. Lederman, M. A. Guttman, D. C. Peters, R. B. Thompson, J. M. Sorger, A. J. Dick, V. K. Raman, and E. R. McVeigh, “Catheter-based endomyocardial injection with real-time magnetic resonance imaging,” Circulation 105(11), 1282–1284 (2002).
[Crossref] [PubMed]

Dickfeld, T. L.

S. Nazarian, A. Kolandaivelu, M. M. Zviman, G. R. Meininger, R. Kato, R. C. Susil, A. Roguin, T. L. Dickfeld, H. Ashikaga, H. Calkins, R. D. Berger, D. A. Bluemke, A. C. Lardo, and H. R. Halperin, “Feasibility of real-time magnetic resonance imaging for catheter guidance in electrophysiology studies,” Circulation 118(3), 223–229 (2008).
[Crossref] [PubMed]

DiMarco, J. P.

S. Nath, J. P. DiMarco, and D. E. Haines, “Basic aspects of radiofrequency catheter ablation,” J. Cardiovasc. Electrophysiol. 5(10), 863–876 (1994).
[Crossref] [PubMed]

Doblado, M.

N. Pérez-Castellano, J. Villacastín, J. Salinas, M. Vega, J. Moreno, M. Doblado, E. Ruiz, and C. Macaya, “Epicardial connections between the pulmonary veins and left atrium: relevance for atrial fibrillation ablation,” J. Cardiovasc. Electrophysiol. 22(2), 149–159 (2011).
[PubMed]

Dukkipati, S. R.

S. R. Dukkipati, F. Cuoco, I. Kutinsky, A. Aryana, T. D. Bahnson, D. Lakkireddy, I. Woollett, Z. F. Issa, A. Natale, V. Y. Reddy, and HeartLight Study Investigators, “Pulmonary Vein Isolation Using the Visually Guided Laser Balloon: A Prospective, Multicenter, and Randomized Comparison to Standard Radiofrequency Ablation,” J. Am. Coll. Cardiol. 66(12), 1350–1360 (2015).
[Crossref] [PubMed]

Estes, N. A.

A. Garan, A. Al-Ahmad, T. Mihalik, C. Cartier, L. Capuano, D. Holtan, C. Song, M. K. Homoud, M. S. Link, N. A. Estes, and P. J. Wang, “Cryoablation of the pulmonary veins using a novel balloon catheter,” J. Interv. Card. Electrophysiol. 15(2), 79–81 (2006).
[Crossref] [PubMed]

Everett, T. H.

M. A. Mitchell, I. D. McRury, T. H. Everett, H. Li, J. M. Mangrum, and D. E. Haines, “Morphological and physiological characteristics of discontinuous linear atrial ablations during atrial pacing and atrial fibrillation,” J. Cardiovasc. Electrophysiol. 10(3), 378–386 (1999).
[Crossref] [PubMed]

Fallon, J.

V. Y. Reddy, C. Houghtaling, J. Fallon, G. Fischer, N. Farr, J. Clarke, J. McIntyre, E. Sinofsky, J. N. Ruskin, and D. Keane, “Use of a diode laser balloon ablation catheter to generate circumferential pulmonary venous lesions in an open-thoracotomy caprine model,” Pacing Clin. Electrophysiol. 27(1), 52–57 (2004).
[Crossref] [PubMed]

Farr, N.

V. Y. Reddy, C. Houghtaling, J. Fallon, G. Fischer, N. Farr, J. Clarke, J. McIntyre, E. Sinofsky, J. N. Ruskin, and D. Keane, “Use of a diode laser balloon ablation catheter to generate circumferential pulmonary venous lesions in an open-thoracotomy caprine model,” Pacing Clin. Electrophysiol. 27(1), 52–57 (2004).
[Crossref] [PubMed]

Feinberg, W. M.

W. M. Feinberg, J. L. Blackshear, A. Laupacis, R. Kronmal, and R. G. Hart, “Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications,” Arch. Intern. Med. 155(5), 469–473 (1995).
[Crossref] [PubMed]

Fischer, G.

V. Y. Reddy, C. Houghtaling, J. Fallon, G. Fischer, N. Farr, J. Clarke, J. McIntyre, E. Sinofsky, J. N. Ruskin, and D. Keane, “Use of a diode laser balloon ablation catheter to generate circumferential pulmonary venous lesions in an open-thoracotomy caprine model,” Pacing Clin. Electrophysiol. 27(1), 52–57 (2004).
[Crossref] [PubMed]

Fleming, C. P.

C. P. Fleming, N. Rosenthal, A. M. Rollins, and M. M. Arruda, “First in vivo real-time imaging of endocardial radiofrequency ablation by optical coherence tomography: Implications on safety and the birth of “electrostructuralsubstrate-guided ablation”,” Innovations in Cardiac Rhythm Management 2, 199–201 (2011).

C. P. Fleming, K. J. Quan, H. Wang, G. Amit, and A. M. Rollins, “In vitro characterization of cardiac radiofrequency ablation lesions using optical coherence tomography,” Opt. Express 18(3), 3079–3092 (2010).
[Crossref] [PubMed]

Flock, S. T.

S. T. Flock, M. S. Patterson, B. C. Wilson, and D. R. Wyman, “Monte Carlo modeling of light propagation in highly scattering tissue--I: Model predictions and comparison with diffusion theory,” IEEE Trans. Biomed. Eng. 36(12), 1162–1168 (1989).
[Crossref] [PubMed]

Fokkenrood, S.

M. Wright, E. Harks, S. Deladi, F. Suijver, M. Barley, A. van Dusschoten, S. Fokkenrood, F. Zuo, F. Sacher, M. Hocini, M. Haïssaguerre, and P. Jaïs, “Real-time lesion assessment using a novel combined ultrasound and radiofrequency ablation catheter,” Heart Rhythm 8(2), 304–312 (2011).
[Crossref] [PubMed]

Fu, X.

Gan, Y.

X. Yao, Y. Gan, Y. Ling, C. C. Marboe, and C. P. Hendon, “Multicontrast endomyocardial imaging by single-channel high-resolution cross-polarization optical coherence tomography,” J. Biophotonics 11(4), e201700204 (2018).
[Crossref] [PubMed]

Y. Gan, D. Tsay, S. B. Amir, C. C. Marboe, and C. P. Hendon, “Automated classification of optical coherence tomography images of human atrial tissue,” J. Biomed. Opt. 21(10), 101407 (2016).
[Crossref] [PubMed]

Y. Gan, W. Yao, K. M. Myers, J. Y. Vink, R. J. Wapner, and C. P. Hendon, “Analyzing three-dimensional ultrastructure of human cervical tissue using optical coherence tomography,” Biomed. Opt. Express 6(4), 1090–1108 (2015).
[Crossref] [PubMed]

Ganesan, A. N.

A. N. Ganesan, N. J. Shipp, A. G. Brooks, P. Kuklik, D. H. Lau, H. S. Lim, T. Sullivan, K. C. Roberts-Thomson, and P. Sanders, “Long-term outcomes of catheter ablation of atrial fibrillation: a systematic review and meta-analysis,” J. Am. Heart Assoc. 2(2), e004549 (2013).
[Crossref] [PubMed]

Garan, A.

A. Garan, A. Al-Ahmad, T. Mihalik, C. Cartier, L. Capuano, D. Holtan, C. Song, M. K. Homoud, M. S. Link, N. A. Estes, and P. J. Wang, “Cryoablation of the pulmonary veins using a novel balloon catheter,” J. Interv. Card. Electrophysiol. 15(2), 79–81 (2006).
[Crossref] [PubMed]

Garrigue, S.

P. Jaïs, D. C. Shah, M. Haïssaguerre, A. Takahashi, T. Lavergne, M. Hocini, S. Garrigue, S. S. Barold, P. Le Métayer, and J. Clémenty, “Efficacy and safety of septal and left-atrial linear ablation for atrial fibrillation,” Am. J. Cardiol. 84(9), 139R–146R (1999).
[Crossref] [PubMed]

Gazelle, G. S.

S. N. Goldberg, G. S. Gazelle, E. F. Halpern, W. J. Rittman, P. R. Mueller, and D. I. Rosenthal, “Radiofrequency tissue ablation: importance of local temperature along the electrode tip exposure in determining lesion shape and size,” Acad. Radiol. 3(3), 212–218 (1996).
[Crossref] [PubMed]

Ghate, S.

H. Celik, V. Ramanan, J. Barry, S. Ghate, V. Leber, S. Oduneye, Y. Gu, M. Jamali, N. Ghugre, J. A. Stainsby, M. Shurrab, E. Crystal, and G. A. Wright, “Intrinsic contrast for characterization of acute radiofrequency ablation lesions,” Circ Arrhythm Electrophysiol 7(4), 718–727 (2014).
[Crossref] [PubMed]

Ghugre, N.

H. Celik, V. Ramanan, J. Barry, S. Ghate, V. Leber, S. Oduneye, Y. Gu, M. Jamali, N. Ghugre, J. A. Stainsby, M. Shurrab, E. Crystal, and G. A. Wright, “Intrinsic contrast for characterization of acute radiofrequency ablation lesions,” Circ Arrhythm Electrophysiol 7(4), 718–727 (2014).
[Crossref] [PubMed]

Gil, D. A.

D. A. Gil, L. M. Swift, H. Asfour, N. Muselimyan, M. A. Mercader, and N. A. Sarvazyan, “Autofluorescence hyperspectral imaging of radiofrequency ablation lesions in porcine cardiac tissue,” J. Biophotonics 10(8), 1008–1017 (2017).
[Crossref] [PubMed]

Gloschat, C.

G. R. Vergara, S. Vijayakumar, E. G. Kholmovski, J. J. Blauer, M. A. Guttman, C. Gloschat, G. Payne, K. Vij, N. W. Akoum, M. Daccarett, C. J. McGann, R. S. Macleod, and N. F. Marrouche, “Real-time magnetic resonance imaging-guided radiofrequency atrial ablation and visualization of lesion formation at 3 Tesla,” Heart Rhythm 8(2), 295–303 (2011).
[Crossref] [PubMed]

Go, A. S.

A. S. Go, E. M. Hylek, K. A. Phillips, Y. Chang, L. E. Henault, J. V. Selby, and D. E. Singer, “Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study,” JAMA 285(18), 2370–2375 (2001).
[Crossref] [PubMed]

Goldberg, S. N.

S. N. Goldberg, G. S. Gazelle, E. F. Halpern, W. J. Rittman, P. R. Mueller, and D. I. Rosenthal, “Radiofrequency tissue ablation: importance of local temperature along the electrode tip exposure in determining lesion shape and size,” Acad. Radiol. 3(3), 212–218 (1996).
[Crossref] [PubMed]

Govari, A.

E. Leshem, I. Zilberman, C. M. Tschabrunn, M. Barkagan, F. M. Contreras-Valdes, A. Govari, and E. Anter, “High-Power and Short-Duration Ablation for Pulmonary Vein Isolation: Biophysical Characterization,” JACC Clin. Electrophysiol. 4(4), 467–479 (2018).
[Crossref] [PubMed]

Gu, Y.

H. Celik, V. Ramanan, J. Barry, S. Ghate, V. Leber, S. Oduneye, Y. Gu, M. Jamali, N. Ghugre, J. A. Stainsby, M. Shurrab, E. Crystal, and G. A. Wright, “Intrinsic contrast for characterization of acute radiofrequency ablation lesions,” Circ Arrhythm Electrophysiol 7(4), 718–727 (2014).
[Crossref] [PubMed]

Guttman, M. A.

G. R. Vergara, S. Vijayakumar, E. G. Kholmovski, J. J. Blauer, M. A. Guttman, C. Gloschat, G. Payne, K. Vij, N. W. Akoum, M. Daccarett, C. J. McGann, R. S. Macleod, and N. F. Marrouche, “Real-time magnetic resonance imaging-guided radiofrequency atrial ablation and visualization of lesion formation at 3 Tesla,” Heart Rhythm 8(2), 295–303 (2011).
[Crossref] [PubMed]

R. J. Lederman, M. A. Guttman, D. C. Peters, R. B. Thompson, J. M. Sorger, A. J. Dick, V. K. Raman, and E. R. McVeigh, “Catheter-based endomyocardial injection with real-time magnetic resonance imaging,” Circulation 105(11), 1282–1284 (2002).
[Crossref] [PubMed]

Haines, D. E.

M. A. Mitchell, I. D. McRury, T. H. Everett, H. Li, J. M. Mangrum, and D. E. Haines, “Morphological and physiological characteristics of discontinuous linear atrial ablations during atrial pacing and atrial fibrillation,” J. Cardiovasc. Electrophysiol. 10(3), 378–386 (1999).
[Crossref] [PubMed]

S. Nath, J. P. DiMarco, and D. E. Haines, “Basic aspects of radiofrequency catheter ablation,” J. Cardiovasc. Electrophysiol. 5(10), 863–876 (1994).
[Crossref] [PubMed]

Haïssaguerre, M.

M. Wright, E. Harks, S. Deladi, F. Suijver, M. Barley, A. van Dusschoten, S. Fokkenrood, F. Zuo, F. Sacher, M. Hocini, M. Haïssaguerre, and P. Jaïs, “Real-time lesion assessment using a novel combined ultrasound and radiofrequency ablation catheter,” Heart Rhythm 8(2), 304–312 (2011).
[Crossref] [PubMed]

P. Jaïs, D. C. Shah, M. Haïssaguerre, A. Takahashi, T. Lavergne, M. Hocini, S. Garrigue, S. S. Barold, P. Le Métayer, and J. Clémenty, “Efficacy and safety of septal and left-atrial linear ablation for atrial fibrillation,” Am. J. Cardiol. 84(9), 139R–146R (1999).
[Crossref] [PubMed]

Halperin, H. R.

S. Nazarian, A. Kolandaivelu, M. M. Zviman, G. R. Meininger, R. Kato, R. C. Susil, A. Roguin, T. L. Dickfeld, H. Ashikaga, H. Calkins, R. D. Berger, D. A. Bluemke, A. C. Lardo, and H. R. Halperin, “Feasibility of real-time magnetic resonance imaging for catheter guidance in electrophysiology studies,” Circulation 118(3), 223–229 (2008).
[Crossref] [PubMed]

Halpern, E. F.

S. N. Goldberg, G. S. Gazelle, E. F. Halpern, W. J. Rittman, P. R. Mueller, and D. I. Rosenthal, “Radiofrequency tissue ablation: importance of local temperature along the electrode tip exposure in determining lesion shape and size,” Acad. Radiol. 3(3), 212–218 (1996).
[Crossref] [PubMed]

Harks, E.

M. Wright, E. Harks, S. Deladi, F. Suijver, M. Barley, A. van Dusschoten, S. Fokkenrood, F. Zuo, F. Sacher, M. Hocini, M. Haïssaguerre, and P. Jaïs, “Real-time lesion assessment using a novel combined ultrasound and radiofrequency ablation catheter,” Heart Rhythm 8(2), 304–312 (2011).
[Crossref] [PubMed]

Hart, R. G.

W. M. Feinberg, J. L. Blackshear, A. Laupacis, R. Kronmal, and R. G. Hart, “Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications,” Arch. Intern. Med. 155(5), 469–473 (1995).
[Crossref] [PubMed]

Haverkamp, W.

A. Verma, C. Y. Jiang, T. R. Betts, J. Chen, I. Deisenhofer, R. Mantovan, L. Macle, C. A. Morillo, W. Haverkamp, R. Weerasooriya, J. P. Albenque, S. Nardi, E. Menardi, P. Novak, P. Sanders, and STAR AF II Investigators, “Approaches to catheter ablation for persistent atrial fibrillation,” N. Engl. J. Med. 372(19), 1812–1822 (2015).
[Crossref] [PubMed]

Henault, L. E.

A. S. Go, E. M. Hylek, K. A. Phillips, Y. Chang, L. E. Henault, J. V. Selby, and D. E. Singer, “Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study,” JAMA 285(18), 2370–2375 (2001).
[Crossref] [PubMed]

Hendon, C. P.

T. H. Lye, V. Iyer, C. C. Marboe, and C. P. Hendon, “Mapping the human pulmonary venoatrial junction with optical coherence tomography,” Biomed. Opt. Express 10(2), 434–448 (2019).
[Crossref] [PubMed]

R. P. Singh-Moon, X. Yao, V. Iyer, C. Marboe, W. Whang, and C. P. Hendon, “Real-time optical spectroscopic monitoring of non-irrigated lesion progression within atrial and ventricular tissues,” J. Biophotonics 12, 201800144 (2018).
[PubMed]

X. Yao, Y. Gan, Y. Ling, C. C. Marboe, and C. P. Hendon, “Multicontrast endomyocardial imaging by single-channel high-resolution cross-polarization optical coherence tomography,” J. Biophotonics 11(4), e201700204 (2018).
[Crossref] [PubMed]

Y. Gan, D. Tsay, S. B. Amir, C. C. Marboe, and C. P. Hendon, “Automated classification of optical coherence tomography images of human atrial tissue,” J. Biomed. Opt. 21(10), 101407 (2016).
[Crossref] [PubMed]

R. P. Singh-Moon, C. C. Marboe, and C. P. Hendon, “Near-infrared spectroscopy integrated catheter for characterization of myocardial tissues: preliminary demonstrations to radiofrequency ablation therapy for atrial fibrillation,” Biomed. Opt. Express 6(7), 2494–2511 (2015).
[Crossref] [PubMed]

Y. Gan, W. Yao, K. M. Myers, J. Y. Vink, R. J. Wapner, and C. P. Hendon, “Analyzing three-dimensional ultrastructure of human cervical tissue using optical coherence tomography,” Biomed. Opt. Express 6(4), 1090–1108 (2015).
[Crossref] [PubMed]

Hocini, M.

M. Wright, E. Harks, S. Deladi, F. Suijver, M. Barley, A. van Dusschoten, S. Fokkenrood, F. Zuo, F. Sacher, M. Hocini, M. Haïssaguerre, and P. Jaïs, “Real-time lesion assessment using a novel combined ultrasound and radiofrequency ablation catheter,” Heart Rhythm 8(2), 304–312 (2011).
[Crossref] [PubMed]

P. Jaïs, D. C. Shah, M. Haïssaguerre, A. Takahashi, T. Lavergne, M. Hocini, S. Garrigue, S. S. Barold, P. Le Métayer, and J. Clémenty, “Efficacy and safety of septal and left-atrial linear ablation for atrial fibrillation,” Am. J. Cardiol. 84(9), 139R–146R (1999).
[Crossref] [PubMed]

Holtan, D.

A. Garan, A. Al-Ahmad, T. Mihalik, C. Cartier, L. Capuano, D. Holtan, C. Song, M. K. Homoud, M. S. Link, N. A. Estes, and P. J. Wang, “Cryoablation of the pulmonary veins using a novel balloon catheter,” J. Interv. Card. Electrophysiol. 15(2), 79–81 (2006).
[Crossref] [PubMed]

Homoud, M. K.

A. Garan, A. Al-Ahmad, T. Mihalik, C. Cartier, L. Capuano, D. Holtan, C. Song, M. K. Homoud, M. S. Link, N. A. Estes, and P. J. Wang, “Cryoablation of the pulmonary veins using a novel balloon catheter,” J. Interv. Card. Electrophysiol. 15(2), 79–81 (2006).
[Crossref] [PubMed]

Houghtaling, C.

V. Y. Reddy, C. Houghtaling, J. Fallon, G. Fischer, N. Farr, J. Clarke, J. McIntyre, E. Sinofsky, J. N. Ruskin, and D. Keane, “Use of a diode laser balloon ablation catheter to generate circumferential pulmonary venous lesions in an open-thoracotomy caprine model,” Pacing Clin. Electrophysiol. 27(1), 52–57 (2004).
[Crossref] [PubMed]

Hylek, E. M.

A. S. Go, E. M. Hylek, K. A. Phillips, Y. Chang, L. E. Henault, J. V. Selby, and D. E. Singer, “Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study,” JAMA 285(18), 2370–2375 (2001).
[Crossref] [PubMed]

Iskander-Rizk, S.

Issa, Z. F.

S. R. Dukkipati, F. Cuoco, I. Kutinsky, A. Aryana, T. D. Bahnson, D. Lakkireddy, I. Woollett, Z. F. Issa, A. Natale, V. Y. Reddy, and HeartLight Study Investigators, “Pulmonary Vein Isolation Using the Visually Guided Laser Balloon: A Prospective, Multicenter, and Randomized Comparison to Standard Radiofrequency Ablation,” J. Am. Coll. Cardiol. 66(12), 1350–1360 (2015).
[Crossref] [PubMed]

Iyer, V.

T. H. Lye, V. Iyer, C. C. Marboe, and C. P. Hendon, “Mapping the human pulmonary venoatrial junction with optical coherence tomography,” Biomed. Opt. Express 10(2), 434–448 (2019).
[Crossref] [PubMed]

R. P. Singh-Moon, X. Yao, V. Iyer, C. Marboe, W. Whang, and C. P. Hendon, “Real-time optical spectroscopic monitoring of non-irrigated lesion progression within atrial and ventricular tissues,” J. Biophotonics 12, 201800144 (2018).
[PubMed]

Jacques, S. L.

S. L. Jacques, “Optical properties of biological tissues: a review,” Phys. Med. Biol. 58(11), R37–R61 (2013).
[Crossref] [PubMed]

Jaïs, P.

M. Wright, E. Harks, S. Deladi, F. Suijver, M. Barley, A. van Dusschoten, S. Fokkenrood, F. Zuo, F. Sacher, M. Hocini, M. Haïssaguerre, and P. Jaïs, “Real-time lesion assessment using a novel combined ultrasound and radiofrequency ablation catheter,” Heart Rhythm 8(2), 304–312 (2011).
[Crossref] [PubMed]

P. Jaïs, D. C. Shah, M. Haïssaguerre, A. Takahashi, T. Lavergne, M. Hocini, S. Garrigue, S. S. Barold, P. Le Métayer, and J. Clémenty, “Efficacy and safety of septal and left-atrial linear ablation for atrial fibrillation,” Am. J. Cardiol. 84(9), 139R–146R (1999).
[Crossref] [PubMed]

Jamali, M.

H. Celik, V. Ramanan, J. Barry, S. Ghate, V. Leber, S. Oduneye, Y. Gu, M. Jamali, N. Ghugre, J. A. Stainsby, M. Shurrab, E. Crystal, and G. A. Wright, “Intrinsic contrast for characterization of acute radiofrequency ablation lesions,” Circ Arrhythm Electrophysiol 7(4), 718–727 (2014).
[Crossref] [PubMed]

Jenkins, M. W.

Jiang, C. Y.

A. Verma, C. Y. Jiang, T. R. Betts, J. Chen, I. Deisenhofer, R. Mantovan, L. Macle, C. A. Morillo, W. Haverkamp, R. Weerasooriya, J. P. Albenque, S. Nardi, E. Menardi, P. Novak, P. Sanders, and STAR AF II Investigators, “Approaches to catheter ablation for persistent atrial fibrillation,” N. Engl. J. Med. 372(19), 1812–1822 (2015).
[Crossref] [PubMed]

Kannel, W. B.

E. J. Benjamin, P. A. Wolf, R. B. D’Agostino, H. Silbershatz, W. B. Kannel, and D. Levy, “Impact of atrial fibrillation on the risk of death: the Framingham Heart Study,” Circulation 98(10), 946–952 (1998).
[Crossref] [PubMed]

P. A. Wolf, R. D. Abbott, and W. B. Kannel, “Atrial fibrillation as an independent risk factor for stroke: the Framingham Study,” Stroke 22(8), 983–988 (1991).
[Crossref] [PubMed]

Karaskov, A.

E. Pokushalov, A. Romanov, G. Corbucci, S. Artyomenko, V. Baranova, A. Turov, N. Shirokova, A. Karaskov, S. Mittal, and J. S. Steinberg, “A randomized comparison of pulmonary vein isolation with versus without concomitant renal artery denervation in patients with refractory symptomatic atrial fibrillation and resistant hypertension,” J. Am. Coll. Cardiol. 60(13), 1163–1170 (2012).
[Crossref] [PubMed]

Kato, R.

S. Nazarian, A. Kolandaivelu, M. M. Zviman, G. R. Meininger, R. Kato, R. C. Susil, A. Roguin, T. L. Dickfeld, H. Ashikaga, H. Calkins, R. D. Berger, D. A. Bluemke, A. C. Lardo, and H. R. Halperin, “Feasibility of real-time magnetic resonance imaging for catheter guidance in electrophysiology studies,” Circulation 118(3), 223–229 (2008).
[Crossref] [PubMed]

Kay, M.

M. Mercader, L. Swift, S. Sood, H. Asfour, M. Kay, and N. Sarvazyan, “Use of endogenous NADH fluorescence for real-time in situ visualization of epicardial radiofrequency ablation lesions and gaps,” Am. J. Physiol. Heart Circ. Physiol. 302(10), H2131–H2138 (2012).
[Crossref] [PubMed]

Keane, D.

V. Y. Reddy, C. Houghtaling, J. Fallon, G. Fischer, N. Farr, J. Clarke, J. McIntyre, E. Sinofsky, J. N. Ruskin, and D. Keane, “Use of a diode laser balloon ablation catheter to generate circumferential pulmonary venous lesions in an open-thoracotomy caprine model,” Pacing Clin. Electrophysiol. 27(1), 52–57 (2004).
[Crossref] [PubMed]

Kholmovski, E. G.

G. R. Vergara, S. Vijayakumar, E. G. Kholmovski, J. J. Blauer, M. A. Guttman, C. Gloschat, G. Payne, K. Vij, N. W. Akoum, M. Daccarett, C. J. McGann, R. S. Macleod, and N. F. Marrouche, “Real-time magnetic resonance imaging-guided radiofrequency atrial ablation and visualization of lesion formation at 3 Tesla,” Heart Rhythm 8(2), 295–303 (2011).
[Crossref] [PubMed]

Kolandaivelu, A.

S. Nazarian, A. Kolandaivelu, M. M. Zviman, G. R. Meininger, R. Kato, R. C. Susil, A. Roguin, T. L. Dickfeld, H. Ashikaga, H. Calkins, R. D. Berger, D. A. Bluemke, A. C. Lardo, and H. R. Halperin, “Feasibility of real-time magnetic resonance imaging for catheter guidance in electrophysiology studies,” Circulation 118(3), 223–229 (2008).
[Crossref] [PubMed]

Kralovec, S.

H. Ahmed, P. Neuzil, J. Skoda, J. Petru, L. Sediva, S. Kralovec, and V. Y. Reddy, “Initial clinical experience with a novel visualization and virtual electrode radiofrequency ablation catheter to treat atrial flutter,” Heart Rhythm 8(3), 361–367 (2011).
[Crossref] [PubMed]

Kronmal, R.

W. M. Feinberg, J. L. Blackshear, A. Laupacis, R. Kronmal, and R. G. Hart, “Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications,” Arch. Intern. Med. 155(5), 469–473 (1995).
[Crossref] [PubMed]

Kruizinga, P.

Kuck, K. H.

M. Antz, K. R. Chun, F. Ouyang, and K. H. Kuck, “Ablation of atrial fibrillation in humans using a balloon-based ablation system: identification of the site of phrenic nerve damage using pacing maneuvers and CARTO,” J. Cardiovasc. Electrophysiol. 17(11), 1242–1245 (2006).
[Crossref] [PubMed]

Kuklik, P.

A. N. Ganesan, N. J. Shipp, A. G. Brooks, P. Kuklik, D. H. Lau, H. S. Lim, T. Sullivan, K. C. Roberts-Thomson, and P. Sanders, “Long-term outcomes of catheter ablation of atrial fibrillation: a systematic review and meta-analysis,” J. Am. Heart Assoc. 2(2), e004549 (2013).
[Crossref] [PubMed]

Kutinsky, I.

S. R. Dukkipati, F. Cuoco, I. Kutinsky, A. Aryana, T. D. Bahnson, D. Lakkireddy, I. Woollett, Z. F. Issa, A. Natale, V. Y. Reddy, and HeartLight Study Investigators, “Pulmonary Vein Isolation Using the Visually Guided Laser Balloon: A Prospective, Multicenter, and Randomized Comparison to Standard Radiofrequency Ablation,” J. Am. Coll. Cardiol. 66(12), 1350–1360 (2015).
[Crossref] [PubMed]

Lakkireddy, D.

S. R. Dukkipati, F. Cuoco, I. Kutinsky, A. Aryana, T. D. Bahnson, D. Lakkireddy, I. Woollett, Z. F. Issa, A. Natale, V. Y. Reddy, and HeartLight Study Investigators, “Pulmonary Vein Isolation Using the Visually Guided Laser Balloon: A Prospective, Multicenter, and Randomized Comparison to Standard Radiofrequency Ablation,” J. Am. Coll. Cardiol. 66(12), 1350–1360 (2015).
[Crossref] [PubMed]

Lardo, A. C.

S. Nazarian, A. Kolandaivelu, M. M. Zviman, G. R. Meininger, R. Kato, R. C. Susil, A. Roguin, T. L. Dickfeld, H. Ashikaga, H. Calkins, R. D. Berger, D. A. Bluemke, A. C. Lardo, and H. R. Halperin, “Feasibility of real-time magnetic resonance imaging for catheter guidance in electrophysiology studies,” Circulation 118(3), 223–229 (2008).
[Crossref] [PubMed]

Larson, C.

L. M. Swift, H. Asfour, N. Muselimyan, C. Larson, K. Armstrong, and N. A. Sarvazyan, “Hyperspectral imaging for label-free in vivo identification of myocardial scars and sites of radiofrequency ablation lesions,” Heart Rhythm 15(4), 564–575 (2018).
[Crossref] [PubMed]

Lau, D. H.

A. N. Ganesan, N. J. Shipp, A. G. Brooks, P. Kuklik, D. H. Lau, H. S. Lim, T. Sullivan, K. C. Roberts-Thomson, and P. Sanders, “Long-term outcomes of catheter ablation of atrial fibrillation: a systematic review and meta-analysis,” J. Am. Heart Assoc. 2(2), e004549 (2013).
[Crossref] [PubMed]

Laupacis, A.

W. M. Feinberg, J. L. Blackshear, A. Laupacis, R. Kronmal, and R. G. Hart, “Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications,” Arch. Intern. Med. 155(5), 469–473 (1995).
[Crossref] [PubMed]

Lavergne, T.

P. Jaïs, D. C. Shah, M. Haïssaguerre, A. Takahashi, T. Lavergne, M. Hocini, S. Garrigue, S. S. Barold, P. Le Métayer, and J. Clémenty, “Efficacy and safety of septal and left-atrial linear ablation for atrial fibrillation,” Am. J. Cardiol. 84(9), 139R–146R (1999).
[Crossref] [PubMed]

Le Métayer, P.

P. Jaïs, D. C. Shah, M. Haïssaguerre, A. Takahashi, T. Lavergne, M. Hocini, S. Garrigue, S. S. Barold, P. Le Métayer, and J. Clémenty, “Efficacy and safety of septal and left-atrial linear ablation for atrial fibrillation,” Am. J. Cardiol. 84(9), 139R–146R (1999).
[Crossref] [PubMed]

Leber, V.

H. Celik, V. Ramanan, J. Barry, S. Ghate, V. Leber, S. Oduneye, Y. Gu, M. Jamali, N. Ghugre, J. A. Stainsby, M. Shurrab, E. Crystal, and G. A. Wright, “Intrinsic contrast for characterization of acute radiofrequency ablation lesions,” Circ Arrhythm Electrophysiol 7(4), 718–727 (2014).
[Crossref] [PubMed]

Lederman, R. J.

R. J. Lederman, M. A. Guttman, D. C. Peters, R. B. Thompson, J. M. Sorger, A. J. Dick, V. K. Raman, and E. R. McVeigh, “Catheter-based endomyocardial injection with real-time magnetic resonance imaging,” Circulation 105(11), 1282–1284 (2002).
[Crossref] [PubMed]

Leshem, E.

E. Leshem, I. Zilberman, C. M. Tschabrunn, M. Barkagan, F. M. Contreras-Valdes, A. Govari, and E. Anter, “High-Power and Short-Duration Ablation for Pulmonary Vein Isolation: Biophysical Characterization,” JACC Clin. Electrophysiol. 4(4), 467–479 (2018).
[Crossref] [PubMed]

Levy, D.

E. J. Benjamin, P. A. Wolf, R. B. D’Agostino, H. Silbershatz, W. B. Kannel, and D. Levy, “Impact of atrial fibrillation on the risk of death: the Framingham Heart Study,” Circulation 98(10), 946–952 (1998).
[Crossref] [PubMed]

Li, H.

M. A. Mitchell, I. D. McRury, T. H. Everett, H. Li, J. M. Mangrum, and D. E. Haines, “Morphological and physiological characteristics of discontinuous linear atrial ablations during atrial pacing and atrial fibrillation,” J. Cardiovasc. Electrophysiol. 10(3), 378–386 (1999).
[Crossref] [PubMed]

Lim, H. S.

A. N. Ganesan, N. J. Shipp, A. G. Brooks, P. Kuklik, D. H. Lau, H. S. Lim, T. Sullivan, K. C. Roberts-Thomson, and P. Sanders, “Long-term outcomes of catheter ablation of atrial fibrillation: a systematic review and meta-analysis,” J. Am. Heart Assoc. 2(2), e004549 (2013).
[Crossref] [PubMed]

Ling, Y.

X. Yao, Y. Gan, Y. Ling, C. C. Marboe, and C. P. Hendon, “Multicontrast endomyocardial imaging by single-channel high-resolution cross-polarization optical coherence tomography,” J. Biophotonics 11(4), e201700204 (2018).
[Crossref] [PubMed]

Link, M. S.

A. Garan, A. Al-Ahmad, T. Mihalik, C. Cartier, L. Capuano, D. Holtan, C. Song, M. K. Homoud, M. S. Link, N. A. Estes, and P. J. Wang, “Cryoablation of the pulmonary veins using a novel balloon catheter,” J. Interv. Card. Electrophysiol. 15(2), 79–81 (2006).
[Crossref] [PubMed]

Littmann, L.

R. Splinter, R. H. Svenson, L. Littmann, J. R. Tuntelder, C. H. Chuang, G. P. Tatsis, and M. Thompson, “Optical properties of normal, diseased, and laser photocoagulated myocardium at the Nd: YAG wavelength,” Lasers Surg. Med. 11(2), 117–124 (1991).
[Crossref] [PubMed]

Liu, D. L.

Lucassen, G. W.

A. M. Nilsson, G. W. Lucassen, W. Verkruysse, S. Andersson-Engels, and M. J. van Gemert, “Changes in optical properties of human whole blood in vitro due to slow heating,” Photochem. Photobiol. 65(2), 366–373 (1997).
[Crossref] [PubMed]

Lye, T. H.

Macaya, C.

N. Pérez-Castellano, J. Villacastín, J. Salinas, M. Vega, J. Moreno, M. Doblado, E. Ruiz, and C. Macaya, “Epicardial connections between the pulmonary veins and left atrium: relevance for atrial fibrillation ablation,” J. Cardiovasc. Electrophysiol. 22(2), 149–159 (2011).
[PubMed]

Macle, L.

A. Verma, C. Y. Jiang, T. R. Betts, J. Chen, I. Deisenhofer, R. Mantovan, L. Macle, C. A. Morillo, W. Haverkamp, R. Weerasooriya, J. P. Albenque, S. Nardi, E. Menardi, P. Novak, P. Sanders, and STAR AF II Investigators, “Approaches to catheter ablation for persistent atrial fibrillation,” N. Engl. J. Med. 372(19), 1812–1822 (2015).
[Crossref] [PubMed]

Macleod, R. S.

G. R. Vergara, S. Vijayakumar, E. G. Kholmovski, J. J. Blauer, M. A. Guttman, C. Gloschat, G. Payne, K. Vij, N. W. Akoum, M. Daccarett, C. J. McGann, R. S. Macleod, and N. F. Marrouche, “Real-time magnetic resonance imaging-guided radiofrequency atrial ablation and visualization of lesion formation at 3 Tesla,” Heart Rhythm 8(2), 295–303 (2011).
[Crossref] [PubMed]

Mangrum, J. M.

M. A. Mitchell, I. D. McRury, T. H. Everett, H. Li, J. M. Mangrum, and D. E. Haines, “Morphological and physiological characteristics of discontinuous linear atrial ablations during atrial pacing and atrial fibrillation,” J. Cardiovasc. Electrophysiol. 10(3), 378–386 (1999).
[Crossref] [PubMed]

Mantovan, R.

A. Verma, C. Y. Jiang, T. R. Betts, J. Chen, I. Deisenhofer, R. Mantovan, L. Macle, C. A. Morillo, W. Haverkamp, R. Weerasooriya, J. P. Albenque, S. Nardi, E. Menardi, P. Novak, P. Sanders, and STAR AF II Investigators, “Approaches to catheter ablation for persistent atrial fibrillation,” N. Engl. J. Med. 372(19), 1812–1822 (2015).
[Crossref] [PubMed]

Marboe, C.

R. P. Singh-Moon, X. Yao, V. Iyer, C. Marboe, W. Whang, and C. P. Hendon, “Real-time optical spectroscopic monitoring of non-irrigated lesion progression within atrial and ventricular tissues,” J. Biophotonics 12, 201800144 (2018).
[PubMed]

Marboe, C. C.

T. H. Lye, V. Iyer, C. C. Marboe, and C. P. Hendon, “Mapping the human pulmonary venoatrial junction with optical coherence tomography,” Biomed. Opt. Express 10(2), 434–448 (2019).
[Crossref] [PubMed]

X. Yao, Y. Gan, Y. Ling, C. C. Marboe, and C. P. Hendon, “Multicontrast endomyocardial imaging by single-channel high-resolution cross-polarization optical coherence tomography,” J. Biophotonics 11(4), e201700204 (2018).
[Crossref] [PubMed]

Y. Gan, D. Tsay, S. B. Amir, C. C. Marboe, and C. P. Hendon, “Automated classification of optical coherence tomography images of human atrial tissue,” J. Biomed. Opt. 21(10), 101407 (2016).
[Crossref] [PubMed]

R. P. Singh-Moon, C. C. Marboe, and C. P. Hendon, “Near-infrared spectroscopy integrated catheter for characterization of myocardial tissues: preliminary demonstrations to radiofrequency ablation therapy for atrial fibrillation,” Biomed. Opt. Express 6(7), 2494–2511 (2015).
[Crossref] [PubMed]

Marrouche, N. F.

G. R. Vergara, S. Vijayakumar, E. G. Kholmovski, J. J. Blauer, M. A. Guttman, C. Gloschat, G. Payne, K. Vij, N. W. Akoum, M. Daccarett, C. J. McGann, R. S. Macleod, and N. F. Marrouche, “Real-time magnetic resonance imaging-guided radiofrequency atrial ablation and visualization of lesion formation at 3 Tesla,” Heart Rhythm 8(2), 295–303 (2011).
[Crossref] [PubMed]

Mazhari, R.

N. Muselimyan, L. M. Swift, H. Asfour, T. Chahbazian, R. Mazhari, M. A. Mercader, and N. A. Sarvazyan, “Seeing the Invisible: Revealing Atrial Ablation Lesions Using Hyperspectral Imaging Approach,” PLoS One 11(12), e0167760 (2016).
[Crossref] [PubMed]

McGann, C. J.

G. R. Vergara, S. Vijayakumar, E. G. Kholmovski, J. J. Blauer, M. A. Guttman, C. Gloschat, G. Payne, K. Vij, N. W. Akoum, M. Daccarett, C. J. McGann, R. S. Macleod, and N. F. Marrouche, “Real-time magnetic resonance imaging-guided radiofrequency atrial ablation and visualization of lesion formation at 3 Tesla,” Heart Rhythm 8(2), 295–303 (2011).
[Crossref] [PubMed]

McIntyre, J.

V. Y. Reddy, C. Houghtaling, J. Fallon, G. Fischer, N. Farr, J. Clarke, J. McIntyre, E. Sinofsky, J. N. Ruskin, and D. Keane, “Use of a diode laser balloon ablation catheter to generate circumferential pulmonary venous lesions in an open-thoracotomy caprine model,” Pacing Clin. Electrophysiol. 27(1), 52–57 (2004).
[Crossref] [PubMed]

McRury, I. D.

M. A. Mitchell, I. D. McRury, T. H. Everett, H. Li, J. M. Mangrum, and D. E. Haines, “Morphological and physiological characteristics of discontinuous linear atrial ablations during atrial pacing and atrial fibrillation,” J. Cardiovasc. Electrophysiol. 10(3), 378–386 (1999).
[Crossref] [PubMed]

McVeigh, E. R.

R. J. Lederman, M. A. Guttman, D. C. Peters, R. B. Thompson, J. M. Sorger, A. J. Dick, V. K. Raman, and E. R. McVeigh, “Catheter-based endomyocardial injection with real-time magnetic resonance imaging,” Circulation 105(11), 1282–1284 (2002).
[Crossref] [PubMed]

Meininger, G. R.

S. Nazarian, A. Kolandaivelu, M. M. Zviman, G. R. Meininger, R. Kato, R. C. Susil, A. Roguin, T. L. Dickfeld, H. Ashikaga, H. Calkins, R. D. Berger, D. A. Bluemke, A. C. Lardo, and H. R. Halperin, “Feasibility of real-time magnetic resonance imaging for catheter guidance in electrophysiology studies,” Circulation 118(3), 223–229 (2008).
[Crossref] [PubMed]

Menardi, E.

A. Verma, C. Y. Jiang, T. R. Betts, J. Chen, I. Deisenhofer, R. Mantovan, L. Macle, C. A. Morillo, W. Haverkamp, R. Weerasooriya, J. P. Albenque, S. Nardi, E. Menardi, P. Novak, P. Sanders, and STAR AF II Investigators, “Approaches to catheter ablation for persistent atrial fibrillation,” N. Engl. J. Med. 372(19), 1812–1822 (2015).
[Crossref] [PubMed]

Mercader, M.

M. Mercader, L. Swift, S. Sood, H. Asfour, M. Kay, and N. Sarvazyan, “Use of endogenous NADH fluorescence for real-time in situ visualization of epicardial radiofrequency ablation lesions and gaps,” Am. J. Physiol. Heart Circ. Physiol. 302(10), H2131–H2138 (2012).
[Crossref] [PubMed]

Mercader, M. A.

D. A. Gil, L. M. Swift, H. Asfour, N. Muselimyan, M. A. Mercader, and N. A. Sarvazyan, “Autofluorescence hyperspectral imaging of radiofrequency ablation lesions in porcine cardiac tissue,” J. Biophotonics 10(8), 1008–1017 (2017).
[Crossref] [PubMed]

N. Muselimyan, L. M. Swift, H. Asfour, T. Chahbazian, R. Mazhari, M. A. Mercader, and N. A. Sarvazyan, “Seeing the Invisible: Revealing Atrial Ablation Lesions Using Hyperspectral Imaging Approach,” PLoS One 11(12), e0167760 (2016).
[Crossref] [PubMed]

Mihalik, T.

A. Garan, A. Al-Ahmad, T. Mihalik, C. Cartier, L. Capuano, D. Holtan, C. Song, M. K. Homoud, M. S. Link, N. A. Estes, and P. J. Wang, “Cryoablation of the pulmonary veins using a novel balloon catheter,” J. Interv. Card. Electrophysiol. 15(2), 79–81 (2006).
[Crossref] [PubMed]

Mitchell, M. A.

M. A. Mitchell, I. D. McRury, T. H. Everett, H. Li, J. M. Mangrum, and D. E. Haines, “Morphological and physiological characteristics of discontinuous linear atrial ablations during atrial pacing and atrial fibrillation,” J. Cardiovasc. Electrophysiol. 10(3), 378–386 (1999).
[Crossref] [PubMed]

Mittal, S.

E. Pokushalov, A. Romanov, G. Corbucci, S. Artyomenko, V. Baranova, A. Turov, N. Shirokova, A. Karaskov, S. Mittal, and J. S. Steinberg, “A randomized comparison of pulmonary vein isolation with versus without concomitant renal artery denervation in patients with refractory symptomatic atrial fibrillation and resistant hypertension,” J. Am. Coll. Cardiol. 60(13), 1163–1170 (2012).
[Crossref] [PubMed]

Moreno, J.

N. Pérez-Castellano, J. Villacastín, J. Salinas, M. Vega, J. Moreno, M. Doblado, E. Ruiz, and C. Macaya, “Epicardial connections between the pulmonary veins and left atrium: relevance for atrial fibrillation ablation,” J. Cardiovasc. Electrophysiol. 22(2), 149–159 (2011).
[PubMed]

Morillo, C. A.

A. Verma, C. Y. Jiang, T. R. Betts, J. Chen, I. Deisenhofer, R. Mantovan, L. Macle, C. A. Morillo, W. Haverkamp, R. Weerasooriya, J. P. Albenque, S. Nardi, E. Menardi, P. Novak, P. Sanders, and STAR AF II Investigators, “Approaches to catheter ablation for persistent atrial fibrillation,” N. Engl. J. Med. 372(19), 1812–1822 (2015).
[Crossref] [PubMed]

Mueller, P. R.

S. N. Goldberg, G. S. Gazelle, E. F. Halpern, W. J. Rittman, P. R. Mueller, and D. I. Rosenthal, “Radiofrequency tissue ablation: importance of local temperature along the electrode tip exposure in determining lesion shape and size,” Acad. Radiol. 3(3), 212–218 (1996).
[Crossref] [PubMed]

Muselimyan, N.

L. M. Swift, H. Asfour, N. Muselimyan, C. Larson, K. Armstrong, and N. A. Sarvazyan, “Hyperspectral imaging for label-free in vivo identification of myocardial scars and sites of radiofrequency ablation lesions,” Heart Rhythm 15(4), 564–575 (2018).
[Crossref] [PubMed]

D. A. Gil, L. M. Swift, H. Asfour, N. Muselimyan, M. A. Mercader, and N. A. Sarvazyan, “Autofluorescence hyperspectral imaging of radiofrequency ablation lesions in porcine cardiac tissue,” J. Biophotonics 10(8), 1008–1017 (2017).
[Crossref] [PubMed]

N. Muselimyan, L. M. Swift, H. Asfour, T. Chahbazian, R. Mazhari, M. A. Mercader, and N. A. Sarvazyan, “Seeing the Invisible: Revealing Atrial Ablation Lesions Using Hyperspectral Imaging Approach,” PLoS One 11(12), e0167760 (2016).
[Crossref] [PubMed]

Myers, K. M.

Nadort, A.

R. H. Bremmer, A. Nadort, T. G. van Leeuwen, M. J. van Gemert, and M. C. Aalders, “Age estimation of blood stains by hemoglobin derivative determination using reflectance spectroscopy,” Forensic Sci. Int. 206(1-3), 166–171 (2011).
[Crossref] [PubMed]

Nardi, S.

A. Verma, C. Y. Jiang, T. R. Betts, J. Chen, I. Deisenhofer, R. Mantovan, L. Macle, C. A. Morillo, W. Haverkamp, R. Weerasooriya, J. P. Albenque, S. Nardi, E. Menardi, P. Novak, P. Sanders, and STAR AF II Investigators, “Approaches to catheter ablation for persistent atrial fibrillation,” N. Engl. J. Med. 372(19), 1812–1822 (2015).
[Crossref] [PubMed]

Natale, A.

S. R. Dukkipati, F. Cuoco, I. Kutinsky, A. Aryana, T. D. Bahnson, D. Lakkireddy, I. Woollett, Z. F. Issa, A. Natale, V. Y. Reddy, and HeartLight Study Investigators, “Pulmonary Vein Isolation Using the Visually Guided Laser Balloon: A Prospective, Multicenter, and Randomized Comparison to Standard Radiofrequency Ablation,” J. Am. Coll. Cardiol. 66(12), 1350–1360 (2015).
[Crossref] [PubMed]

Nath, S.

S. Nath, J. P. DiMarco, and D. E. Haines, “Basic aspects of radiofrequency catheter ablation,” J. Cardiovasc. Electrophysiol. 5(10), 863–876 (1994).
[Crossref] [PubMed]

Nazarian, S.

S. Nazarian, A. Kolandaivelu, M. M. Zviman, G. R. Meininger, R. Kato, R. C. Susil, A. Roguin, T. L. Dickfeld, H. Ashikaga, H. Calkins, R. D. Berger, D. A. Bluemke, A. C. Lardo, and H. R. Halperin, “Feasibility of real-time magnetic resonance imaging for catheter guidance in electrophysiology studies,” Circulation 118(3), 223–229 (2008).
[Crossref] [PubMed]

Neuzil, P.

H. Ahmed, P. Neuzil, J. Skoda, J. Petru, L. Sediva, S. Kralovec, and V. Y. Reddy, “Initial clinical experience with a novel visualization and virtual electrode radiofrequency ablation catheter to treat atrial flutter,” Heart Rhythm 8(3), 361–367 (2011).
[Crossref] [PubMed]

Nilsson, A. M.

A. M. Nilsson, C. Sturesson, D. L. Liu, and S. Andersson-Engels, “Changes in spectral shape of tissue optical properties in conjunction with laser-induced thermotherapy,” Appl. Opt. 37(7), 1256–1267 (1998).
[Crossref] [PubMed]

A. M. Nilsson, G. W. Lucassen, W. Verkruysse, S. Andersson-Engels, and M. J. van Gemert, “Changes in optical properties of human whole blood in vitro due to slow heating,” Photochem. Photobiol. 65(2), 366–373 (1997).
[Crossref] [PubMed]

Novak, P.

A. Verma, C. Y. Jiang, T. R. Betts, J. Chen, I. Deisenhofer, R. Mantovan, L. Macle, C. A. Morillo, W. Haverkamp, R. Weerasooriya, J. P. Albenque, S. Nardi, E. Menardi, P. Novak, P. Sanders, and STAR AF II Investigators, “Approaches to catheter ablation for persistent atrial fibrillation,” N. Engl. J. Med. 372(19), 1812–1822 (2015).
[Crossref] [PubMed]

Oduneye, S.

H. Celik, V. Ramanan, J. Barry, S. Ghate, V. Leber, S. Oduneye, Y. Gu, M. Jamali, N. Ghugre, J. A. Stainsby, M. Shurrab, E. Crystal, and G. A. Wright, “Intrinsic contrast for characterization of acute radiofrequency ablation lesions,” Circ Arrhythm Electrophysiol 7(4), 718–727 (2014).
[Crossref] [PubMed]

Olsson, S. B.

J. Swartling, S. Pålsson, P. Platonov, S. B. Olsson, and S. Andersson-Engels, “Changes in tissue optical properties due to radio-frequency ablation of myocardium,” Med. Biol. Eng. Comput. 41(4), 403–409 (2003).
[Crossref] [PubMed]

Ouyang, F.

M. Antz, K. R. Chun, F. Ouyang, and K. H. Kuck, “Ablation of atrial fibrillation in humans using a balloon-based ablation system: identification of the site of phrenic nerve damage using pacing maneuvers and CARTO,” J. Cardiovasc. Electrophysiol. 17(11), 1242–1245 (2006).
[Crossref] [PubMed]

Pålsson, S.

J. Swartling, S. Pålsson, P. Platonov, S. B. Olsson, and S. Andersson-Engels, “Changes in tissue optical properties due to radio-frequency ablation of myocardium,” Med. Biol. Eng. Comput. 41(4), 403–409 (2003).
[Crossref] [PubMed]

Patterson, M. S.

S. T. Flock, M. S. Patterson, B. C. Wilson, and D. R. Wyman, “Monte Carlo modeling of light propagation in highly scattering tissue--I: Model predictions and comparison with diffusion theory,” IEEE Trans. Biomed. Eng. 36(12), 1162–1168 (1989).
[Crossref] [PubMed]

Payne, G.

G. R. Vergara, S. Vijayakumar, E. G. Kholmovski, J. J. Blauer, M. A. Guttman, C. Gloschat, G. Payne, K. Vij, N. W. Akoum, M. Daccarett, C. J. McGann, R. S. Macleod, and N. F. Marrouche, “Real-time magnetic resonance imaging-guided radiofrequency atrial ablation and visualization of lesion formation at 3 Tesla,” Heart Rhythm 8(2), 295–303 (2011).
[Crossref] [PubMed]

Pérez-Castellano, N.

N. Pérez-Castellano, J. Villacastín, J. Salinas, M. Vega, J. Moreno, M. Doblado, E. Ruiz, and C. Macaya, “Epicardial connections between the pulmonary veins and left atrium: relevance for atrial fibrillation ablation,” J. Cardiovasc. Electrophysiol. 22(2), 149–159 (2011).
[PubMed]

Peters, D. C.

R. J. Lederman, M. A. Guttman, D. C. Peters, R. B. Thompson, J. M. Sorger, A. J. Dick, V. K. Raman, and E. R. McVeigh, “Catheter-based endomyocardial injection with real-time magnetic resonance imaging,” Circulation 105(11), 1282–1284 (2002).
[Crossref] [PubMed]

Petru, J.

H. Ahmed, P. Neuzil, J. Skoda, J. Petru, L. Sediva, S. Kralovec, and V. Y. Reddy, “Initial clinical experience with a novel visualization and virtual electrode radiofrequency ablation catheter to treat atrial flutter,” Heart Rhythm 8(3), 361–367 (2011).
[Crossref] [PubMed]

Phillips, K. A.

A. S. Go, E. M. Hylek, K. A. Phillips, Y. Chang, L. E. Henault, J. V. Selby, and D. E. Singer, “Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study,” JAMA 285(18), 2370–2375 (2001).
[Crossref] [PubMed]

Platonov, P.

J. Swartling, S. Pålsson, P. Platonov, S. B. Olsson, and S. Andersson-Engels, “Changes in tissue optical properties due to radio-frequency ablation of myocardium,” Med. Biol. Eng. Comput. 41(4), 403–409 (2003).
[Crossref] [PubMed]

Pokushalov, E.

E. Pokushalov, A. Romanov, G. Corbucci, S. Artyomenko, V. Baranova, A. Turov, N. Shirokova, A. Karaskov, S. Mittal, and J. S. Steinberg, “A randomized comparison of pulmonary vein isolation with versus without concomitant renal artery denervation in patients with refractory symptomatic atrial fibrillation and resistant hypertension,” J. Am. Coll. Cardiol. 60(13), 1163–1170 (2012).
[Crossref] [PubMed]

Quan, K. J.

Raman, V. K.

R. J. Lederman, M. A. Guttman, D. C. Peters, R. B. Thompson, J. M. Sorger, A. J. Dick, V. K. Raman, and E. R. McVeigh, “Catheter-based endomyocardial injection with real-time magnetic resonance imaging,” Circulation 105(11), 1282–1284 (2002).
[Crossref] [PubMed]

Ramanan, V.

H. Celik, V. Ramanan, J. Barry, S. Ghate, V. Leber, S. Oduneye, Y. Gu, M. Jamali, N. Ghugre, J. A. Stainsby, M. Shurrab, E. Crystal, and G. A. Wright, “Intrinsic contrast for characterization of acute radiofrequency ablation lesions,” Circ Arrhythm Electrophysiol 7(4), 718–727 (2014).
[Crossref] [PubMed]

Reddy, V. Y.

S. R. Dukkipati, F. Cuoco, I. Kutinsky, A. Aryana, T. D. Bahnson, D. Lakkireddy, I. Woollett, Z. F. Issa, A. Natale, V. Y. Reddy, and HeartLight Study Investigators, “Pulmonary Vein Isolation Using the Visually Guided Laser Balloon: A Prospective, Multicenter, and Randomized Comparison to Standard Radiofrequency Ablation,” J. Am. Coll. Cardiol. 66(12), 1350–1360 (2015).
[Crossref] [PubMed]

H. Ahmed, P. Neuzil, J. Skoda, J. Petru, L. Sediva, S. Kralovec, and V. Y. Reddy, “Initial clinical experience with a novel visualization and virtual electrode radiofrequency ablation catheter to treat atrial flutter,” Heart Rhythm 8(3), 361–367 (2011).
[Crossref] [PubMed]

V. Y. Reddy, C. Houghtaling, J. Fallon, G. Fischer, N. Farr, J. Clarke, J. McIntyre, E. Sinofsky, J. N. Ruskin, and D. Keane, “Use of a diode laser balloon ablation catheter to generate circumferential pulmonary venous lesions in an open-thoracotomy caprine model,” Pacing Clin. Electrophysiol. 27(1), 52–57 (2004).
[Crossref] [PubMed]

Rittman, W. J.

S. N. Goldberg, G. S. Gazelle, E. F. Halpern, W. J. Rittman, P. R. Mueller, and D. I. Rosenthal, “Radiofrequency tissue ablation: importance of local temperature along the electrode tip exposure in determining lesion shape and size,” Acad. Radiol. 3(3), 212–218 (1996).
[Crossref] [PubMed]

Roberts-Thomson, K. C.

A. N. Ganesan, N. J. Shipp, A. G. Brooks, P. Kuklik, D. H. Lau, H. S. Lim, T. Sullivan, K. C. Roberts-Thomson, and P. Sanders, “Long-term outcomes of catheter ablation of atrial fibrillation: a systematic review and meta-analysis,” J. Am. Heart Assoc. 2(2), e004549 (2013).
[Crossref] [PubMed]

Roguin, A.

S. Nazarian, A. Kolandaivelu, M. M. Zviman, G. R. Meininger, R. Kato, R. C. Susil, A. Roguin, T. L. Dickfeld, H. Ashikaga, H. Calkins, R. D. Berger, D. A. Bluemke, A. C. Lardo, and H. R. Halperin, “Feasibility of real-time magnetic resonance imaging for catheter guidance in electrophysiology studies,” Circulation 118(3), 223–229 (2008).
[Crossref] [PubMed]

Rollins, A. M.

X. Fu, Z. Wang, H. Wang, Y. T. Wang, M. W. Jenkins, and A. M. Rollins, “Fiber-optic catheter-based polarization-sensitive OCT for radio-frequency ablation monitoring,” Opt. Lett. 39(17), 5066–5069 (2014).
[Crossref] [PubMed]

C. P. Fleming, N. Rosenthal, A. M. Rollins, and M. M. Arruda, “First in vivo real-time imaging of endocardial radiofrequency ablation by optical coherence tomography: Implications on safety and the birth of “electrostructuralsubstrate-guided ablation”,” Innovations in Cardiac Rhythm Management 2, 199–201 (2011).

C. P. Fleming, K. J. Quan, H. Wang, G. Amit, and A. M. Rollins, “In vitro characterization of cardiac radiofrequency ablation lesions using optical coherence tomography,” Opt. Express 18(3), 3079–3092 (2010).
[Crossref] [PubMed]

Romanov, A.

E. Pokushalov, A. Romanov, G. Corbucci, S. Artyomenko, V. Baranova, A. Turov, N. Shirokova, A. Karaskov, S. Mittal, and J. S. Steinberg, “A randomized comparison of pulmonary vein isolation with versus without concomitant renal artery denervation in patients with refractory symptomatic atrial fibrillation and resistant hypertension,” J. Am. Coll. Cardiol. 60(13), 1163–1170 (2012).
[Crossref] [PubMed]

Rosenthal, D. I.

S. N. Goldberg, G. S. Gazelle, E. F. Halpern, W. J. Rittman, P. R. Mueller, and D. I. Rosenthal, “Radiofrequency tissue ablation: importance of local temperature along the electrode tip exposure in determining lesion shape and size,” Acad. Radiol. 3(3), 212–218 (1996).
[Crossref] [PubMed]

Rosenthal, N.

C. P. Fleming, N. Rosenthal, A. M. Rollins, and M. M. Arruda, “First in vivo real-time imaging of endocardial radiofrequency ablation by optical coherence tomography: Implications on safety and the birth of “electrostructuralsubstrate-guided ablation”,” Innovations in Cardiac Rhythm Management 2, 199–201 (2011).

Ruiz, E.

N. Pérez-Castellano, J. Villacastín, J. Salinas, M. Vega, J. Moreno, M. Doblado, E. Ruiz, and C. Macaya, “Epicardial connections between the pulmonary veins and left atrium: relevance for atrial fibrillation ablation,” J. Cardiovasc. Electrophysiol. 22(2), 149–159 (2011).
[PubMed]

Ruskin, J. N.

V. Y. Reddy, C. Houghtaling, J. Fallon, G. Fischer, N. Farr, J. Clarke, J. McIntyre, E. Sinofsky, J. N. Ruskin, and D. Keane, “Use of a diode laser balloon ablation catheter to generate circumferential pulmonary venous lesions in an open-thoracotomy caprine model,” Pacing Clin. Electrophysiol. 27(1), 52–57 (2004).
[Crossref] [PubMed]

Sacher, F.

M. Wright, E. Harks, S. Deladi, F. Suijver, M. Barley, A. van Dusschoten, S. Fokkenrood, F. Zuo, F. Sacher, M. Hocini, M. Haïssaguerre, and P. Jaïs, “Real-time lesion assessment using a novel combined ultrasound and radiofrequency ablation catheter,” Heart Rhythm 8(2), 304–312 (2011).
[Crossref] [PubMed]

Salinas, J.

N. Pérez-Castellano, J. Villacastín, J. Salinas, M. Vega, J. Moreno, M. Doblado, E. Ruiz, and C. Macaya, “Epicardial connections between the pulmonary veins and left atrium: relevance for atrial fibrillation ablation,” J. Cardiovasc. Electrophysiol. 22(2), 149–159 (2011).
[PubMed]

Sanders, P.

A. Verma, C. Y. Jiang, T. R. Betts, J. Chen, I. Deisenhofer, R. Mantovan, L. Macle, C. A. Morillo, W. Haverkamp, R. Weerasooriya, J. P. Albenque, S. Nardi, E. Menardi, P. Novak, P. Sanders, and STAR AF II Investigators, “Approaches to catheter ablation for persistent atrial fibrillation,” N. Engl. J. Med. 372(19), 1812–1822 (2015).
[Crossref] [PubMed]

A. N. Ganesan, N. J. Shipp, A. G. Brooks, P. Kuklik, D. H. Lau, H. S. Lim, T. Sullivan, K. C. Roberts-Thomson, and P. Sanders, “Long-term outcomes of catheter ablation of atrial fibrillation: a systematic review and meta-analysis,” J. Am. Heart Assoc. 2(2), e004549 (2013).
[Crossref] [PubMed]

Sarvazyan, N.

M. Mercader, L. Swift, S. Sood, H. Asfour, M. Kay, and N. Sarvazyan, “Use of endogenous NADH fluorescence for real-time in situ visualization of epicardial radiofrequency ablation lesions and gaps,” Am. J. Physiol. Heart Circ. Physiol. 302(10), H2131–H2138 (2012).
[Crossref] [PubMed]

Sarvazyan, N. A.

L. M. Swift, H. Asfour, N. Muselimyan, C. Larson, K. Armstrong, and N. A. Sarvazyan, “Hyperspectral imaging for label-free in vivo identification of myocardial scars and sites of radiofrequency ablation lesions,” Heart Rhythm 15(4), 564–575 (2018).
[Crossref] [PubMed]

D. A. Gil, L. M. Swift, H. Asfour, N. Muselimyan, M. A. Mercader, and N. A. Sarvazyan, “Autofluorescence hyperspectral imaging of radiofrequency ablation lesions in porcine cardiac tissue,” J. Biophotonics 10(8), 1008–1017 (2017).
[Crossref] [PubMed]

N. Muselimyan, L. M. Swift, H. Asfour, T. Chahbazian, R. Mazhari, M. A. Mercader, and N. A. Sarvazyan, “Seeing the Invisible: Revealing Atrial Ablation Lesions Using Hyperspectral Imaging Approach,” PLoS One 11(12), e0167760 (2016).
[Crossref] [PubMed]

Sediva, L.

H. Ahmed, P. Neuzil, J. Skoda, J. Petru, L. Sediva, S. Kralovec, and V. Y. Reddy, “Initial clinical experience with a novel visualization and virtual electrode radiofrequency ablation catheter to treat atrial flutter,” Heart Rhythm 8(3), 361–367 (2011).
[Crossref] [PubMed]

Selby, J. V.

A. S. Go, E. M. Hylek, K. A. Phillips, Y. Chang, L. E. Henault, J. V. Selby, and D. E. Singer, “Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study,” JAMA 285(18), 2370–2375 (2001).
[Crossref] [PubMed]

Shah, D. C.

P. Jaïs, D. C. Shah, M. Haïssaguerre, A. Takahashi, T. Lavergne, M. Hocini, S. Garrigue, S. S. Barold, P. Le Métayer, and J. Clémenty, “Efficacy and safety of septal and left-atrial linear ablation for atrial fibrillation,” Am. J. Cardiol. 84(9), 139R–146R (1999).
[Crossref] [PubMed]

Sharareh, S.

Shipp, N. J.

A. N. Ganesan, N. J. Shipp, A. G. Brooks, P. Kuklik, D. H. Lau, H. S. Lim, T. Sullivan, K. C. Roberts-Thomson, and P. Sanders, “Long-term outcomes of catheter ablation of atrial fibrillation: a systematic review and meta-analysis,” J. Am. Heart Assoc. 2(2), e004549 (2013).
[Crossref] [PubMed]

Shirokova, N.

E. Pokushalov, A. Romanov, G. Corbucci, S. Artyomenko, V. Baranova, A. Turov, N. Shirokova, A. Karaskov, S. Mittal, and J. S. Steinberg, “A randomized comparison of pulmonary vein isolation with versus without concomitant renal artery denervation in patients with refractory symptomatic atrial fibrillation and resistant hypertension,” J. Am. Coll. Cardiol. 60(13), 1163–1170 (2012).
[Crossref] [PubMed]

Shurrab, M.

H. Celik, V. Ramanan, J. Barry, S. Ghate, V. Leber, S. Oduneye, Y. Gu, M. Jamali, N. Ghugre, J. A. Stainsby, M. Shurrab, E. Crystal, and G. A. Wright, “Intrinsic contrast for characterization of acute radiofrequency ablation lesions,” Circ Arrhythm Electrophysiol 7(4), 718–727 (2014).
[Crossref] [PubMed]

Silbershatz, H.

E. J. Benjamin, P. A. Wolf, R. B. D’Agostino, H. Silbershatz, W. B. Kannel, and D. Levy, “Impact of atrial fibrillation on the risk of death: the Framingham Heart Study,” Circulation 98(10), 946–952 (1998).
[Crossref] [PubMed]

Singer, D. E.

A. S. Go, E. M. Hylek, K. A. Phillips, Y. Chang, L. E. Henault, J. V. Selby, and D. E. Singer, “Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study,” JAMA 285(18), 2370–2375 (2001).
[Crossref] [PubMed]

Singh-Moon, R. P.

R. P. Singh-Moon, X. Yao, V. Iyer, C. Marboe, W. Whang, and C. P. Hendon, “Real-time optical spectroscopic monitoring of non-irrigated lesion progression within atrial and ventricular tissues,” J. Biophotonics 12, 201800144 (2018).
[PubMed]

R. P. Singh-Moon, C. C. Marboe, and C. P. Hendon, “Near-infrared spectroscopy integrated catheter for characterization of myocardial tissues: preliminary demonstrations to radiofrequency ablation therapy for atrial fibrillation,” Biomed. Opt. Express 6(7), 2494–2511 (2015).
[Crossref] [PubMed]

Sinofsky, E.

V. Y. Reddy, C. Houghtaling, J. Fallon, G. Fischer, N. Farr, J. Clarke, J. McIntyre, E. Sinofsky, J. N. Ruskin, and D. Keane, “Use of a diode laser balloon ablation catheter to generate circumferential pulmonary venous lesions in an open-thoracotomy caprine model,” Pacing Clin. Electrophysiol. 27(1), 52–57 (2004).
[Crossref] [PubMed]

Skoda, J.

H. Ahmed, P. Neuzil, J. Skoda, J. Petru, L. Sediva, S. Kralovec, and V. Y. Reddy, “Initial clinical experience with a novel visualization and virtual electrode radiofrequency ablation catheter to treat atrial flutter,” Heart Rhythm 8(3), 361–367 (2011).
[Crossref] [PubMed]

Song, C.

A. Garan, A. Al-Ahmad, T. Mihalik, C. Cartier, L. Capuano, D. Holtan, C. Song, M. K. Homoud, M. S. Link, N. A. Estes, and P. J. Wang, “Cryoablation of the pulmonary veins using a novel balloon catheter,” J. Interv. Card. Electrophysiol. 15(2), 79–81 (2006).
[Crossref] [PubMed]

Sood, S.

M. Mercader, L. Swift, S. Sood, H. Asfour, M. Kay, and N. Sarvazyan, “Use of endogenous NADH fluorescence for real-time in situ visualization of epicardial radiofrequency ablation lesions and gaps,” Am. J. Physiol. Heart Circ. Physiol. 302(10), H2131–H2138 (2012).
[Crossref] [PubMed]

Sorger, J. M.

R. J. Lederman, M. A. Guttman, D. C. Peters, R. B. Thompson, J. M. Sorger, A. J. Dick, V. K. Raman, and E. R. McVeigh, “Catheter-based endomyocardial injection with real-time magnetic resonance imaging,” Circulation 105(11), 1282–1284 (2002).
[Crossref] [PubMed]

Splinter, R.

R. Splinter, R. H. Svenson, L. Littmann, J. R. Tuntelder, C. H. Chuang, G. P. Tatsis, and M. Thompson, “Optical properties of normal, diseased, and laser photocoagulated myocardium at the Nd: YAG wavelength,” Lasers Surg. Med. 11(2), 117–124 (1991).
[Crossref] [PubMed]

Stainsby, J. A.

H. Celik, V. Ramanan, J. Barry, S. Ghate, V. Leber, S. Oduneye, Y. Gu, M. Jamali, N. Ghugre, J. A. Stainsby, M. Shurrab, E. Crystal, and G. A. Wright, “Intrinsic contrast for characterization of acute radiofrequency ablation lesions,” Circ Arrhythm Electrophysiol 7(4), 718–727 (2014).
[Crossref] [PubMed]

Steinberg, J. S.

E. Pokushalov, A. Romanov, G. Corbucci, S. Artyomenko, V. Baranova, A. Turov, N. Shirokova, A. Karaskov, S. Mittal, and J. S. Steinberg, “A randomized comparison of pulmonary vein isolation with versus without concomitant renal artery denervation in patients with refractory symptomatic atrial fibrillation and resistant hypertension,” J. Am. Coll. Cardiol. 60(13), 1163–1170 (2012).
[Crossref] [PubMed]

Sturesson, C.

Suijver, F.

M. Wright, E. Harks, S. Deladi, F. Suijver, M. Barley, A. van Dusschoten, S. Fokkenrood, F. Zuo, F. Sacher, M. Hocini, M. Haïssaguerre, and P. Jaïs, “Real-time lesion assessment using a novel combined ultrasound and radiofrequency ablation catheter,” Heart Rhythm 8(2), 304–312 (2011).
[Crossref] [PubMed]

Sullivan, T.

A. N. Ganesan, N. J. Shipp, A. G. Brooks, P. Kuklik, D. H. Lau, H. S. Lim, T. Sullivan, K. C. Roberts-Thomson, and P. Sanders, “Long-term outcomes of catheter ablation of atrial fibrillation: a systematic review and meta-analysis,” J. Am. Heart Assoc. 2(2), e004549 (2013).
[Crossref] [PubMed]

Susil, R. C.

S. Nazarian, A. Kolandaivelu, M. M. Zviman, G. R. Meininger, R. Kato, R. C. Susil, A. Roguin, T. L. Dickfeld, H. Ashikaga, H. Calkins, R. D. Berger, D. A. Bluemke, A. C. Lardo, and H. R. Halperin, “Feasibility of real-time magnetic resonance imaging for catheter guidance in electrophysiology studies,” Circulation 118(3), 223–229 (2008).
[Crossref] [PubMed]

Svenson, R. H.

R. Splinter, R. H. Svenson, L. Littmann, J. R. Tuntelder, C. H. Chuang, G. P. Tatsis, and M. Thompson, “Optical properties of normal, diseased, and laser photocoagulated myocardium at the Nd: YAG wavelength,” Lasers Surg. Med. 11(2), 117–124 (1991).
[Crossref] [PubMed]

Swartling, J.

J. Swartling, S. Pålsson, P. Platonov, S. B. Olsson, and S. Andersson-Engels, “Changes in tissue optical properties due to radio-frequency ablation of myocardium,” Med. Biol. Eng. Comput. 41(4), 403–409 (2003).
[Crossref] [PubMed]

Swift, L.

M. Mercader, L. Swift, S. Sood, H. Asfour, M. Kay, and N. Sarvazyan, “Use of endogenous NADH fluorescence for real-time in situ visualization of epicardial radiofrequency ablation lesions and gaps,” Am. J. Physiol. Heart Circ. Physiol. 302(10), H2131–H2138 (2012).
[Crossref] [PubMed]

Swift, L. M.

L. M. Swift, H. Asfour, N. Muselimyan, C. Larson, K. Armstrong, and N. A. Sarvazyan, “Hyperspectral imaging for label-free in vivo identification of myocardial scars and sites of radiofrequency ablation lesions,” Heart Rhythm 15(4), 564–575 (2018).
[Crossref] [PubMed]

D. A. Gil, L. M. Swift, H. Asfour, N. Muselimyan, M. A. Mercader, and N. A. Sarvazyan, “Autofluorescence hyperspectral imaging of radiofrequency ablation lesions in porcine cardiac tissue,” J. Biophotonics 10(8), 1008–1017 (2017).
[Crossref] [PubMed]

N. Muselimyan, L. M. Swift, H. Asfour, T. Chahbazian, R. Mazhari, M. A. Mercader, and N. A. Sarvazyan, “Seeing the Invisible: Revealing Atrial Ablation Lesions Using Hyperspectral Imaging Approach,” PLoS One 11(12), e0167760 (2016).
[Crossref] [PubMed]

Takahashi, A.

P. Jaïs, D. C. Shah, M. Haïssaguerre, A. Takahashi, T. Lavergne, M. Hocini, S. Garrigue, S. S. Barold, P. Le Métayer, and J. Clémenty, “Efficacy and safety of septal and left-atrial linear ablation for atrial fibrillation,” Am. J. Cardiol. 84(9), 139R–146R (1999).
[Crossref] [PubMed]

Tatsis, G. P.

R. Splinter, R. H. Svenson, L. Littmann, J. R. Tuntelder, C. H. Chuang, G. P. Tatsis, and M. Thompson, “Optical properties of normal, diseased, and laser photocoagulated myocardium at the Nd: YAG wavelength,” Lasers Surg. Med. 11(2), 117–124 (1991).
[Crossref] [PubMed]

Thompson, M.

R. Splinter, R. H. Svenson, L. Littmann, J. R. Tuntelder, C. H. Chuang, G. P. Tatsis, and M. Thompson, “Optical properties of normal, diseased, and laser photocoagulated myocardium at the Nd: YAG wavelength,” Lasers Surg. Med. 11(2), 117–124 (1991).
[Crossref] [PubMed]

Thompson, R. B.

R. J. Lederman, M. A. Guttman, D. C. Peters, R. B. Thompson, J. M. Sorger, A. J. Dick, V. K. Raman, and E. R. McVeigh, “Catheter-based endomyocardial injection with real-time magnetic resonance imaging,” Circulation 105(11), 1282–1284 (2002).
[Crossref] [PubMed]

Thomsen, S.

S. Thomsen, “Microscopic correlates of macroscopic optical property changes during thermal coagulation of myocardium,” Proc. Soc. Photo-Opt 1202, 2–10 (1990).

Tsay, D.

Y. Gan, D. Tsay, S. B. Amir, C. C. Marboe, and C. P. Hendon, “Automated classification of optical coherence tomography images of human atrial tissue,” J. Biomed. Opt. 21(10), 101407 (2016).
[Crossref] [PubMed]

Tschabrunn, C. M.

E. Leshem, I. Zilberman, C. M. Tschabrunn, M. Barkagan, F. M. Contreras-Valdes, A. Govari, and E. Anter, “High-Power and Short-Duration Ablation for Pulmonary Vein Isolation: Biophysical Characterization,” JACC Clin. Electrophysiol. 4(4), 467–479 (2018).
[Crossref] [PubMed]

Tuntelder, J. R.

R. Splinter, R. H. Svenson, L. Littmann, J. R. Tuntelder, C. H. Chuang, G. P. Tatsis, and M. Thompson, “Optical properties of normal, diseased, and laser photocoagulated myocardium at the Nd: YAG wavelength,” Lasers Surg. Med. 11(2), 117–124 (1991).
[Crossref] [PubMed]

Turov, A.

E. Pokushalov, A. Romanov, G. Corbucci, S. Artyomenko, V. Baranova, A. Turov, N. Shirokova, A. Karaskov, S. Mittal, and J. S. Steinberg, “A randomized comparison of pulmonary vein isolation with versus without concomitant renal artery denervation in patients with refractory symptomatic atrial fibrillation and resistant hypertension,” J. Am. Coll. Cardiol. 60(13), 1163–1170 (2012).
[Crossref] [PubMed]

van der Steen, A. F. W.

van Dusschoten, A.

M. Wright, E. Harks, S. Deladi, F. Suijver, M. Barley, A. van Dusschoten, S. Fokkenrood, F. Zuo, F. Sacher, M. Hocini, M. Haïssaguerre, and P. Jaïs, “Real-time lesion assessment using a novel combined ultrasound and radiofrequency ablation catheter,” Heart Rhythm 8(2), 304–312 (2011).
[Crossref] [PubMed]

van Gemert, M. J.

R. H. Bremmer, A. Nadort, T. G. van Leeuwen, M. J. van Gemert, and M. C. Aalders, “Age estimation of blood stains by hemoglobin derivative determination using reflectance spectroscopy,” Forensic Sci. Int. 206(1-3), 166–171 (2011).
[Crossref] [PubMed]

A. M. Nilsson, G. W. Lucassen, W. Verkruysse, S. Andersson-Engels, and M. J. van Gemert, “Changes in optical properties of human whole blood in vitro due to slow heating,” Photochem. Photobiol. 65(2), 366–373 (1997).
[Crossref] [PubMed]

van Leeuwen, T. G.

R. H. Bremmer, A. Nadort, T. G. van Leeuwen, M. J. van Gemert, and M. C. Aalders, “Age estimation of blood stains by hemoglobin derivative determination using reflectance spectroscopy,” Forensic Sci. Int. 206(1-3), 166–171 (2011).
[Crossref] [PubMed]

van Soest, G.

Vega, M.

N. Pérez-Castellano, J. Villacastín, J. Salinas, M. Vega, J. Moreno, M. Doblado, E. Ruiz, and C. Macaya, “Epicardial connections between the pulmonary veins and left atrium: relevance for atrial fibrillation ablation,” J. Cardiovasc. Electrophysiol. 22(2), 149–159 (2011).
[PubMed]

Vergara, G. R.

G. R. Vergara, S. Vijayakumar, E. G. Kholmovski, J. J. Blauer, M. A. Guttman, C. Gloschat, G. Payne, K. Vij, N. W. Akoum, M. Daccarett, C. J. McGann, R. S. Macleod, and N. F. Marrouche, “Real-time magnetic resonance imaging-guided radiofrequency atrial ablation and visualization of lesion formation at 3 Tesla,” Heart Rhythm 8(2), 295–303 (2011).
[Crossref] [PubMed]

Verkruysse, W.

A. M. Nilsson, G. W. Lucassen, W. Verkruysse, S. Andersson-Engels, and M. J. van Gemert, “Changes in optical properties of human whole blood in vitro due to slow heating,” Photochem. Photobiol. 65(2), 366–373 (1997).
[Crossref] [PubMed]

Verma, A.

A. Verma, C. Y. Jiang, T. R. Betts, J. Chen, I. Deisenhofer, R. Mantovan, L. Macle, C. A. Morillo, W. Haverkamp, R. Weerasooriya, J. P. Albenque, S. Nardi, E. Menardi, P. Novak, P. Sanders, and STAR AF II Investigators, “Approaches to catheter ablation for persistent atrial fibrillation,” N. Engl. J. Med. 372(19), 1812–1822 (2015).
[Crossref] [PubMed]

Vij, K.

G. R. Vergara, S. Vijayakumar, E. G. Kholmovski, J. J. Blauer, M. A. Guttman, C. Gloschat, G. Payne, K. Vij, N. W. Akoum, M. Daccarett, C. J. McGann, R. S. Macleod, and N. F. Marrouche, “Real-time magnetic resonance imaging-guided radiofrequency atrial ablation and visualization of lesion formation at 3 Tesla,” Heart Rhythm 8(2), 295–303 (2011).
[Crossref] [PubMed]

Vijayakumar, S.

G. R. Vergara, S. Vijayakumar, E. G. Kholmovski, J. J. Blauer, M. A. Guttman, C. Gloschat, G. Payne, K. Vij, N. W. Akoum, M. Daccarett, C. J. McGann, R. S. Macleod, and N. F. Marrouche, “Real-time magnetic resonance imaging-guided radiofrequency atrial ablation and visualization of lesion formation at 3 Tesla,” Heart Rhythm 8(2), 295–303 (2011).
[Crossref] [PubMed]

Villacastín, J.

N. Pérez-Castellano, J. Villacastín, J. Salinas, M. Vega, J. Moreno, M. Doblado, E. Ruiz, and C. Macaya, “Epicardial connections between the pulmonary veins and left atrium: relevance for atrial fibrillation ablation,” J. Cardiovasc. Electrophysiol. 22(2), 149–159 (2011).
[PubMed]

Vink, J. Y.

Wang, H.

Wang, P. J.

A. Garan, A. Al-Ahmad, T. Mihalik, C. Cartier, L. Capuano, D. Holtan, C. Song, M. K. Homoud, M. S. Link, N. A. Estes, and P. J. Wang, “Cryoablation of the pulmonary veins using a novel balloon catheter,” J. Interv. Card. Electrophysiol. 15(2), 79–81 (2006).
[Crossref] [PubMed]

Wang, Y. T.

Wang, Z.

Wapner, R. J.

Weerasooriya, R.

A. Verma, C. Y. Jiang, T. R. Betts, J. Chen, I. Deisenhofer, R. Mantovan, L. Macle, C. A. Morillo, W. Haverkamp, R. Weerasooriya, J. P. Albenque, S. Nardi, E. Menardi, P. Novak, P. Sanders, and STAR AF II Investigators, “Approaches to catheter ablation for persistent atrial fibrillation,” N. Engl. J. Med. 372(19), 1812–1822 (2015).
[Crossref] [PubMed]

Whang, W.

R. P. Singh-Moon, X. Yao, V. Iyer, C. Marboe, W. Whang, and C. P. Hendon, “Real-time optical spectroscopic monitoring of non-irrigated lesion progression within atrial and ventricular tissues,” J. Biophotonics 12, 201800144 (2018).
[PubMed]

Wilson, B. C.

S. T. Flock, M. S. Patterson, B. C. Wilson, and D. R. Wyman, “Monte Carlo modeling of light propagation in highly scattering tissue--I: Model predictions and comparison with diffusion theory,” IEEE Trans. Biomed. Eng. 36(12), 1162–1168 (1989).
[Crossref] [PubMed]

Wolf, P. A.

E. J. Benjamin, P. A. Wolf, R. B. D’Agostino, H. Silbershatz, W. B. Kannel, and D. Levy, “Impact of atrial fibrillation on the risk of death: the Framingham Heart Study,” Circulation 98(10), 946–952 (1998).
[Crossref] [PubMed]

P. A. Wolf, R. D. Abbott, and W. B. Kannel, “Atrial fibrillation as an independent risk factor for stroke: the Framingham Study,” Stroke 22(8), 983–988 (1991).
[Crossref] [PubMed]

Wood, M. A.

M. A. Wood, “Exposing gaps in linear radiofrequency lesions: form before function,” Circ Arrhythm Electrophysiol 4(3), 257–259 (2011).
[Crossref] [PubMed]

Woollett, I.

S. R. Dukkipati, F. Cuoco, I. Kutinsky, A. Aryana, T. D. Bahnson, D. Lakkireddy, I. Woollett, Z. F. Issa, A. Natale, V. Y. Reddy, and HeartLight Study Investigators, “Pulmonary Vein Isolation Using the Visually Guided Laser Balloon: A Prospective, Multicenter, and Randomized Comparison to Standard Radiofrequency Ablation,” J. Am. Coll. Cardiol. 66(12), 1350–1360 (2015).
[Crossref] [PubMed]

Wright, G. A.

H. Celik, V. Ramanan, J. Barry, S. Ghate, V. Leber, S. Oduneye, Y. Gu, M. Jamali, N. Ghugre, J. A. Stainsby, M. Shurrab, E. Crystal, and G. A. Wright, “Intrinsic contrast for characterization of acute radiofrequency ablation lesions,” Circ Arrhythm Electrophysiol 7(4), 718–727 (2014).
[Crossref] [PubMed]

Wright, M.

M. Wright, E. Harks, S. Deladi, F. Suijver, M. Barley, A. van Dusschoten, S. Fokkenrood, F. Zuo, F. Sacher, M. Hocini, M. Haïssaguerre, and P. Jaïs, “Real-time lesion assessment using a novel combined ultrasound and radiofrequency ablation catheter,” Heart Rhythm 8(2), 304–312 (2011).
[Crossref] [PubMed]

Wyman, D. R.

S. T. Flock, M. S. Patterson, B. C. Wilson, and D. R. Wyman, “Monte Carlo modeling of light propagation in highly scattering tissue--I: Model predictions and comparison with diffusion theory,” IEEE Trans. Biomed. Eng. 36(12), 1162–1168 (1989).
[Crossref] [PubMed]

Yao, W.

Yao, X.

R. P. Singh-Moon, X. Yao, V. Iyer, C. Marboe, W. Whang, and C. P. Hendon, “Real-time optical spectroscopic monitoring of non-irrigated lesion progression within atrial and ventricular tissues,” J. Biophotonics 12, 201800144 (2018).
[PubMed]

X. Yao, Y. Gan, Y. Ling, C. C. Marboe, and C. P. Hendon, “Multicontrast endomyocardial imaging by single-channel high-resolution cross-polarization optical coherence tomography,” J. Biophotonics 11(4), e201700204 (2018).
[Crossref] [PubMed]

Zilberman, I.

E. Leshem, I. Zilberman, C. M. Tschabrunn, M. Barkagan, F. M. Contreras-Valdes, A. Govari, and E. Anter, “High-Power and Short-Duration Ablation for Pulmonary Vein Isolation: Biophysical Characterization,” JACC Clin. Electrophysiol. 4(4), 467–479 (2018).
[Crossref] [PubMed]

Zuo, F.

M. Wright, E. Harks, S. Deladi, F. Suijver, M. Barley, A. van Dusschoten, S. Fokkenrood, F. Zuo, F. Sacher, M. Hocini, M. Haïssaguerre, and P. Jaïs, “Real-time lesion assessment using a novel combined ultrasound and radiofrequency ablation catheter,” Heart Rhythm 8(2), 304–312 (2011).
[Crossref] [PubMed]

Zviman, M. M.

S. Nazarian, A. Kolandaivelu, M. M. Zviman, G. R. Meininger, R. Kato, R. C. Susil, A. Roguin, T. L. Dickfeld, H. Ashikaga, H. Calkins, R. D. Berger, D. A. Bluemke, A. C. Lardo, and H. R. Halperin, “Feasibility of real-time magnetic resonance imaging for catheter guidance in electrophysiology studies,” Circulation 118(3), 223–229 (2008).
[Crossref] [PubMed]

Acad. Radiol. (1)

S. N. Goldberg, G. S. Gazelle, E. F. Halpern, W. J. Rittman, P. R. Mueller, and D. I. Rosenthal, “Radiofrequency tissue ablation: importance of local temperature along the electrode tip exposure in determining lesion shape and size,” Acad. Radiol. 3(3), 212–218 (1996).
[Crossref] [PubMed]

Am. J. Cardiol. (1)

P. Jaïs, D. C. Shah, M. Haïssaguerre, A. Takahashi, T. Lavergne, M. Hocini, S. Garrigue, S. S. Barold, P. Le Métayer, and J. Clémenty, “Efficacy and safety of septal and left-atrial linear ablation for atrial fibrillation,” Am. J. Cardiol. 84(9), 139R–146R (1999).
[Crossref] [PubMed]

Am. J. Physiol. Heart Circ. Physiol. (1)

M. Mercader, L. Swift, S. Sood, H. Asfour, M. Kay, and N. Sarvazyan, “Use of endogenous NADH fluorescence for real-time in situ visualization of epicardial radiofrequency ablation lesions and gaps,” Am. J. Physiol. Heart Circ. Physiol. 302(10), H2131–H2138 (2012).
[Crossref] [PubMed]

Appl. Opt. (1)

Arch. Intern. Med. (1)

W. M. Feinberg, J. L. Blackshear, A. Laupacis, R. Kronmal, and R. G. Hart, “Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications,” Arch. Intern. Med. 155(5), 469–473 (1995).
[Crossref] [PubMed]

Biomed. Opt. Express (4)

Circ Arrhythm Electrophysiol (2)

H. Celik, V. Ramanan, J. Barry, S. Ghate, V. Leber, S. Oduneye, Y. Gu, M. Jamali, N. Ghugre, J. A. Stainsby, M. Shurrab, E. Crystal, and G. A. Wright, “Intrinsic contrast for characterization of acute radiofrequency ablation lesions,” Circ Arrhythm Electrophysiol 7(4), 718–727 (2014).
[Crossref] [PubMed]

M. A. Wood, “Exposing gaps in linear radiofrequency lesions: form before function,” Circ Arrhythm Electrophysiol 4(3), 257–259 (2011).
[Crossref] [PubMed]

Circulation (3)

E. J. Benjamin, P. A. Wolf, R. B. D’Agostino, H. Silbershatz, W. B. Kannel, and D. Levy, “Impact of atrial fibrillation on the risk of death: the Framingham Heart Study,” Circulation 98(10), 946–952 (1998).
[Crossref] [PubMed]

R. J. Lederman, M. A. Guttman, D. C. Peters, R. B. Thompson, J. M. Sorger, A. J. Dick, V. K. Raman, and E. R. McVeigh, “Catheter-based endomyocardial injection with real-time magnetic resonance imaging,” Circulation 105(11), 1282–1284 (2002).
[Crossref] [PubMed]

S. Nazarian, A. Kolandaivelu, M. M. Zviman, G. R. Meininger, R. Kato, R. C. Susil, A. Roguin, T. L. Dickfeld, H. Ashikaga, H. Calkins, R. D. Berger, D. A. Bluemke, A. C. Lardo, and H. R. Halperin, “Feasibility of real-time magnetic resonance imaging for catheter guidance in electrophysiology studies,” Circulation 118(3), 223–229 (2008).
[Crossref] [PubMed]

Forensic Sci. Int. (1)

R. H. Bremmer, A. Nadort, T. G. van Leeuwen, M. J. van Gemert, and M. C. Aalders, “Age estimation of blood stains by hemoglobin derivative determination using reflectance spectroscopy,” Forensic Sci. Int. 206(1-3), 166–171 (2011).
[Crossref] [PubMed]

Heart Rhythm (4)

H. Ahmed, P. Neuzil, J. Skoda, J. Petru, L. Sediva, S. Kralovec, and V. Y. Reddy, “Initial clinical experience with a novel visualization and virtual electrode radiofrequency ablation catheter to treat atrial flutter,” Heart Rhythm 8(3), 361–367 (2011).
[Crossref] [PubMed]

G. R. Vergara, S. Vijayakumar, E. G. Kholmovski, J. J. Blauer, M. A. Guttman, C. Gloschat, G. Payne, K. Vij, N. W. Akoum, M. Daccarett, C. J. McGann, R. S. Macleod, and N. F. Marrouche, “Real-time magnetic resonance imaging-guided radiofrequency atrial ablation and visualization of lesion formation at 3 Tesla,” Heart Rhythm 8(2), 295–303 (2011).
[Crossref] [PubMed]

M. Wright, E. Harks, S. Deladi, F. Suijver, M. Barley, A. van Dusschoten, S. Fokkenrood, F. Zuo, F. Sacher, M. Hocini, M. Haïssaguerre, and P. Jaïs, “Real-time lesion assessment using a novel combined ultrasound and radiofrequency ablation catheter,” Heart Rhythm 8(2), 304–312 (2011).
[Crossref] [PubMed]

L. M. Swift, H. Asfour, N. Muselimyan, C. Larson, K. Armstrong, and N. A. Sarvazyan, “Hyperspectral imaging for label-free in vivo identification of myocardial scars and sites of radiofrequency ablation lesions,” Heart Rhythm 15(4), 564–575 (2018).
[Crossref] [PubMed]

IEEE Trans. Biomed. Eng. (1)

S. T. Flock, M. S. Patterson, B. C. Wilson, and D. R. Wyman, “Monte Carlo modeling of light propagation in highly scattering tissue--I: Model predictions and comparison with diffusion theory,” IEEE Trans. Biomed. Eng. 36(12), 1162–1168 (1989).
[Crossref] [PubMed]

Innovations in Cardiac Rhythm Management (1)

C. P. Fleming, N. Rosenthal, A. M. Rollins, and M. M. Arruda, “First in vivo real-time imaging of endocardial radiofrequency ablation by optical coherence tomography: Implications on safety and the birth of “electrostructuralsubstrate-guided ablation”,” Innovations in Cardiac Rhythm Management 2, 199–201 (2011).

J. Am. Coll. Cardiol. (2)

E. Pokushalov, A. Romanov, G. Corbucci, S. Artyomenko, V. Baranova, A. Turov, N. Shirokova, A. Karaskov, S. Mittal, and J. S. Steinberg, “A randomized comparison of pulmonary vein isolation with versus without concomitant renal artery denervation in patients with refractory symptomatic atrial fibrillation and resistant hypertension,” J. Am. Coll. Cardiol. 60(13), 1163–1170 (2012).
[Crossref] [PubMed]

S. R. Dukkipati, F. Cuoco, I. Kutinsky, A. Aryana, T. D. Bahnson, D. Lakkireddy, I. Woollett, Z. F. Issa, A. Natale, V. Y. Reddy, and HeartLight Study Investigators, “Pulmonary Vein Isolation Using the Visually Guided Laser Balloon: A Prospective, Multicenter, and Randomized Comparison to Standard Radiofrequency Ablation,” J. Am. Coll. Cardiol. 66(12), 1350–1360 (2015).
[Crossref] [PubMed]

J. Am. Heart Assoc. (1)

A. N. Ganesan, N. J. Shipp, A. G. Brooks, P. Kuklik, D. H. Lau, H. S. Lim, T. Sullivan, K. C. Roberts-Thomson, and P. Sanders, “Long-term outcomes of catheter ablation of atrial fibrillation: a systematic review and meta-analysis,” J. Am. Heart Assoc. 2(2), e004549 (2013).
[Crossref] [PubMed]

J. Biol. Chem. (1)

W. J. Bowen, “The absorption spectra and extinction coefficients of myoglobin,” J. Biol. Chem. 179(1), 235–245 (1949).
[PubMed]

J. Biomed. Opt. (1)

Y. Gan, D. Tsay, S. B. Amir, C. C. Marboe, and C. P. Hendon, “Automated classification of optical coherence tomography images of human atrial tissue,” J. Biomed. Opt. 21(10), 101407 (2016).
[Crossref] [PubMed]

J. Biophotonics (3)

D. A. Gil, L. M. Swift, H. Asfour, N. Muselimyan, M. A. Mercader, and N. A. Sarvazyan, “Autofluorescence hyperspectral imaging of radiofrequency ablation lesions in porcine cardiac tissue,” J. Biophotonics 10(8), 1008–1017 (2017).
[Crossref] [PubMed]

R. P. Singh-Moon, X. Yao, V. Iyer, C. Marboe, W. Whang, and C. P. Hendon, “Real-time optical spectroscopic monitoring of non-irrigated lesion progression within atrial and ventricular tissues,” J. Biophotonics 12, 201800144 (2018).
[PubMed]

X. Yao, Y. Gan, Y. Ling, C. C. Marboe, and C. P. Hendon, “Multicontrast endomyocardial imaging by single-channel high-resolution cross-polarization optical coherence tomography,” J. Biophotonics 11(4), e201700204 (2018).
[Crossref] [PubMed]

J. Cardiovasc. Electrophysiol. (4)

M. A. Mitchell, I. D. McRury, T. H. Everett, H. Li, J. M. Mangrum, and D. E. Haines, “Morphological and physiological characteristics of discontinuous linear atrial ablations during atrial pacing and atrial fibrillation,” J. Cardiovasc. Electrophysiol. 10(3), 378–386 (1999).
[Crossref] [PubMed]

N. Pérez-Castellano, J. Villacastín, J. Salinas, M. Vega, J. Moreno, M. Doblado, E. Ruiz, and C. Macaya, “Epicardial connections between the pulmonary veins and left atrium: relevance for atrial fibrillation ablation,” J. Cardiovasc. Electrophysiol. 22(2), 149–159 (2011).
[PubMed]

M. Antz, K. R. Chun, F. Ouyang, and K. H. Kuck, “Ablation of atrial fibrillation in humans using a balloon-based ablation system: identification of the site of phrenic nerve damage using pacing maneuvers and CARTO,” J. Cardiovasc. Electrophysiol. 17(11), 1242–1245 (2006).
[Crossref] [PubMed]

S. Nath, J. P. DiMarco, and D. E. Haines, “Basic aspects of radiofrequency catheter ablation,” J. Cardiovasc. Electrophysiol. 5(10), 863–876 (1994).
[Crossref] [PubMed]

J. Interv. Card. Electrophysiol. (1)

A. Garan, A. Al-Ahmad, T. Mihalik, C. Cartier, L. Capuano, D. Holtan, C. Song, M. K. Homoud, M. S. Link, N. A. Estes, and P. J. Wang, “Cryoablation of the pulmonary veins using a novel balloon catheter,” J. Interv. Card. Electrophysiol. 15(2), 79–81 (2006).
[Crossref] [PubMed]

JACC Clin. Electrophysiol. (1)

E. Leshem, I. Zilberman, C. M. Tschabrunn, M. Barkagan, F. M. Contreras-Valdes, A. Govari, and E. Anter, “High-Power and Short-Duration Ablation for Pulmonary Vein Isolation: Biophysical Characterization,” JACC Clin. Electrophysiol. 4(4), 467–479 (2018).
[Crossref] [PubMed]

JAMA (1)

A. S. Go, E. M. Hylek, K. A. Phillips, Y. Chang, L. E. Henault, J. V. Selby, and D. E. Singer, “Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study,” JAMA 285(18), 2370–2375 (2001).
[Crossref] [PubMed]

Lasers Surg. Med. (1)

R. Splinter, R. H. Svenson, L. Littmann, J. R. Tuntelder, C. H. Chuang, G. P. Tatsis, and M. Thompson, “Optical properties of normal, diseased, and laser photocoagulated myocardium at the Nd: YAG wavelength,” Lasers Surg. Med. 11(2), 117–124 (1991).
[Crossref] [PubMed]

Med. Biol. Eng. Comput. (1)

J. Swartling, S. Pålsson, P. Platonov, S. B. Olsson, and S. Andersson-Engels, “Changes in tissue optical properties due to radio-frequency ablation of myocardium,” Med. Biol. Eng. Comput. 41(4), 403–409 (2003).
[Crossref] [PubMed]

N. Engl. J. Med. (1)

A. Verma, C. Y. Jiang, T. R. Betts, J. Chen, I. Deisenhofer, R. Mantovan, L. Macle, C. A. Morillo, W. Haverkamp, R. Weerasooriya, J. P. Albenque, S. Nardi, E. Menardi, P. Novak, P. Sanders, and STAR AF II Investigators, “Approaches to catheter ablation for persistent atrial fibrillation,” N. Engl. J. Med. 372(19), 1812–1822 (2015).
[Crossref] [PubMed]

Opt. Express (2)

Opt. Lett. (1)

Pacing Clin. Electrophysiol. (1)

V. Y. Reddy, C. Houghtaling, J. Fallon, G. Fischer, N. Farr, J. Clarke, J. McIntyre, E. Sinofsky, J. N. Ruskin, and D. Keane, “Use of a diode laser balloon ablation catheter to generate circumferential pulmonary venous lesions in an open-thoracotomy caprine model,” Pacing Clin. Electrophysiol. 27(1), 52–57 (2004).
[Crossref] [PubMed]

Photochem. Photobiol. (1)

A. M. Nilsson, G. W. Lucassen, W. Verkruysse, S. Andersson-Engels, and M. J. van Gemert, “Changes in optical properties of human whole blood in vitro due to slow heating,” Photochem. Photobiol. 65(2), 366–373 (1997).
[Crossref] [PubMed]

Phys. Med. Biol. (1)

S. L. Jacques, “Optical properties of biological tissues: a review,” Phys. Med. Biol. 58(11), R37–R61 (2013).
[Crossref] [PubMed]

PLoS One (1)

N. Muselimyan, L. M. Swift, H. Asfour, T. Chahbazian, R. Mazhari, M. A. Mercader, and N. A. Sarvazyan, “Seeing the Invisible: Revealing Atrial Ablation Lesions Using Hyperspectral Imaging Approach,” PLoS One 11(12), e0167760 (2016).
[Crossref] [PubMed]

Proc. Soc. Photo-Opt (1)

S. Thomsen, “Microscopic correlates of macroscopic optical property changes during thermal coagulation of myocardium,” Proc. Soc. Photo-Opt 1202, 2–10 (1990).

Stroke (1)

P. A. Wolf, R. D. Abbott, and W. B. Kannel, “Atrial fibrillation as an independent risk factor for stroke: the Framingham Study,” Stroke 22(8), 983–988 (1991).
[Crossref] [PubMed]

Other (2)

“Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials,” Arch. Intern. Med.154(13), 1449–1457 (1994).
[Crossref] [PubMed]

J. de Vries, “Barrel and pincushion lens distortion correction,” MATLAB Central File Exchange (2012).

Cited By

OSA participates in Crossref's Cited-By Linking service. Citing articles from OSA journals and other participating publishers are listed here.

Alert me when this article is cited.


Figures (10)

Fig. 1
Fig. 1 Dominant cardiac chromophores used to approximate a single absorption coefficient spectrum. All chromophores were found in published literature. Oxyhemoglobin ( Hb O 2 ) a,  b&c ; deoxyhemoglobin ( Hb ) a,  b&c ; oxymyoglobin   ( Mb O 2 ) a,  b&c ; metmyoglobin   ( MMb ) a,  b&c ; water   ( H 2 O ) a ; hemichrome ( HC ) d and lipi d b . . a obtained from [34]; . b obtained from [35]; . c obtained from [36].; . d obtained from [37].
Fig. 2
Fig. 2 A schematic diagram of endoscopic multispectral imaging system. The system is optically enclosed to block light interference during the experiment. A) shows reference data set of spectrally flat reflectance surface. B) displays raw data of ablated tissue with three lesions taken with the system. Two lesions are shown with light concentrated on the center but are hard to locate exactly all three lesions. In C), normalized image of swine left atrial tissue with three lesions is shown. D) shows distortion corrected image. Since it is difficult to see the correction, a sample grid is shown in E) and F). Image magnification decreases with distance from the center.
Fig. 3
Fig. 3 Experiment procedure and sample preparation flow chart is shown. In A), Fresh swine hearts are retrieved and placed on ice prior to experiment. The pulmonary veins were dissected free from the rest of the heart B) shows experimental setup used for creating lesions using commercial radio-frequency ablation system under phosphate buffered saline. C) displays lesions with gaps created along the pulmonary vein. Image data set acquired from endoscopic multispectral imaging system. Tissue samples are submerged under warm PBS and laid flat as possible. One data set includes images from five specific wavelength channels: 450 nm, 550nm, 625 nm, 810 nm, and 940 nm. D) represents gross pathology of lesion cross-section stained in TTC vital stain and shows Masson’s Trichrome stating of transmural lesion. Dash line highlights the areas of tissue necrosis.
Fig. 4
Fig. 4 Flow chart of main data processing procedure. Images are first calibrated using reference data set and are corrected for barrel distortion and saturation. Images are stitched to create one full data set for each LA sample. Images are manually segmented for each tissue types using RGB image. Classifier is tested and validated using leave-one-out cross validation (LOOCV).
Fig. 5
Fig. 5 Aberration corrected and stitched swine LA tissue sample. A) shows RGB composite image of swine sample with 2 ablated lesions: 1 transmural and 1 non-transmural lesions. B) and C) channel illuminates pulmonary vein and thick endocardium. Lesion contours show high reflectance, but the cores are heavily absorbent. D) shows contrast between the lesion core and the periphery but does not show significant contrast in PV. E) and F) channels reflect less around PV and lesions do not show cores. A full data set includes all five spectral data.
Fig. 6
Fig. 6 Statistical analysis of five wavelength-specific data. Mean relative reflectance values of each segmented normal tissue, pulmonary vein, transmural, and non-transmural lesions were analyzed using ANOVA with Turkey’s multiple comparison test. The number of samples for all tissue types are as follows: 64 transmural, 15 non-transmural lesions, 48 pulmonary vein, 61 normal regions. Boxes represent mean and standard deviations and whiskers indicate the range for each reflectance channel. ** (p < 0.01), *** (p < 0.001), **** (p < 0.0001)
Fig. 7
Fig. 7 Statistical analysis of LOI 1 and LOI 2 is shown at the top. Two pairs show the most significant pairs out of all ratiometric parameters. Boxes represent mean and standard deviations and whiskers indicate the range for each reflectance channel. ** (p < 0.01), *** (p < 0.001), **** (p < 0.0001). The ratiometric maps of LOI 1 and LOI 2 are presented at the bottom.
Fig. 8
Fig. 8 Reconstructed classified image with probability distributions from each tissue type. (A-F) shows an example set with lesion line formed along the PV. A) shows RGB image captured through the system with appropriate labels. B) Pixel by pixel QDA classifier identifies where pulmonary vein exists. C) illustrates normal tissue’s probability distribution of the classifier. D) and E) are probability distributions of transmural and non-transmural lesions respectively. In F), each pixel values are classified to a corresponding tissue type. (G-L) shows direct comparison study of transmural and non-transmural lesions.
Fig. 9
Fig. 9 A) shows a human left atrium captured with digital camera (Nikon). Three irrigated transmural lesions are generated using RF catheter with saline port. B) represents histology of transmural lesion. Ablated areas are more purple relative to normal tissue. C) shows histology of normal tissue. Thicker endocardium is shown in human sample.
Fig. 10
Fig. 10 A) is an RGB composite image of human LA tissue sample with three irrigated lesions. B-F are the five spectral channels collected through our optical system. In all wavelength channels, irrigated lesions are difficult to locate without LOIs. In G), LOI 1 parameter highlights the three irrigated lesions that weren’t visible within individual wavelength channels shown in B-F. Also, gap between two lesions is clearly viewed. In H), LOI 2 map bears little to no lesion contrast.

Tables (3)

Tables Icon

Table 1 Optical depth penetration estimates from diffusion theory

Tables Icon

Table 2 Confusion matrix of QDA classifier based on reflectance

Tables Icon

Table 3 Confusion matrix of QDA classifier based on reflectance and LOI features

Equations (2)

Equations on this page are rendered with MathJax. Learn more.

LO I 1 = 625nm 940nm #
LO I 2 = 530nm 450nm #

Metrics